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Abstract 
 
Human epidemiological studies have indentified obesity as an independent risk factor for renal 
disease. In addition, maternal nutrient restriction (MNR) during gestation results in a series of 
adaptations that may predispose those offspring to obesity and hypertension. Recent reports 
demonstrated that obese sheep exposed to MNR during early to mid gestation have a 
predisposition to ectopic lipid deposition in the heart and a rise in necrotic adipocytes, which are 
markers of severe metabolic dysfunction. Surprisingly, in this model of MNR, the renal tissue of 
those offspring showed an apparent reduction in cell apoptosis. However, renal diseases 
associated with obesity have a slow progression and their mechanisms are not completely 
understood. In the light of these results, the main hypothesis of my thesis is that the renal 
amelioration observed in those nutrient restricted (NR) obese offspring is a product of post-
injury responses, inducing scarring and others adaptations to obesity. Therefore, some of the 
main regulatory factors in renal and perirenal adipose tissue (PAT) development were analysed 
in seven-day-old and one-year-old obese sheep offspring exposed to MNR (3.5 KJ/days) from 
WRJHVWDWLRQDOGD\VWHUP§GD\V 
At one week of age, the renal composition and gene expression showed small changes between 
NR offspring and those born to control mothers. However, in PAT of NR offspring, an increased 
in expression of the methyltransferase DNMT-1 and a decrease in mRNA abundance of IGF-2 
were observed.  
At six months of age, obesity onset was accompanied by raised plasma cortisol and leptin 
concentration in NR offspring compared to control. By one year of age, whilst plasma leptin 
concentration was similar between the obese groups, in the PAT of the NR offspring there was 
an increase in gene expression of pro-inflammatory factors and DNMT-1, suggesting advanced 
adipose tissue remodelling. In kidney, regardless of in utero diet, obesity induced similar 
amounts of oxidative stress, activation of cellular proliferative factors and collagen deposition. 
Although, both obese groups had equal activation of pro-apoptotic factors (e.g p-53 and Bax), 
renal iron and mRNA abundance of the death receptor, Fas only increased in obese offspring 
born to control fed mothers. A major finding in the NR kidney was increased ectopic 
triglyceride deposition, indicating early onset post-injury in response to sympathetic activation 
and lipotoxity.  
The main conclusion of my thesis is that functional changes observed in the adipose tissue lead 
the kidney to an initial cycle of cell proliferation, apoptosis and arrest, followed by tissue 
remodelling, characterised by the presence of collagen. However, this adaptation to obesity is 
accompanied by an increase in lipid deposition in the kidney of the NR group that may be a sign 
of an advanced state of metabolic dysfunction. 
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 Chapter 1 - Introduction 
 
1.1 Maternal nutritional status during pregnancy and its influence on offspring 
in later life 
1.1.1 Early life nutrition and its influence on adult development 
In humans, as with other animals, health and life span are sensitive to external 
environmental conditions. Variation in nutrition at different stages of development 
might play an important part in overcoming health problems. Numerous human 
epidemiological and animal studies have suggested that early nutrition modulates the 
physiological response to an environmental challenge by reducing susceptibility to 
chronic diseases in adulthood (Stein et al., 1996). 
A landmark publication by Kermack et al., analysing the rise in life expectancy in 
Sweden and the United Kingdom between 1751 and 1930, concluded that the improved 
welfare of infants and adolescents was the strongest determining factor of non-
transmissible diseases in later life (Kermack et al., 2001). Other research conducted by 
Forsdahl also supported this finding and added that children and adolescents exposed to 
significant poverty, followed by a period of prosperity, are also at high risk of 
developing chronic heart disease in later life (Forsdahl, 1977). In the early 20th century, 
the impact of improved infant dietary patterns was recognised as one factor in the 
gradual reduction in cardiovascular mortality in adulthood in the industrialised world 
(Barker et al., 1992). 
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Studies on the effects of early nutrition also include the maternal environment 
during the different stages of pregnancy in humans (Painter et al., 2005). For instance, 
the effects of poor nutrition during pregnancy, which may affect fetal and infant 
development, were associated with an increased risk of cardiovascular disease in 
offspring in adulthood. In 1986, Baker et al. noted a similarity between the geographical 
distribution of stroke and cardiovascular diseases (1968-78) and neonatal mortality 
records (1921-5) in England and Wales (Barker & Osmond, 1986). This study was the 
first to demonstrate the potential importance of fetal development as a risk factor for 
heart disease in later life. Epidemiological studies of offspring exposed to the Dutch 
Famine (1944-5) confirmed these findings, adding that perinatal, and later infant, 
nutrition both influence adult body mass index (BMI), cardiovascular disease, cognitive 
disorders and other chronic diseases (Roseboom et al., 2000; Painter et al., 2005). In 
2000, Law et al. reported that blood pressure was inversely proportionate to body size at 
birth among children born in several developing countries commonly affected by 
maternal undernutrition (Law et al., 2001). Furthermore, past studies conducted in 
Western countries have shown that this pattern in blood pressure persists into adulthood, 
even without an increase in body weight (Barker et al., 1989; Osmond et al., 1993). 
Additional epidemiological human observations and animal models have strongly 
suggested that perinatal and early life growth affects the predisposition to adult obesity, 
cardiovascular diseases and type 2 diabetes in later life (Hales et al., 1991) . 
1.1.2 The thrifty phenotype and other hypotheses 
 In an attempt to unify several human epidemiological and animal studies with 
long term chronic diseases associated with exposure to suboptimal fetal and neonatal 
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environments, a number of hypotheses have been proposed. In 1991, Lucas proposed the 
SULQFLSOH RI µfetal programming¶ (Lucas, 1998). This term describes the link between 
adaptive responses in the offspring to an insult generated during pregnancy, including 
malnutrition, resulting in long term physiological or somatic consequences. Later, in 
1992, Barker & Hales et alSURGXFHGDWKHRU\WHUPHGWKHµthrifty phenotype hypothesis¶
(Hales & Barker, 2001). The central proposal of this hypothesis is that it is possible to 
trace the sources of the metabolic syndrome back from adulthood to a maternal 
suboptimal environment (including diet) during pregnancy or early infancy. As a 
consequence, early adaptations to malnutrition might, for example, reduce the secretion 
of insulin, affecting the activity of the insulin dependent organs and changing patterns of 
body development (Fig.1.1). Such observations may explain the effects of exposure to 
suboptimal diet during fetal growth, resulting in deficient development of pancreatic-ȕ
cell mass and function, which increases the risk of type 2 diabetes in later life (Hales et 
al., 1991; Ravelli et al., 1998; Petrik et al., 1999; Jaquet et al., 2000). It was proposed 
that such adaptations would become detrimental when, in later life, an individual is 
exposed to a richer diet than experienced in the prenatal environment. Thus, enhanced 
calorie intake in later life would induce glucose intolerance, leading to obesity.  
$ ODUJH ERG\ RI DQLPDO GDWD DQG KXPDQ VWXGLHV VXSSRUW WKH µthrifty phenotype 
hypothesis¶. The epidemiological data collected by Hale et al. showed that Hertfordshire 
men (1920-30) who were underweight at birth and in early infancy displayed an 
increased predisposition to impaired glucose tolerance and non-insulin dependent 
diabetes (Hales et al., 1991). Extensive studies, conducted on small and large mammals, 
show that malnutrition during pregnancy may have a permanent effect on pancreatic cell 
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insulin secretion, cognitive development and changes in blood pressure, leading to 
adverse effects on the longevity of the offspring (Petrik et al., 1999; Oliver et al., 2002; 
Erhard et al., 2004; Ozanne et al., 2005) ,Q DGGLWLRQ WKH FRQFHSWV RI µfetal 
programming¶ DQGµthrifty phenotype hypothesis¶ZHUHH[WHQGHGWRLQFOXGHWKHH[LVWHQFH
of critical or sensitive periods during pregnancy, during which the effects of these 
prenatal adaptations to a suboptimal intrauterine environment generate adverse 
outcomes for specific body tissues in later life (Hoek et al., 1998; Ravelli et al., 1998; 
Roseboom et al., 2000).  Evidence regarding the existence of such critical periods came 
from retrospective studies examining men and women who were in utero during the 
Dutch Famine. By dividing this entire period of gestational malnutrition into trimesters, 
it was possible to determine that different outcomes occurred, depending on the period 
of pregnancy in which the fetus was exposed to famine (Painter et al., 2005). Famine 
exposure during the first three months of gestation contributed to an increased risk in 
coronary heart disease and neurodevelopmental disorders in adulthood (Hoek et al., 
1998; Roseboom et al., 2000). Offspring who were exposed to the famine during the 
second trimester showed an increase in renal-vascular diseases (Painter et al., 2005). 
Finally, prenatal exposure to famine during late gestation resulted in low weight at birth 
and was associated with permanent changes in insulin-glucose metabolism and obesity 
in adults (Ravelli et al., 1998). 
In spite of the significant body of evidence from human and animal studies that 
validates this hypothesis, alternative explanations exist. In 2001, Frayling and Hattersley 
proposed the µfetal insulin hypothesis¶, suggesting that mutation of a single gene has two 
different independent outcomes: low birth weight and type 2-diabetes (Hattersley et al., 
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1998). One possible cause of insulin deficiency is the presence of a glucokinase 
autosomal recessive mutation in the fetus, which is associated with low weight at birth 
and reduction of insulin secretion. However, permanent glucokinase deficiency caused 
by this type of mutation is unusual. Studies conducted with low weight identical twins 
have demonstrated that their weight at birth is regulated by different independent genes 
(Njolstad et al., 2003).   
 
Figure 1.1 The original diagrammatic interpretation of the thrifty phenotype hypothesis by Hales 
and Barker 
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1.1.2.1 Fetal suboptimal nutritional environment as a future health factor 
As the Dutch Famine illustrated, there are critical windows in fetal development 
during which the maternal environment may cause irreversible alterations in growth and 
metabolism. These adaptations occur in response to specific nutritional conditions in 
early life which are limited to susceptible critical periods during early development and 
have a persistent life effect. In addition, their outcome can be specific and measurable, 
may differ among individuals and is a response to a specific maternal or postnatal 
environment (Waterland & Garza, 1999).  For instance, Painter et al., observed that, 
following exposure to the Dutch Famine during early-mid gestation, all newborns had a 
normal weight at birth. However, during adulthood, these individuals developed a series 
of specific health complications, which included a rise in microalbuminuria and airways 
obstruction (Painter et al., 2005).  
Human epidemiological studies report that maternal body status (age, weight and 
life style) and diet composition (micro and macro-nutrients) at the time of conception 
and during pregnancy can have a large influence on the offspring outcome (Naeye, 
1990; Christian et al., 2003; Olson et al., 2008). Godfrey et al. suggested that a high 
carbohydrate intake in early pregnancy suppresses placental growth, which limits the 
capacity of the mother to supply nutrients to the fetus and compromises its growth 
during late gestation (Godfrey et al., 1996). Several studies have demonstrated that 
perinatal mortality and other abnormalities are associated with high or low maternal 
body weight in comparison to normal weight mothers before or during pregnancy 
(Lechtig et al., 1975; Barker et al., 1990; Nucci et al., 2001; Olson et al., 2008). For 
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instance, excessive pregnancy weight gain may increase the risks of obesity in children 
(Olson et al., 2008).                   
Another important area of research in intrauterine growth is the role of 
micronutrients during pregnancy, which has not been fully elucidated. Individual 
micronutrients, such as folic acid, zinc, iron and vitamin A have received attention in 
several studies (Katz et al., 2000; Osendarp et al., 2000; Christian et al., 2003). Trials in 
malnourished populations in Peru and Bangladesh did not confirm an improvement in 
birth weight or neonatal mortality with antenatal zinc supplementation (Caulfield et al., 
1999; Osendarp et al., 2000). However, a large trial among malnourished rural 
communities in Nepal, which tested maternal supplementation with folic acid and iron, 
achieved a modest increase in birth weight (Christian et al., 2003). Iron supplementation 
in mothers suffering from anaemia is known to reduce the synthesis of cortcotropin 
releasing hormone, causing a reduction in fetal cortisol and consequential increased fetal 
growth. In addition, iron deficiency increases oxidative stress of erythrocytes and the 
fetoplacental unit, which may result in intrauterine growth retardation and preterm 
delivery (Allen, 2001). Finally, iron supplementation may increase maternal appetite 
and energy consumption during pregnancy, inducing fetal growth (Lawless et al., 1994; 
Allen, 2001).  
To many authors, it has become apparent that the nutritional status of the mother 
alters the metabolic features of the offspring, changing the functions of different key 
organs. One suggestion is that these adaptations prepare the newborn for survival under 
unfavourable nutritional conditions, such as famine. An alternative option is that these 
organs are simply immature and their final physiological readiness depends on the right 
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nutritional postnatal environment (Zidar et al., 1998; Bateson et al., 2004). However, it 
is important to analyse the real consequences of these adaptations of offspring in 
adulthood in such a nutritional environment. 
1.1.2.2  Adaptation to new nutritional environments 
The success of an adaptation to any environmental challenge, including changes in 
diet, can be achieved by a period of phenotypic modifications. Bateson et al. suggested 
that maternal physical and nutritional status is able to modify the chances of adaptation. 
In adverse circumstances, small size or underdeveloped organs and acute metabolic 
responses may be seen as advantageous for survival by reaching reproductive age faster, 
even if the consequence of this would be a reduction in lifespan (Bateson et al., 2004). 
For example, male offspring of maternal protein-restricted rats show normal glucose 
tolerance at an early age, but they mature faster than their controls, achieving adulthood 
more quickly. However, at 15 months of age, they show signs of advanced ageing by an 
increase in insulin secretion, poor glucose tolerance and a reduction in renal telomeres 
(Tarry-Adkins et al., 2006; Tarry-Adkins et al., 2009). Such responses could be seen as 
having short term advantages, but long term disadvantages, by accelerating the rate of 
the ageing process to environmental changes, such as an increase in food consumption. 
Following the µthrifty phenotype hypothesis¶, a poor prenatal environment and 
modifications in organ function, along with changes in nutrition, might generate an 
adverse adaptation in later life (Barker et al., 2002). Migrant or historically low income 
populations exposed to an excess of nutrition in adult life best illustrate these 
inappropriate adaptive responses. Additional associations between intrauterine 
deprivation and other physiological adaptations are found to increase the risk of 
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development of renal and cardiovascular diseases (Eriksson et al., 2001; Barker et al., 
2002; Jimenez-Cruz et al., 2003; Hoehner et al., 2006). High blood pressure was found 
to be prevalent in children and adults exposed to maternal and infant under-nutrition. 
Eriksson et al. reported that there is an association between early infant obesity and 
coronary heart disease, suggesting that its pathogenesis was influenced by events in 
utero (Eriksson et al., 2001). A study of Pima Indians, who were exposed to poor 
nutrition in early life in their communities, confirmed a positive association between 
increased access to food and the increased risk of type 2 diabetes and renal dysfunction 
in adulthood (Nelson et al., 1998). Moreover, poor intrauterine growth and the 
development of decreased glucose tolerance are linked with the rapid progression of 
kidney diseases and injuries, such as IgA nephropathy, membranous nephropathy and 
glomerulosclerosis. This suggests that these renal adaptations to unfavourable fetal-
maternal environment are not beneficial in the long term (Barker et al., 1989; Nelson et 
al., 1998; Zidar et al., 1998). 
1.1.3 The sheep as animal model for studies of maternal nutritional manipulation 
Epidemiological studies, as with other retrospective studies, have weaknesses that 
may limit their ability to provide definitive answers. The choice of methodology used to 
quantify and analyse data, the time between exposure to variables and measurable 
RXWFRPHV DVZHOO DV WKH UHVHDUFKHU¶VSHUVSHFWLYHPD\ OHDG WRYDULDEOH LQWHUSUHWDWLRQV
(Wadsworth et al., 1985; Barker & Osmond, 1986; de Onis et al., 1998). For further 
investigation and to verify the biological relevance of such observations, it may be 
necessary to create and use animal models. 
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Thus, in an attempt to validate the epidemiological data and understand the 
biological mechanisms behind the association between maternal nutrition and long term 
metabolic changes in offspring, several animal models have been developed. These 
models employ a large number of techniques, including maternal nutrient restriction and 
hormonal insults in order to simulate similar conditions, as seen during the Dutch 
Famine (Ravelli et al. 1976).     
1.1.3.1 Prenatal nutrition manipulation in sheep and its consequences 
'XHWRLWVDELOLW\WRJHQHUDWHDQRIIVSULQJRIVLPLODUZHLJKWWRKXPDQQHZERUQV§
4.5 kg), with fully developed organs at birth, the sheep is one of the most reliable animal 
models for the study of the effects of prenatal undernutrition at specific stages of 
pregnancy (Symonds et al., 2007). 
Studies using the offspring of undernourished pregnant sheep mothers throughout 
all or late (around the final one-third of gestation; teUP§GD\VJHVWDWLRQVKRZHGD
reduction in weight at birth (Oliver et al., 2002). A global reduction in maternal 
QXWULWLRQLQWKHSHULRGRIODWHJHVWDWLRQWR0-SHUGD\§-0.05% of metabolic 
needs; 105 gestational days to term 145 days) affects the concentrations of fetal plasma 
glucose, decreasing the lean mass tissue as the main factor of weight loss in the newborn 
(Oliver et al., 2002). However, several groups demonstrated that maternal undernutrition 
0-G§RIPHWDEROLFQHHGVDURXQGHDUO\WRPLGJHVWDWLRQJHQHUDWHVSODFHQWDO
growth and morphological changes, without affecting weight at birth (Heasman et al., 
1998). Such alterations in placental development may reduce its capacity to transport 
supplies, compromising fetal organ development mainly in the later stages of gestation 
(Heasman et al., 1998; Bispham et al., 2003; Jaquiery et al., 2006).  
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 Maternal nutrient restriction impacts on metabolic programming in insulin-
sensitive tissues. Livers of 3-year-old offspring exposed to early to mid gestation 
nutrient restriction were disproportionately smaller to body weight and showed an 
increase in mRNA abundance of glucocorticoid receptor, which is possible evidence of 
reduced gluconeogenic activity. In addition, this adaptation includes an imbalance 
between mitogenic and pro-apoptotic mechanisms, such as a reduction in IGF hepatic 
sensitivity (Hyatt et al., 2007).  A reduction of maternal nutrition during late gestation 
also showed a decrease in GLUT 4 abundance in adipose tissue, possibly one of the 
factors triggering an increase in fat mass (Gardner et al., 2005). This was followed by 
glucose intolerance and insulin resistance, which may increase glucose uptake by 
adipose tissue in an insulin-independent manner. Moreover, insulin secretion to a 
glucose challenge was increased, suggesting a possible reason for the reduction of 
GLUT 4 abundance in nutrient restricted offspring. Both nutritional interventions may 
induce permanent changes in mitochondrial function in the liver and adipose tissue 
(Gardner et al., 2005; Hyatt et al., 2007). 
As the epidemiological observations illustrate, animal studies also suggest a strong 
correlation between maternal nutrition and the risk of cardiovascular diseases in later 
life (Barker et al., 1990). Although, at 1 year of age, ovine offspring born of nutrient 
restricted mothers between 0 to 30 days of gestation have similar systolic and diastolic 
resting blood pressure, Gardner et al. showed evidence of altered baroreflex function 
and renin-angiotensin system activity (RAS) (Gardner et al., 2004). This data suggests 
that those offspring have an increased risk of developing cardiac dysfunction in later life 
due to a leftward shift of the baroreceptor , which is a symptom preceding hypertension 
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in humans (Zidar et al., 1998). The similar relationship between maternal nutrition and 
alterations in blood pressure is also seen in nutritional intervention at mid gestation. 
Whilst blood pressure in offspring exposed to maternal nutrient restriction in early to 
mid gestation is reduced before puberty, in late juvenile life there is a leftward shift of 
the baroreceptor reflex and this is followed by an increase in blood pressure relative to 
control offspring by adulthood (Gopalakrishnan et al., 2005). In addition, at 6 months of 
age, these offspring have a clear reduction in nephron number, which may be an 
indication of early renal deficit function and later cardiovascular health decline 
(Gopalakrishnan et al., 2004). The human epidemiological data showed similar patterns 
in renal and cardiovascular development to that seen in sheep studies (Zidar et al., 
1998). Finally, it is important to note that, in the end, these interventions had no 
observable detrimental effects on viability of these nutrient restricted offspring. 
1.1.3.2 Fetal programming and glucocorticoids  
The long term effects of intrauterine treatment to corticosteroids, including 
dexamethasone, have been studied extensively in the sheep model. Dodic et al. 
GHPRQVWUDWHG DQ DFXWH HIIHFW RQ FDUGLRYDVFXODU DFWLYLW\ DIWHU  KRXUV¶ H[SRVXUH WR
cortisol (5 mg/h) in pregnant ewes between 26 and 28 days of gestation. This 
overexposure resulted in high blood pressure in the offspring at 2 months postnatal age 
(Dodic et al., 2002). Similar studies with dexamethasone (0.5 mg/h) exacerbated the 
induction of programmed hypertension by increasing cardiac output with age, although 
the same dose of dexamethasone given at 64-66 days gestation had no effect (Dodic et 
al., 1999).  
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A possible explanation for this outcome of acute treatment is that the steroid 
intervention given by Dodic et al. coincided with the first stages of nephrogenesis, 
altering future renal functional development. Nephrogenesis in sheep starts at 
approximately 26 days of gestation and the proFHVV LV FRPSOHWH DW DURXQG  GD\V¶
gestation, i.e EHIRUH WHUP §GD\V (Moritz et al., 2005). Furthermore, it has been 
shown previously that the mesonephrons at 26-30 days of gestation express functional 
glucocorticoid receptor (Peers et al., 2001b). It was suggested that cortisol or 
dexamethasone infusions produce increased blood pressure via glucorticoid receptors 
(Dodic et al., 1999; Dodic et al., 2002). Therefore, following exposure to 
dexamethasone during early nephrogenesis (0.48 mg/h, for 48 hours), the sheep not only 
became hypertensive, but renal morphology was also altered by a significant reduction 
in the number of nephrons, followed by an increase in glomerular volume at 7 years of 
age. This reduction in nephron numbers was associated with enlarged and dilated 
proximal tubes and greater accumulation of collagen type I and II in the tubular 
periadventitia of the renal cortical and cardiac vessels (Wintour et al., 2003). In 
addition, studies in a similar sheep model indicated a rise of mRNA abundance for 
elements of the RAS in the fetal kidney and vascular vessels at 130 days of gestation 
(Moritz et al., 2002). The hypertension was followed by alterations in cardiac output, 
associated with left ventricular hypertrophy (Dodic et al., 1999; Dodic et al., 2001).  
At 127 days of gestation, the physiological results obtained from angiotensin II 
infusions more resembled a neonatal or adult response than a fetal response, showing an 
acceleration in renal maturity. Moreover, there was also a rapid increase in mRNA renal 
expression of the same RAS elements, including angiotensinogen and angiotensin 
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receptor (ATR1 and ATR2), which is commonly found in postnatal, but not fetal 
kidneys (Peers et al., 2001a). Alterations in RAS responses persisted well after birth: at 
10-14 days of age, newborn lambs showed alterations in baroreflex and vascular 
responses after an angiotensin challenge. The changes in cardiac activity were 
accompanied by an increase in sympathetic activity and a reduction in nitric oxide 
vasodilatory function (Segar et al., 2006).  
Taken together, these results suggest that early prenatal steroid over-exposure 
caused a premature maturation of the fetal kidney, normally associated with the end of 
the nephrogenesis process. In addition, exposure to glucocorticoids induces premature 
development of coronary artery dysfunction, triggered by alterations in RAS and other 
vascular regulatory hormones.   
Different results were obtained when the fetus was exposed to dexamethasone or 
cortisol at late gestation (around 100-40 gestational days). Prenatal cortisol infusion (0.1 
mg/h) caused significant increases in basal systolic and diastolic blood pressure 
respectively, without inducing renal morphological changes (Molnar et al., 2002). 
Furthermore, an enhanced vascular response to angiotensin II was registered, but not to 
noradrenaline (Tangalakis et al., 1992). Glucocorticoid infusion decreased the 
concentrations of fetal noradrenaline and adrenaline, which may explain, in part, the 
enhanced vascular sensitivity to angiotensin II (Forhead & Fowden, 2004). 
As seen following early prenatatal exposure to dexamethasone, late infusions also 
produced microvascular dysfunction in adulthood at 5 months of age. This dysfunction 
was characterised by a combination of enhanced endothelin-1 vasoconstriction and 
abnormal independent vasodilatation, as characterised by a reduction in nitric oxide 
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release in the endothelium.  An imbalance between these two functions may contribute 
to microvascular dysfunction as one of the factors leading to hypertension in these 
animals (Molnar et al., 2002; Molnar et al., 2003). 
Such studies of glucocorticoid administration during fetal development provide 
examples of changes induced in renal development and key tissues of the cardiovascular 
system. However, subsequent findings in maternal nutrient restriction at early to mid 
gestation indicate that overexposure to glucocorticoids is unlikely within up to a 50% 
reduction in maternal nutrition during this period of gestation (Bispham et al., 2003; 
Jaquiery et al., 2006). 
1.1.3.3 Glucocorticoid exposure and relationship to maternal nutrient restriction     
The natural placental barrier to maternal glucocorticoids is regulated by placental 
11-ȕK\GUR[\VWHURLGGHK\GURJHQDVHW\SH(11-ȕ+'6ZKLFKFRQYHUWVFRUWLVROWRLWV
inert form, cortisone (in humans and sheep). During the final stages of pregnancy until 
birth, in sheep and other animal species, there is a rise in circulating cortisol 
concentration, which accelerates the maturation of the organs and metabolic pathways, 
in preparation for life outside the maternal womb (Moritz et al., 2005). 
Previous studies of undernutrition in pregnant rats (i.e 50% reduction in energy 
intake) show an increase in maternal and neonatal glucocorticoids (Lesage et al., 2001). 
In sheep, acute restriction in nutrient intake throughout pregnancy results in the activity 
reduction of 11-ȕ+'6DVVRFLDWHGZLWKSODFHQWDOUHPRGHOOing (Whorwood et al., 2001; 
McMullen et al., 2004). A reduction of 50% of the metabolic needs in maternal nutrition 
during the period of rapid placental growth (28-77 days) in sheep resulted in a decrease 
in 11-ȕ+'6H[SUHVVLRQLQWKHSODFHQWDDQGVRPHIHWDOWLVVXHV, including kidneys and 
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adrenals (Whorwood et al., 2001). Furthermore, due the increase in abundance of 
glucocorticoid receptor and angiotensin 1 receptor mRNA, these tissues showed the 
same pattern of renal development as seen in glucocorticoid over-exposure (Whorwood 
et al., 2001; Dodic et al.,1999). However, pregnant sheep NR from 28 to 80 days of 
gestation (50% of metabolic need during gestation), followed by a control diet after this 
period, showed plasma cortisol concentrations lower than their controls (Bispham et al., 
2003). Similar results were obtained in pregnant ewes that had been undernourished 
from 60 days before mating to 30 days after mating (Bloomfield et al., 2004). Jaquiery 
et al. showed that, immediately after an acute decrease in nutrition from 30 days prior to 
mating to the first 50 days of pregnancy, only a minor increase in maternal of 
glucocorticoids was produced. However, the mothers quickly adapted to prolonged 
undernutrition and cortisol concentrations returned to basal levels (Jaquiery et al., 2006). 
In a different study in which a moderate maternal NR was induced at early mid 
gestation, similar adaptation was followed by an increase in free fatty acids and a 
decrease in leptin, IGF-I and T4. Bispham et al. suggested that this is a mechanism to 
reduce maternal carbohydrate oxidation and promote lipolysis, thereby maintaining 
glucose supply to support the normal development of placenta and fetus. Furthermore, 
fetuses of sheep exposed to pre-conceptional undernutrition also showed accelerated 
maturation of the HPA axis (Bloomfield et al., 2004). Bloomfield et al. showed that 
fetal lambs, whose mothers were undernourished in the periconceptional period, had 
accelerated maturation of their HPA axis, resulting in a shortened gestation length, 
which may have an impact on health in adult life (Bloomfield et al., 2004). 
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1.2 Obesity 
Obesity has been one of the leading public health concerns in industrialised 
societies for the last 40 years. There is an increasing prevalence in the USA as well as in 
Europe and this is steadily progressing to the rest of the world.  Obesity among adults 
has been defined by the WHO as a body mass index or BMI above 30 kg/m2 (WHO, 
 &KLOGUHQ DQG DGROHVFHQWV UHJDUGHG DV RYHUZHLJKW DUH UHFRUGHG DV  ³th 
percentile of the sex-specific BMI for tKHLUDJHJURZWKFKDUWV´ :+2 A close 
analysis of the data from the National Health and Nutrition Examination Surveys 
(NHANES) indicates that, between 1980 and 2002, obesity prevalence doubled in adults 
(aged 20-74 years) and the prevalence of overweight children and adolescents (aged 6±
19 years) tripled in the USA (Ogden et al., 2006). In Europe, several countries also 
showed an increase in the prevalence of obesity, including a major increase in the 
United Kingdom over the last three decades. In 1980, among men (aged 16-60 years), 
the obesity rate was approximately 6%, rising to 15% by 1995 and 22% by 2003. More 
recent statistics from the WHO indicate that obesity affects 400 million adults 
worldwide today (WHO, 2006).  
Obesity is associated with a large range of chronic diseases, including 
hypertension, ischemic heart disease, type 2 diabetes and a combination of these chronic 
diseases, now called metabolic syndrome (Hotamisligil et al., 1993; McCance et al., 
1994; Festa et al., 2000). It has been recognised that adipose tissue is an active 
participant in numerous physiological and pathophysiological processes. Under 
increasing exposure to glucose and insulin, as seen in obesity, the adipocytes are able to 
express and secrete seYHUDO LQIODPPDWRU\ PROHFXOHV LQFOXGLQJ 71) Į DQG ,/-6 
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(Hotamisligil et al., 1993; Fried et al., 1998; Bastard et al., 2002).  These may result in 
an activation of the innate immune system, exceeding local effects in adipose tissue but 
also having systemic effects, such as macrophage infiltration into other tissues, 
including kidneys, pancreas and others. Therefore, obesity is described as low grade 
inflammation which may subsequently lead to the metabolic syndrome (Plomgaard et 
al., 2007). 
Previous epidemiological observations and animal models show a good correlation 
between suboptimal maternal environments during fetal or neonatal development, which 
may alter the carbohydrate metabolism of the offspring in later life, leading to obesity 
(Gale et al., 2001; Budge et al., 2004). Furthermore, there is evidence in rodents that a 
maternal low protein diet during pregnancy and lactation not only alters postnatal 
growth and appetite behaviour but also programmes the expression of lipogenic genes in 
the offspring (Zambrano et al., 2006). In sheep, maternal nutrient restriction in late 
gestation enhances fetal fat deposition and reduces lean mass (Budge et al., 2004). 
Similar results in humans exposed to a suboptimal maternal environment show a 
decrease in muscle growth and an increase in adipogenesis (Ravelli et al., 1998). In this 
context, it is important to first analyse, in depth, the epidemiological relationship 
between the prenatal environment, postnatal growth and its association with adult 
adiposity. 
1.2.1 Epidemiological associations between maternal nutrient restriction and 
obesity 
Widespread reports indicate a complex relationship between maternal nutritional 
status and offspring adult fat mass (Ravelli et al.,1998; Roseboom et al.,  2000). A large 
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number of studies have reported that there is a correlation between birth weight and 
adult BMI or body composition. These reports suggest that a higher prevalence of adult 
obesity were found at both extremes of the birth weight distribution in human 
SRSXODWLRQORZELUWKZHLJKWJKLJKZHLJKWELUWKJ (Bavdekar et al., 
1999; Boney et al., 2005). In addition, the analyses of the Dutch Famine and additional 
studies of human cohorts showed evidence of metabolic alterations associated with 
µfetal programming¶ in individuals born in the normal range of human birth weight 
(Ravelli et al., 1999). These differences suggest that there is a much more complex 
association between growth in utero and obesity. For instance, there is a small prenatal 
inverse effect of fetal growth and the risk of developing abdominal obesity in men who 
had experienced a rapid period of infant growth (Kuh et al., 2002; Singhal et al., 2003). 
Others studies suggests that there is an increased risk of adult obesity among people 
with a low weight at birth, whose weight increases rapidly in middle and late childhood. 
An Indian study demonstrated that lower weight at birth is associated with obesity and 
other characteristics, such as higher fasting plasma insulin, higher systolic blood 
pressure and an increased fat mass in early childhood (Bavdekar et al., 1999). Body 
composition, including percentage of body fat and fat distribution, may also be 
programmed during early development and contribute later to the risk of obesity and 
associated disease. For example, in a study of children aged between 6 and 9 years, low-
birth-weight children have a higher percentage of fat than children with a higher birth 
weight, after adjustments for current weight and height. This relationship may explain 
the prevalence of obesity associated with cardiovascular diseases, found in these 
individuals in later life (Kuh et al., 2002; Elia et al., 2007).  
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Additional studies have reported the opposite: that high birth weight associated 
with maternal health status is the main factor for child or adult obesity. A large number 
of observations found a borderline correlation between heavier birth weight and 
maternal obesity or gestational diabetes. Bone et al. found that more than 50% of 11 
year old children exposed to high levels of maternal insulin were considered overweight 
for their age group and this relationship continues in later life (Boney et al., 2005). 
Another cohort found a small positive effect of neonatal increased weight on the adult 
BMI at age 33; birth weight was directly associated with maternal weight during 
pregnancy (Parsons et al., 2001). Even with the bulk of the evidence proving the 
influence of maternal health, nutritional status, and placental function on fetal and birth 
characteristics, the influence of parental height and other genetic factors on BMI fetal 
programming is still unclear (Singhal et al., 2003; Painter et al., 2008). Data extracted 
from the Dutch Famine demonstrates that exposure to reduced nutrient supply (1680 to 
2360 KJ/day) during early gestation only, resulted in an increase in adiposity in later 
OLIH GHVSLWH ELUWK ZHLJKW EHLQJ LQ WKH QRUPDO UDQJH  §  NJ 2QO\ LQ WKH IHPDOH
population exposed to this famine during the first trimester of pregnancy was there an 
associated rise in body weight and BMI at 50 years of age (Ravelli et al., 1999). 
Interestingly, Roseboom et al. found that those women who were exposed to the famine 
in early gestation transmitted their phenotype to the next generation (Painter et al., 
2008). These transgenerational effects are characterised by increased neonatal adiposity 
and a decline in health in later life. 
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1.2.2 Inflammation during obesity 
Several epidemiologic studies described obesity as a low chronic inflammatory 
response, associated with an abnormal secretion by the adipose tissue of cytokines or 
adipokines, such as tumour necrosis factor-Į 71)-Į DQG LQWHUOHXNLQ-6 (IL-6) 
(Hotamisligil et al., 1993; Bastard et al., 2002). The over-expression of adipokines by 
adipose tissue contributes to the elevation of some pro-inflammatory elements, inducing 
an activation of the immune system (Lord et al., 1998; Farooqi et al., 2002; Barzilay et 
al., 2006). This increase in adipokines has a predominant role in the development of a 
large number of pathologies and co-morbidities associated with obesity, such as type 2 
diabetes, cardiovascular diseases (CVD) and renal dysfunction (Engstrom et al., 2003).  
Several observations noted large differences in the metabolic activity and 
cardiovascular risk associated with the location of excessive adipose tissue in the body. 
Depot differences between visceral (including omental and peririnal fat) and 
subcutaneous fat cells differ metabolically (Fried et al., 1998; Tchernof et al., 2006; Lee 
et al., 2009). For example, visceral fat cells are more hyperlipolytic in response to 
catecholamine stimulation and less sensitive to inhibition of lipolysis by insulin than 
subcutaneous adipocytes (Greenberg et al., 1992; Fried et al., 1998; Bastard et al., 
2002). This particular characteristic of visceral adipocytes increases their propensity to 
release high levels of free-fatty-acids (FFA). In addition, their anatomical proximity to 
the portal vein and the generation of FFA would be critical to the function of other 
organs, such as the liver, by stimulating hepatic gluconeogenesis and reducing insulin 
clearance, leading to ectopic fat accumulation (Castell et al., 1988; Luc et al., 2003). 
Morphologically, adipocytes from the omental rather than subcutaneous fat are smaller, 
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which may reflect a low storage capacity for fat, leading to much quicker lipid 
saturation and cell dysfunction (Tchernof et al., 2006; Tchoukalova et al., 2007). 
Furthermore, visceral adipose tissue from obese subjects has also been found to secrete 
higher levels of leptin, TNF-ĮDQG ,/-6 and lower levels of adiponectin, compared to 
that of lean individuals (Belanger et al., 2006; Tchernof et al., 2006). Results from 
organ tissue cultures showed that adipose tissue production of IL-6 may be inhibited by 
glucocorticoids and not by insulin (Fried et al., 1998; Bastard et al., 2002). IL-6 also 
stimulates adrenal cortisol release by stimulating hypothalamic CRH and ACTH. The 
release of cortisol may act as a feedback inhibitor of IL-6 expression from adipose tissue 
and this might cause an abnormal increase in cortisol secretion, a common feature of 
visceral obesity (Fried et al., 1998). Maachi et al. found a significant correlation 
between the secretion of C-reactive protein (CRP) from the liver and circulating levels 
of visceral fat adipokines, TNF-ĮOHSWin and IL-6 in obese women. Of the inflammatory 
markers available, CRP is the most independent predictor of cardiovascular and 
inflammatory events in humans and its concentration in plasma is mostly linked with 
obesity (Maachi et al., 2004). Finally, the accumulation of visceral adiposity also 
increases additional biological inflammatory markers, including monocyte-chemotactic 
protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1), which are precursors 
of macrophage infiltration in adipose tissue (Samad et al., 1996; Sartipy & Loskutoff, 
2003; Pandey et al., 2005). 
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1.2.2.1 Adipose maturation and macrophage infiltration  
Several findings indicate that the adipocytes and immune cells share a number of 
genes and properties. Rosen et al., and later Hotamisligil et al., showed that fat cells 
produce a number of components of the alternative complement activation, including 
adipsin-factor D and pro-inflammatory cytokines, such as TNF-Į (Rosen et al., 1989; 
Hotamisligil et al., 1993). Furthermore, proliferating pre-adipocytes develop a 
phagocytic phenotype in response to several stimuli. In vitro experiments show that a 
possible stimulus is cell-to-cell contact between pre-adipocytes and macrophages 
(Cousin et al., 1999; Charriere et al., 2003). Following phagocytosis, the microbicide 
activity of pre-adipocytes, as seen in other immune cells, occurs via an oxygen 
dependent mechanism (Cousin et al., 1999). Thus, the possibility that T-cells simulate 
pre-adipocytes to become active phagocytes may influence the biology of both cell 
types. This has important immunological implications as well as metabolic pathogenic 
states (Tontonoz et al., 1998).  
Numerous genes that code for transcription factors, such as cytokines, 
inflammation signalling molecules and fatty acid transporters, are essential for adipocyte 
biology and are also expressed in macrophages (Makowski et al., 2001). Another cross-
talk between the energy metabolism control and immune responses is angiotensin II that 
increases macrophage activity and leucocytes migration. In lean individuals, 85% to 
95% of the total plasma angiotensinogen is synthesised by the liver and secreted into the 
bloodstream as a precursor of the vasoreactive angiotensin II protein (Van Harmelen et 
al., 2000; Massiera et al., 2001a). Angiotensinogen is also known to be expressed by 
adipose tissue and to play an important role in adipocyte development. Aubert et al. 
24 
 
reported that angiotensinogen expression in adipose cells is responsive only to 
glucocorticoids, and not insulin, as in liver cells (Aubert et al., 1997). Therefore, in 
obese individuals, the angiotensinogen contribution from adipocytes increases by up to 
60% (Van Harmelen et al., 2000). The mRNA expression of angiotensinogen is 
enhanced multiple-fold during adipocyte differentiation in human and rodents (Massiera 
et al., 2001; Tchoukalova et al., 2007). Following exposure to angiotensin II, culture 
pre-adipocytes from mice and humans increased lipogenesis and triglyceride 
accumulation, leading to cell hypertrophy (Tchoukalova et al., 2004). When the pre-
adipocyes stopped proliferating and differentiated into adipocytes, the immune 
phagocyte-like cell phenotype disappeared.  During this stage, the adipocytes secrete 
protaglandin I2, a potent inducer of pre-adipocyte differentiation, suggesting that 
angiotensin II is implicated in the formation of new adipocytes (Tchoukalova et al., 
2004).  In addition, it has been demonstrated that increased concentration of angiotensin 
II stimulates the release of TNF-Į 3$,-1 and MCP-1 by pre-adipocytes, possibly 
triggering the macrophage infiltration of the adipocyte hypertrophy commonly 
associated with obesity (Kim et al., 2006; Tsuchiya et al., 2006; Takahashi et al., 2008).  
Another adipose-specific molecule that changes during adipocyte-cell 
differentiation and regulates the immune system is leptin. After adipocyte 
differentiation, the abundance of leptin mRNA increases remarkably. Lord et al. 
observed that administration of leptin to starved mice had a specific effect on T-
lymphocytes, by increasing cytokine release and proliferation. In addition, leptin is able 
to reverse the process of adipocyte maturation induced by angiotensin II, by increasing 
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lipolysis. Leptin administration to ob/ob obese mice (leptin-deficient) activates gene 
products involved in the inflammatory process (Lord et al., 1998; Farooqi et al., 2002).  
Immunochemical and microarray analysis of perirenal and additional depots of 
adipose tissue revealed that the source of these altered pro-inflammatory molecules is 
macrophages. These locally present macrophages are responsible for almost all adipose 
tissue TNF-Į H[SUHVVLRn and significant amounts of iNOS (inducible nitric oxide 
synthesise) and IL-6 expression (Soukas et al., 2000). This increase in macrophage 
infiltration could either represent the cause, or be a consequence, of the low-grade 
inflammatory state associated with obesity. The cellular and molecular mechanisms 
involved in this process are unknown, but it has been suggested that the activation of 
unfolded protein response (UPR) by hypertrophied adipocytes is involved (Ozcan et al., 
2004). Triglyceride accumulation enhanced adipose tissue dysfunction was followed by 
UPR pathway activation, which in turn perturbed inflammation signalling present in pre-
adipocytes and in endothelial cells, leading to macrophage infiltration (Fig 1.2) (Ozawa 
et al., 2005). 
1.2.2.2 Insulin resistance 
Following adipocyte hypertrophy, there is an elevation in fatty acids, glucose and 
plasma concentrations of several cytokines, characteristic of obesity and other 
inflammatory states. Hyperglycemia and hyperlididemia in obesity eventually 
contribute, in part, to the development of insulin resistance in human and several animal 
models of obesity (Dobrian et al., 2001; Lee et al., 2009) .  
At a cellular level, insulin resistance starts with the inhibition by 
DXWRSKRVSKRU\ODWLRQRIWKHȕVXEXQLWVRQWKHWK\URVLQHUHVLGXHVRIWKHLQVXOLQUHFHSWRU
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after binding to insulin. This event is followed by the subsequent inhibition of the 
autophosphorylation of the insulin receptor substrate family (IRS) and other additional 
substrates (Hotamisligil et al., 1996; Paz et al., 1997; Aguirre et al., 2002). Thus, a 
chain reaction is induced by the rising concentrations of elements involved in 
inflammatory adipocyte responses commonly associated with obesity (Furukawa et al., 
2004; Maachi et al., 2004). For instance, the exposure of insulin response cells to 
several cytokines, such as TNF and IL-6 or high concentrations of FFA, produces a 
strong stimulus for the inhibition of the serine residues of intracellular Insulin receptor 
substrate 1 (IRS-1). The phosphorylation inhibition of IRS-1 and insulin receptors 
reduces the ability of insulin intracellular action (Dresner et al., 1999). Insulin resistance 
activates the mechanisms of stress by overloading the capacity of several cell 
compartments (Hotamisligil et al., 1996; Yin et al., 1998; Aguirre et al., 2000). One 
organelle affected by insulin resistance is the endoplasmatic reticulum (ER), which has 
the function of synthesising and secreting several proteins. Inside the ER, a number 
chaperones constantly assemble and correctly fold these proteins. Exposure to cytokines 
or high concentrations of glucose can interfere with the ER function (Ozcan et al., 
2004). Obesity overloads the functional capacity of the ER, initiating the UPR 
mechanism. Depending on the severity of the ER stress, the cell can activate 
inflammatory elements, such as CHOP and GADD 153, therefore contributing to insulin 
resistance (Oyadomari et al., 2001; Nakatani et al., 2005). Another cell organelle that 
causes enhanced activation of the inflammation pathway is the mitochondria (Rossetti et 
al., 1997; Furukawa et al., 2004; Lin et al., 2005b). Increased glucose and FFA 
metabolism induce mitochondria dysfunction, which leads to a rise in oxidative stress 
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(OxS). In obesity, there is chronic elevation of OxS which, in turn, enhances the 
activation of inflammatory pathways (Furukawa et al., 2004). 
The inhibition of the insulin pathway and the dysfunction of the mitochondria and 
ER induce the activation the NF-ț%NLQDVH3&.&IDPLO\DQG-1.$FWLYDWLRQRIWKHVH
serine/threonine kinases demonstrates the importance of the cross-walk between the 
metabolic and immune pathways (Brown et al., 1995; Chen et al., 1995). 
1.2.2.3 Lipotoxicity 
The term lipotoxity is associated with the damaging effects of cellular lipid 
saturation on organ dysfunction, including renal disease (Carroll & Kyser, 2002). These 
include the involvment the of acute toxicity effects produced from cellular accumulation 
of long chain nonesterified fatty acids and their metabolites (fatty acyl CoA, 
diacylglycerol and ceramide) (Dresner et al., 1999; Avramoglu et al., 2003). Excess 
FFA availability promotes a decrease in normal oxidative metabolism, which is often 
followed by triglyceride accumulation in non-adipose cell organs of the body, including 
VNHOHWDODQGFDUGLDFP\RF\WHVKHSDWRF\WHVSDQFUHDWLFȕ-cells and mesangial cells (van 
der Vusse et al., 1992; Cowley et al., 2001; Wang et al., 2003; Abrass, 2004; Johnson et 
al., 2004). This process results in a chronic cellular dysfunction linked to obesity 
(Lowell & Shulman, 2005). The lipid deposition in non-adipose tissue is followed by 
low adiponectin secretion, leptin resistance or deficiency and cytokines release from the 
adipose tissue, inducing dysfunctional effects in skeletal muscle, liver, pancreas, heart 
and kidney (Yamauchi et al., 2001). Lipotoxity is followed by an accumulation of 
neutral lipids in cells triglycerides (TG). Several observations have shown that TG 
themselves are used as storage. However, as toxicity comes mainly from FFA and their 
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by-products that accumulate as a metabolic failure of breakdown or esterification of the 
triglycerides, the effects of FFA metabolism vary from cell to cell and also differ 
between different body tissues (El-Assaad et al., 2003).                                           
1.2.2.3.1 Skeletal muscle  
In skeletal muscle, the excess of  FFA deposition plays a vital contribution to 
insulin resistance, through an elevation in intracellular fatty acyl CoA that activates 
3.& ș DQG ,ț% FDXVLQJ LQKLELWLRQ RI WKH LQVXOLQ UHFHSWRU VXEVWUDWH-1 serine 
phosphorylation (Dresner et al., 1999). Subsequently, activation of phosphatidylinsitol-3 
kinase and AKT is limited, resulting in the translocation of GLUT 4 from the cell 
membrane to the cytosol with a consequent reduction in glucose-insulin regulation 
uptake (Dresner et al., 1999). This process is characterised by a shift in the source of 
oxidative mitochondrial metabolism from glucose to FFA by the skeletal muscle 
(Yamauchi et al., 2001). An increase of intracellular FFA in skeletal myocytes can result 
in a decrease in mitochondrial density or a reduction in respiratory enzyme activity 
(Yamauchi et al., 2001). In addition, FFA deposition in non-adipose tissues produces a 
decrease in circulating cytokines, such as adiponectin that regulate rates of 
mitochondrial oxidation of FFA, reducing further the insulin action. Petersen et al. have 
shown a genetic predisposition in offspring of patients with type 2 diabetes to a 
reduction in mitochondrial oxidative phosphorylation. Using magnetic resonance 
spectroscopy, they demonstrated a reduction of 60% in muscle glucose uptake, 
associated with 80% of intramyocellular lipid content. It is possible to link this increase 
in lipid intracellular content to mitochondrial dysfunction, reflected in a 30% reduction 
in mitochondrial phosphorylation (Petersen et al., 2004). However, a recent study 
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demonstrated that lipid overload in vivo or in vitro did not induce apoptosis in skeletal 
muscle cells, even after mitochondrial functional changes (Turpin et al., 2009). 
1.2.2.3.2 Pancreas 
An accumulation of lipids in the pancreas elevates the expression of elements that 
promote endogenous fatty acid synthesis, such as sterol regulatory element binding 
protein-1c (SREBP-1c) in several animal models (Wang et al., 2003; Jiang et al., 2006; 
Wu et al., 2006). ,Q FXOWXUHG SDQFUHDWLF ȕ-cells, the over-expression of SREBP-1c 
induced an increase of lipid droplets and an inhibition in insulin secretion stimulated by 
glucose, followed by cell dysfunction (Wang et al., 2003). Analysis of gene expression 
UHYHDOHG WKDW ȕ-cell dysfunction is characterised by an abnormal expression of genes 
dedicated to carbohydrate metabolism, lipid biosynthesis, cell growth and apoptosis 
(Johnson et al., 2004). A response to glucose or lipid uptake in the pancreas is an 
increase in the secretion of hormone-VHQVLWLYHOLSDVH+6/VSHFLILFDOO\LQȕ-cell. This 
is reflected in an increase in lipid deposition from triglycerides (El-Assaad et al., 2003). 
Winzell et al SURSRVHG WKDW +/6 LV LQYROYHG LQ PHGLDWLQJ ȕ-cell lipotoxicity by 
providing ligands for peroxisome proliferator-DFWLYDWHGUHFHSWRUĮ33$5-ĮDQGRWKHU
lipid activated transcription factors, which in turn alter the expression of critical genes 
involved in free radical production, such as the uncoupling protein (UCP). Furthermore, 
a rise in UCP-DEXQGDQFHSURPRWHGSURWRQOHDNLQJLQSDQFUHDWLFȕ-cell mitochondria. 
Thereby, the proton loss during respiration reduces the production of adenosine 
triphosphate (ATP) by the mitochondria, which in turn impairs glucose-stimulated 
insulin secretion (Winzell et al., 2003). High glucose and FFA induced activation and 
expression of UCP-2 in the mitochondria of pancreatic cell, suppressing ATP production 
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normally induced by glucose. This limits the closing of plasma membrane of ATP-
potassium channels, leading to mitochondrial depolarisation and increasing the calcium 
influx required for insulin release (Joseph et al., 2004). In addition, UCP-2 over-
expression reduces the cytosolic ratio between ATP and superoxide production in 
response to glucose, which later increases mitochondrial free-radical production, and 
lipid overload-LQGXFHGDSRSWRVLVZLWKDSURJUHVVLYHORVVRIȕ-cell mass (Joseph et al., 
2004).   
1.2.2.3.3 Liver 
The increase in visceral adiposity is associated with larger amounts of lipid 
released in to the portal vein, directly impacting the liver. The triglycerides excess 
deposition leads to hepatocyte insulin resistance in a similar fashion to skeletal muscle. 
Therefore, the cellular pathway involved includes increased production of reactive 
oxygen species from lipid oxidation via mitochondrial electron transport chain, 
SHUR[LVRPDO ȕ-oxidation and microsomal cytochrome P450 and gene expression of 
TNF-Į(Browning & Horton, 2004). The increase in FFA intake promotes an abnormal 
retention of lipids within the hepatocyte cells, further aggravated by excess FFA 
delivery from lipolysis in visceral adipocytes, and resulting in non-alcoholic fatty liver 
disease. FFA treatment of liver cells results in mitochondrial dysfunction via the 
translocation of Bax (a Bcl-2 protein that induces cell apoptosis usually through 
mitochondria membrane permeabilization) to the mitochondria and lysosomes. 
Destabilisation of the lysosomes releases cathepsin B, a lysosomal cysteine protease into 
the cytosol and this process culminates in the expression of TNF-ĮLQYROYLQJWKHLQQDWH
immune system activation (Feldstein et al., 2004). 
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1.2.2.3.4 Heart  
Intracellular accumulation of FFA has been proposed to play an important role in 
the pathogenesis of heart disease (Schwartz et al., 1994). For instance, lipid deposition 
in the hearts of Zucker diabetic rats (ZDF) (fa/fa) induced a reduction of myocardial 
contractility and was associated with unresponsiveness to leptin (Zhou et al., 2000). At 
cellular level, these animals showed an increase of lipids which was higher than that of 
controls and was associated with an increase in with oxidative stress (Schwartz et al., 
1994). In vitro observation demonstrated that saturated FFA and high glucose induce 
apoptosis of cardiac myocytes through the generation of reactive oxygen species 
independent of FFA synthesis  (Listenberger et al., 2001). Similarly, as reviewed by 
Rodrigues et al., human diabetic cardiomypathy is associated with increase myocardial 
triglyceride content, increasing the risk for arrhythmia and reduction in contractile 
function (Rodrigues et al., 1995).    
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Figure 1.2 Proposed model of adipose tissue development adapted from Aihaud et al. 2002. AGT, 
angiotensinogen; Ang I, angiotensin I; Ang II, angiotensin II; IP, prostacyclin; PGI2, prostacyclin; 
UPR, unfolding protein response; TNF-Į WXPRXU QHFURVLV IDFWRU 3$,-1, plasminogen activator 
inhibitor-1; MCP-1, monocytes chemotactic protein-1   
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1.3 Obesity and kidney disease 
1.3.1 Epidemiology of obesity and kidney disease 
The association between obesity and the development of renal diseases is well 
documented. In a large Japanese cohort (n > 100000), followed up after 17 years, 
reported that obesity increased the risk of end-stage renal disease (ESRD) among men. 
This relationship persisted even after adjustments for hypertension and proteinuria, 
suggesting that obesity per se is an independent risk factor for ESRD (Iseki et al., 2004). 
Further research, based on a large population study (n > 300000 adults from both sexes) 
conducted by Hsu et al. in the USA, supported this finding and showed that excess 
weight remained an independent risk factor, even after adjustment for other risk factors, 
such as age, race, sex, education, smoking, diabetes and proteinuria. Compared with 
individuals of normal weight (BMI 18.5 to 24.9 Kg/m2), the adjusted odds ratio (OR) for 
ESRD was 1.87 (95% CI, 1.64 to 2.14) which increased with BMI to 7.07 (CI, 5.37 to 
9.31) for those with morbid obesLW\%0,NJP2) (Hsu et al., 2006). A large cross-
sectional population study demonstrated that being overweight, from the age of 20 to 
any time later in life, was linked with an increased risk of chronic kidney disease (CKD) 
for both men and women. In addition, in this cohort, the risk for CKD in obese people 
considerably increased the risks of hypertension and type 2 diabetes (Ejerblad et al., 
2006). Taken together, the data in these population-based studies shows that obesity is 
an independent risk factor for the development of renal diseases. Nevertheless, because 
of the association between obesity, diabetes and hypertension, the final impact of 
obesity on CKD is still unclear. For instance, as reviewed by Kincaid-Smith, 
hypertension and morbid obesity coexist in 50 to 70% of cases (Kincaid-Smith, 2004). 
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Although, metabolic and vascular dysfunction are prevalent in obese individuals, several 
studies have shown that renal disease is at least temporally related to obesity, 
independent of the development of hypertension or diabetes (Chen et al., 2003b). For 
instance, excess weight plays a fundamental role in the development of proteinuria and 
renal damage in patients with severe renal mass reduction (Gonzalez et al., 2005). 
Furthermore, it was demonstrated that obesity accelerates the increase of proteinuria in 
IgA nephropathy through remodelling of the glomerular membrane (Tanaka et al., 
2007). Therefore, these previous publications demonstrate mediate statistical and renal 
physiological analysis of the role of obesity as a precursor or contributor to renal 
diseases. 
1.3.1.1 Epidemiology of metabolic syndrome and kidney disease  
Epidemiological studies have demonstrated a strong association between the 
metabolic syndrome and several markers of kidney disease, such as an increase in 
microalbuminuria. A retrospective study conducted by Kurella et al. analysed an adult 
population of more than 10000 non-diabetic participants suffering with arteriosclerosis 
and studied their risk for the development of CKD over 9 years. They found that the 
metabolic syndrome reduced kidney function over time compared with healthy 
participants, even after adjustment for hypertension and diabetes (Kurella et al., 2005). 
Chen et al. studied a cohort of more than 6000 adult participants followed over 21 years, 
which also demonstrated a higher risk for renal dysfunction in comparison to non-
diabetic men and women with metabolic syndrome. Importantly, in this study, the 
relationship persisted even after the exclusion of diabetes as a trait of metabolic 
syndrome (Chen et al., 2004a). Several clinical studies have also found that the risk for 
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microalbuminuria was independent of hypertension and associated with different 
components of metabolic syndrome, such as abdominal obesity and BMI (Chen et al., 
2004a; Lin et al., 2007). The combination of insulin resistance, hyperinsulinemia and 
abdominal obesity before the development of clinical diabetes might be a critical risk 
factor in the development of CKD (Chen et al., 2003b).  Thus, metabolic syndrome and 
renal function may have a common starting point long before the appearance of 
hypertension and diabetes.  
1.3.2 Renal structure and function in obesity 
1.3.2.1 Kidney morphology 
Fetal kidney development is a very complex process, controlled by a large number 
of genes in constant modification (Bard, 2002). The fetal mammalian kidney develops 
from the intermediate mesoderm. Kidney development, nephrogenesis, proceeds 
through a series of three successive phases during gestation: the pronesphros, 
mesonephros and metanephros (Bards, 2002). Only metanephros is a permanent 
structure of the kidney; the early two structures degrade during fetal growth. In the 
sheep, the formation of the nephrons starts at day 30 of gestation, increasing the number 
of functional nephrons until birth (Moritz et al., 2005). In humans, around the 36th week 
of pregnancy, approximately 1 million nephrons are formed in each kidney (Brenner et 
al., 1996). This arrest of nephron development at birth is a common feature of renal 
development in several mammals, including sheep, although in rats and other rodents 
this process extends for up to two weeks after birth i.e. lactation period (Moritz et al., 
2005). As, in humans, approximately two thirds of the nephrons are developed during 
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the last trimester of gestation, different challenges during renal development may have a 
major impact on subsequent nephrogenesis.  
The fully developed mammalian kidney is divided morphologically into two 
separate sections: the cortex and the medulla. The main function of the kidney is to filter 
blood and excrete foreign substances. These functions are performed by its basic unit, 
the nephron. These are S-shaped structures, which expand from the kidney cortex to the 
medulla and are composed of different cell types, such as mesangial, podocytes and 
endothelial cells (Brenner et al., 1996). 
1.3.2.2 Changes in renal function and activity in obesity 
In humans, the progression of renal changes associated with obesity is better 
characterised than other mammals and is usually linked with an increase in 
microalbuminuria and variable degrees of proteinuria (Adelman et al., 2001; Kambham 
et al., 2001; Chen et al., 2004a). However, some observations have demonstrated that 
the first possible morphological alteration that precedes the appearance of proteinuria, in 
obesity without apparent renal dysfunction, is tubulointerstitial nephropathy. Rea et al. 
studied the biopsies of 49 obese and 41 non obese renal donors, who met acceptance 
criteria such as microalbumin excretion (< 30mg/day), fasting blood glucose (< 110 
mg/dl) and normal blood pressure. They found no difference in glomerulopathy, tubular 
atrophy or internal fibrosis. However, the obese donors had a larger glomerular planar 
surface area and more tubular dilatation, than the non-obese controls (Fig. 1.3/A-E). 
These parameters correlated with patient weight and urinary microalbumin secretion 
(Rea et al., 2006). In obese individuals with advanced renal insufficiency, the majority 
of the renal biopsy observations were negative for nephrotic syndrome but the common 
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feature was slow and progressive proteinuria (Praga et al., 2000; Kambham et al., 2001). 
Over a 7 year period, Praga et al. followed 15 obese patients who had been diagnosed 
with focal segmental glomerulosclerosis (FSG), but they found an absence of nephrotic 
syndrome, despite nephritic range proteinuria. At the end of this study, 33% of patients 
were on chronic dialysis and another 13% showed advanced chronic insufficiency. An 
estimation analysis (Kaplan-Meier) of this study reveals that, under these parameters 
such as BMI > 30 kg/m2, the renal survival after 5 years was 77% and 5 years later 
declined to 49% (Praga et al., 2001) (Fig. 1.3/H). Thereby, changes in glomerular 
function and structure have been termed obesity related glomerulopathy (ORG). 
Furthermore, Kambham et al. found that ORG shows an increase in patients with a BMI 
> 30 kg/m2. Morphologic features include the presence of glomerulomegaly, a 
predominance of sclerosis lesions and less podocyte injury than non-obese FSG patients 
(Kambham et al., 2001) (Fig. 1.3/G). In addition to the structural changes, non-diabetic 
obese patients showed an alteration in several haemodynamic parameters, such as an 
elevation in renal plasma flow (RPF) and glomerular filtration rate (GFR) (Chagnac et 
al., 2000), possibly induced by the vasodilatory action of insulin in renal microvessels 
(Hayashi et al., 1997). The significance of these results is unclear, but demonstrates that 
chronic obesity produces alterations or adaptations in renal tissues, affecting 
functionality and morphology. 
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1.3.3 Mechanisms of renal disease in obesity 
The exact mechanisms by which obesity initiates the process of renal dysfunction 
are unknown. However, it is known that the obesogenic environment alters several 
inflammatory and metabolic effects and haemodynamic factors, which potentially lead 
to a decrease in renal functionality. A number of epidemiological studies demonstrated 
that inflammation is linked to metabolic syndrome in patients with CKD. A cross-
sectional study  of  94 CDK patients found an association between a high concentration 
of the inflammation PDUNHU&53!PJODQG%0,NJP2 compared to patients 
with normal BMI (< 25 kg/m2) (Ramkumar et al., 2004). Another larger cohort 
demonstrated a correlation between microabumiruria, obesity and serum CRP and that 
the association existed even after the exclusion of diabetes as a contributory factor 
(Nakamura et al., 2004). The gene and immunhistochemistry analysis of glomeruli 
dissected from patients with obesity, proteinuria and biopsy-proven ORG demonstrated 
the involvement of several key genes in lipid metabolism (SREBP-1), inflammation 
(TNF-ĮDQG,/-6) and insulin resistance (VEGF and GLUT-1) in renal dysfunction (Wu 
et al., 2006) (Fig. 1.3/G,F). These results emphasise the role of elements associated with 
metabolic syndrome in the formation of obesity-related glomerular injuries. 
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Figure 1.3 Statistics and morphology of early renal injuries in obese or over-weight subjects without 
diabetes. A. Distribution of histology scores of renal biopsies in obese non-diabetic donors (Rea et al. 
2006). Renal cross sections observed in obese patients: Biopsy (B) - evidence of tubular injury. 
Pictures (C-E) - evidence of obesity associated tubular dilatation or cellular hyperplasia (Herbert et 
al. 2000) (original magnification x 100; PAS staining). By contrast, the second biopsy (F:control; G: 
obese patient) was immuno-stained with VEGF-A antibodies and demonstrates a typical obesity-
related glomerulopathy (original magnification x400). H (Kaplan-Meier analysis) - the increased 
statistical risk of renal failure in years among obese-associated focal glomerulosclerosis (OB-FSG) 
in relation to non-obese patients suffering from the same disease (I-FSG). Number in brackets 
represents the patients at risk at every period (Paga et al., 2001).        
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1.3.3.1 Role of cytokines 
1.3.3.1.1 Leptin 
Five leptin receptors are known to be active in the kidney, only two of which are 
relatively abundant (ob-Ra and ob-Rf) and located in the inner medullar region (Lee et 
al., 1996; Vaisse et al., 1996; Wang et al., 1996). However, fewer leptin receptors 
detected are in other areas of the kidney, including the glomeruli, proximal and distal 
tubules and terminal collecting ducts (Serradeil-Le Gal et al., 1997). Cell culture studies 
demonstrate that leptin stimulates the growth of glomerular, but not mesangial, cells, 
indicating a specific effect on cell proliferation. In rats, infusion of leptin also stimulates 
mRNA expression and production of the profibrogenic cytokine TGF-ȕDQLQFUHDVHLQ
glomerular collagen type IV renal deposition, glomerulosclerosis and proteinuria (Wolf 
et al., 1999). In addition, leptin increases glucose uptake and type I collagen in obese, 
leptin-deficient mice. Hans et al., also postulated that leptin activates the interglomerular 
TGF-ȕ V\VWHP WKURXJK LWV UHFHSWRUV WKHUHE\ FRQWULEXWLQJ WR JORPHUXORVFOHURVLV LQ
obesity (Han et al., 2001). Therefore, the distribution and activity of leptin appears to 
have a direct effect on renal structure and function, possibly playing a role in 
glomerulosclerosis.  
After its secretion by the adipose tissue, leptin is removed from the plasma by the 
kidneys, primarily by glomerular filtration (Sharma et al., 1997). Cumin et al. infused 
lean rats with leptin and demonstrated that leptin is extracted intact and digested by the 
kidney. Furthermore, leptin was only present in small quantities in urine, indicating its 
metabolic degradation in the renal tubules. After binephrectomy, plasma leptin 
concentrations did not increase and its degradation rate was unchanged, suggesting that 
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the capacity for leptin extraction by the kidneys was not overwhelmed (Cumin et al., 
1997). 
Leptin may also affect the kidneys directly, by increasing sympathetic nerve 
trafficking and inducing renal sodium retention, which can cause hypertension (Hall et 
al., 2004). Furthermore, hyperleptinemia induces abnormal sodium handing and 
decreases nitric oxide production by an increase in systemic and intrarenal oxidative 
stress, an effect that may promote hypertension (Beltowski et al., 2004). 
Controversially, Stenvinkel et al. have shown, in severe chronic kidney failure patients, 
that serum leptin increases at the initiation of peritoneal dialysis treatment and is 
inversely related to inflammation and followed by changes in lean body weight. These 
may possibly explain the survival advantage for obese patients with ESRD (Stenvinkel 
et al., 2000). In addition, leptin appears to be an independent predictor for 
cardiovascular events (even after adjustment for CRP concentration and other metabolic 
risk factors) (Wallace et al., 2001). Thus, the increase in secretion of leptin by adipose 
tissue would appear to play an important role in endothelial dysfunction, leading to 
deterioration in renal structure and function. 
1.3.3.1.2 TNF-Į 
Cunningham et al. demonstrated that TNF-ĮLVDNH\PHGLDWRULQWKHGHYHORSPent 
of acute renal failure by the induction of an inflammation response to bacterial 
endotoxines. The effects of TNF-ĮDVVRFLDWHGZLWKUHQDOILEURVLVDUHPHGLDWHGWKURXJK
both receptors, TNFR1 and TNFR2, with TNFR1 playing a predominant role. After 
binding to TNFR1, macrophage infiltration results, leading to renal apoptosis 
(Cunningham et al., 2002). One of the possible mechanisms involving TNF-Į71)5LV
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activation of the innate immune system by the increase in reactive oxygen species 
(ROS), such as oxygen superoxide. This, in turn, induces the recruitment of additional 
cytokines such as MCP-1 (Chen et al., 2004). Furthermore, the neutralisation of 
endogenous TNF-ĮUHGXFHVJORPHUXODULQIODPPDWLRQDQGLQMXULHVLQJORPHUXORQHSKULWLV
(Khan et al., 2005). 
1.3.3.2 Insulin and IGF-1  
The early progression of renal disease in obese pre-diabetic Zucker rats (fa/fa rats) 
started at 6 weeks with the appearance of podocytes but no mesangial cell injury. This 
process was followed by a glomerular infiltration of monocytes and macrophages 
associated with hypertrophy, as well as secondary tubuleinterstitial damage. Therefore, 
in obese fa/fa rats, the first signs of glomerular hypertrophy appeared in conjunction 
with hyperinsulemia, without hypertension or renal matrix deposition and before 
additional indicators of renal dysfunction (Coimbra et al., 2000). Therefore, these results 
demonstrate the importance of insulin as an early factor in renal dysfunction. As a weak 
vasodilatator, a chronic high concentration of insulin does not cause hypertension. 
However, insulin increases endothelial dependent vasodilatation, which could contribute 
to glomerular hypertension, leading to a slow process of renal dysfunction. High plasma 
insulin concentrations significantly increases sodium retention, without producing 
changes in blood pressure (Brands et al., 2009). In vitro observations indicate that 
insulin and insulin-like growth factor-1 (IGF-1) share common pathways involving 
proliferation of mesangial cells, altering the glomerular structure (Abrass et al., 1988; 
Hiromura et al., 2002). In addition, high doses of IGF-1 and insulin induce an increase 
in secretion of extracellular matrix proteins by mesangial and tubular cells affecting 
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glomerular architecture and functionality (Abrass et al., 1994; Hirschberg, 1996). After 
exposure to insulin in vitro, mesangial cells chronically maintained the production of 
these pro-inflammatory collagen proteins and also changed cell morphology, suggesting 
permanent modifications in gene expression (Abrass et al., 1994; Abrass et al., 1995). In 
part, the secretion of collagen type I and IV can by reduced in vitro by exposure of the 
renal tubules to IGF-1 receptor antibodies (Hirschberg, 1996). The histological analysis 
of transgenic knockout glomerular IGF-1 receptors in mice has shown the formation of 
abnormal and small glomeruli. This study suggests that IGF signalling is essential in 
maintaining the function of the podocytes as keepers of the integrity of the renal 
structure, an alteration that may play an important role in the development of 
glomerulosclerosis (Bridgewater et al., 2008).        
Insulin seems to interact with ANG II, increasing the contractile response in 
cultured mesangial cells. Kreisberg et al. suggested that this loss of contractile response 
by mesangial cells, induced by a reduction in insulin production, could lead to an 
increase in glomerular flow which may result in glomerulosclerosis (Kreisberg, 1982). 
In addition, treatment with IGF-1 (100nmol/L) for 1 to 4 weeks resulted in mesangial 
cells which failed to contract normally in response to ANG II. These effects are due to 
an increase in lipid accumulation, as lipid removal restored the contractile response 
(Berfield et al., 2002; Berfield et al., 2006). Furthermore, lipid saturated mesangial cells 
were unable to migrate in response to IGF binding protein 5, an essential response to 
glomerular injury and they lost phagocyte phenotype, an indicator of an increase in the 
severity of the injury (Berfield et al., 2002). 
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1.3.3.3 The renin angiotensin system  
The RAS is an enzymatic cascade in which angiotensinogen is transformed first to 
angiotensin I (ANG I) and later to ANG II by the actions of renin and angiotensin 
converting enzyme (ACE). In obese individuals and animal models, these proteins are 
produced in excess by adipose tissue and the liver despite sodium retention and an 
apparent increase in extracellular fluid volume (Fig.1.1) (Hall, 1994; Engeli et al., 
2005).                          
One of the components of this system is ANG II, known to be associated with the 
progression of renal injury. In rats, after renal mass reduction, it has been possible to 
detect an increase in hypertension parallel to a rise in oxidative stress (Hasdan et al., 
2002). A specific in vitro study demonstrated that ANG II dependent cell contraction in 
rat micro-tissue strips from the medulla is mediated by the generation of oxygen 
superoxide anions (O2.-)(Mori & Cowley, 2003). Zafari et al. have shown that ANG II 
induced a rise in reactive oxygen species in vascular cell cultures through an increase in 
NADPH oxidase activity linked to cell hypertrophy (Zafari et al., 1998). ANG II also 
induces IL-6 synthesis which is mediated by lipoxygenase, a peptide associated with the 
inflammatory response (Luchtefeld et al., 2003). The O2.- has been found to be the main 
cause of the reduction in nitric oxide vasodilatory activity. In patients with renovascular 
hypertension, there is impairment in the endothelium-dependent vasodilatation, 
mediated in part by an increase in oxidative stress (Higashi et al., 2002). Previous 
studies in rats have shown that infusions of ANG II induce different effects on the 
kidneys, depending on dose and duration of the treatment (Lombardi et al., 1999; Welch 
et al., 2005). In renal cortical tissue, low doses (200ng/kg x min/sc) of ANG II for two 
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weeks cause hypoxia, which is followed by inefficient use of oxygen. At these 
concentrations, ANG II may induce a mild hypoxia through reduced renal oxygen use as 
well as enhanced NO production and reduced superoxide generation, at least in the renal 
cortex. However, in the renal cortex at the end of this treatment, ANG II exposure 
causes severe hypoxia and increases the generation of O2.-, inducing apoptosis by 
increased NADPH oxidase in the renal cortex (Welch et al., 2005). In the medulla, 
chronic infusion of ANG II increases the synthesis of NO without generating oxidative 
stress and is accompanied by a reduction in contraction (Zhang et al., 2005). In addition, 
rats exposed to ANG II (435ng/kg min) over two weeks experience structural and 
functional changes, leading to salt sensitive hypertension. The infusion is associated 
with acute hypertension, renal dysfunction and vascular damage. At sites of renal injury, 
there was a reduction in nitric oxide synthetase abundance both in the medulla and 
cortical (Lombardi et al., 1999). Therefore, these specific regional effects of chronic 
ANG II on the kidney may increase the expression of markers of oxidative stress. 
Brenner et al. demonstrated that blocking of the Ang II type I receptor with losartan 
significantly reduced the development of proteinuria, in patients with type 2 diabetes 
and nephropathy (Brenner et al., 2001). Similar treatment reduced the mRNA 
abundance TNF-Į3$,-1, MCP-1 and additional markers of oxidative stress in adipose 
tissue of obese rats, thereby ameliorating the effects of obesity (Kurata et al., 2006). 
Some human studies support these findings: Giacchetti et al. observing regional adipose 
differences in gene expression of components of the RAS. In visceral adipose tissue, 
there was raised expression of angiotensinogen and the ANG II type 1 receptor 
compared with subcutaneous fat of both obese and lean individuals. Thereby, the 
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authors suggested that the presence of these RAS components in visceral adipose tissue 
may play an important role in the development of renal dysfunction in obesity 
(Giacchetti et al., 2002). Moreover, higher plasma concentrations of angiotensinogen, 
rennin and aldosterone and ACE activity levels were found in obese compared to slim 
menopausal women and these were reduced by later weight loss (Engeli et al., 2005). 
However, the gene expression of RAS components in visceral fat was not influenced by 
weight loss (Engeli et al., 2005). Finally, the increase in RAS components and, in 
particular, ANG II by obesity may affect renal function and structure through an 
increase in inflammation, hypertension and an increase in lipid metabolism. 
 
Figure 1.4 Graphical representation of cellular dysfunction in renal tissues proposed in this section 
and the different fate for same of different cells type residing in the renal tissues.  
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1.3.4 Haemodynamic role in renal disease 
1.3.4.1 Hypertension 
As reviewed by Montani et al., obesity predisposes to hypertension, which leads 
to significant structural and functional renal alterations, such as increased glomerular 
filtration rate (GFR), renal plasma flow (RPF) and urinary albumin excretion (Montani 
et al., 2002). During the course of obesity, there is an increase in systemic levels of 
FFA, leptin and insulin, which in turn may increase activity of the sympathetic nervous 
system (Kassab et al., 1995). The conjunction of these factors promotes 
vasonconstriction, sodium and water retention (Montani et al., 2002). As obesity 
progresses, there is an induction of insulin resistance, which is followed by cytokine 
production, exacerbated endothelial dysfunction and a rise in vascular tone (Hotamisligil 
et al., 1993). In addition, the increase in lipid deposition in adipose tissue and the 
sympathetic activation increases the synthesis of RAS components, resulting in further 
sodium and water retention. The combination of these factors is the main promoter of 
hypertension associated with obesity (Giacchetti et al., 2002). 
1.3.4.2 Hyperfiltration 
In the first stages of chronic renal disease, there is usually an elevation in GFR 
along with an increase in RPF, which has been observed in animal models and non-
diabetic obese patients (Chagnac et al., 2000; Williams et al., 2007). These 
haemodynamic alterations probably occur as a result of a change in arteriolar/efferent 
dilatation balance and an increase in glomerular pressure. These effects are likely to be 
mediated by a rise in RAS component activity and abnormal sodium sensitivity 
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(Henegar et al., 2001; Deji et al., 2009). In addition, these changes in haemodynamic 
features are followed by morphological alterations, including renal sclerosis and the 
consistent presence of glomerulomegaly (Deji et al., 2009). In dogs, obesity is followed 
by a rise in GFR and RPF and renal structural changes, such as matrix expansion and 
glomerulosclerosis (Henegar et al., 2001). Moreover, Kassab et al. observed an increase 
in cumulative sodium retention as a possible response to a high fat diet, in part, due to 
enhanced tubular reabsorption by sympathetic activation. Hall et al. proposed that this 
may result in reduced salt delivery to the macula densa, increasing the activity of RAS 
and in turn leading to hypertension (Hall, 1994). Moreover, weight loss in severely 
obese subjects without overt renal disease was followed by improved glomerular 
haemodynamics. These improvements were associated with a decrease in blood pressure 
and GFR (Chagnac et al., 2003). Therefore, the elevated obesity-related hyperfiltration 
induces slow, progressive renal dysfunction, particularly when obesity and hypertension 
are simultaneously present.     
1.3.5 Renal lipotoxicity 
There is an strong association between inflammatory renal diseases and the  
accumulation of lipids the renal on the epithelium (Kimmelstiel, 1936). Recently, 
several animal models supported the possibility that diet-induced obesity increased renal 
lipid accumulation and can cause glomerulosclerosis (Jiang et al., 2005; Proctor et al., 
2006). Generally, FFAs are attached to albumin which, in the kidneys, is filtered 
through glomeruli and reabsorbed into the proximal tubes. Kamijo et al. demonstrated 
that FFA binds to albumin and the interaction of these two is the main contributor for 
nephrotic syndrome through reabsorption into the proximal tubes (Kamijo et al., 2002). 
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The mechanisms of incorporation of non-polar lipids and promotion of lipotoxicity 
involve proximal tubular cells, which in turn, activates the innate immune system 
inducing an inflammatory response leading to cell apoptosis (Arici et al., 2002). An 
additional mechanism of lipotoxicity involves the exposure of mesangial cells to TG-
rich lipoproteins, such as LDL. As a consequence, the mesangial cells undergo cell 
proliferation, whereas oxidised LDL has a cytotoxic effect (Nishida et al., 1999). 
Furthermore, oxidised LDL stimulates the secretions of extracellular matrix and 
cytokines such as IL-6 and TNF-Į IURP PHVDQJLDO FHOOV (Nishida et al., 1999). In 
addition, as previously described, the over-exposure to IGF-1 accelerates the uptake of 
lipids in rat glomerular mesangial cells, which become lipid-laden foam cells. Therefore, 
lipid uptake is mediated through increased endocytosis and its accumulation affects 
cellular organisation, which causes impairment in normal cell function such as 
phagocytosis and migration (Berfield et al., 2002). Over-accumulation of lipids by 
mesangial cells reduces the contractile response to ANG II. Following removal of the 
excess in lipid from these mesangial cells, the contractile response is restored (Berfield 
et al., 2002). Administration of ANG II to rats induces the expression of SREPB-1 and 
results in renal lipid accumulation of TG and cholesterol. There was also a significant 
increase in the expression of factors associated with renal dysfunction and inflammation, 
such as VEGF and collagen IV, leading to glomerulosclerosis and proteinuria (Jiang et 
al., 2005). Changes in ANG II metabolism are also associated with an abnormal 
accumulation of renal iron and increased amounts of superoxide. Several studies 
demonstrated that increase FFA induces renal dysfunction through an enhanced 
generation of ROS. In obese ZDF prediabetic rats, there is an increase in circulating 
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FFA, which promotes the activation of NADPH oxidase, a major producer of vascular 
ROS. In this model of obesity, there is a reduction in aceltylcholine as a vasodilator, 
involving a possible reduction in NO as the main cause of endothelial dysfunction 
(Chinen et al., 2007). Short term elevation in FFA (2 hours) in healthy insulin-sensitive 
subjects induces endothelial dysfunction via a reduction in NO production and action 
(Steinberg et al., 1997). The increase in oxidation may have a modulatory effect on the 
expression of genes related to aging and fibrogenesis (Saito et al., 2005). Jiang et al. 
have found that the inhibition of lipogenic genes in mesangial cells also reduced the 
expression of genes involved in inflammation and modulation of fibrosis (Jiang et al., 
2007).  
1.4 The kidneys and oxidative stress 
1.4.1 Concept of oxidative stress 
ROS are derivates of oxygen metabolism produced by all living organisms 
(Gardner & Fridovich, 1992). These oxygen species are short lived and, because of their 
high reactivity, are able to interact with all surrounding macromolecules, including 
lipids, carbohydrates and nucleotides. When the production of ROS exceeds the 
antioxidant capacity of the cell, it starts a degenerative process called denominated 
oxidative stress (OxS) (Chen et al., 2004b). Thereby, due to its cytotoxicity and 
reactivity, an excess of ROS can induce several processes associated with cell damage, 
including lipid peroxidation, DNA and protein modification (Bae et al., 1997). 
Production of ROS also has important functions in the cell cycle and is involved in 
several biochemical processes, including cellular differentiation, growth arrest, 
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apoptosis, immunity and inflammation (Ding et al., 2000; Levy et al., 2000; Chen et al., 
2004b). The classification of ROS also includes oxygen metabolic by-products of 
oxygen metabolism, such as superoxide (O2.-) and hydrogen peroxidate (H2O2), along 
with reactive nitrogen species, such as nitric oxide (NO) and peroxynitrite radical 
(ONOO.) (Beckman et al., 1990). Although ROS are short-lived molecules, their 
detection is generally based on the trace of modified end products. Thus, during lipid 
peroxidation, unstable products of the reaction between FFA and O2.- break down into 
smaller and more stable products, including malonyldaildehyde (MDA), acrolein, 4-
hydroxynonenal (HNE) or better denominated thiobarbituric acid substances (TBARS). 
Additional examples of ROS-damaged products include oxidised nucleic acid bases 8-
hydro-deoxyguanosine (8-OHdG) and oxidised proteins (nitrated tyrosines). Moreover, 
the reaction between NO and O2.- decreases its vascular function as a vasodilator, 
leading to metabolic dysfunction, which has been implicated in inflammation and early 
renal damage (Ece et al., 2006). The reaction between ONOO- and proteins results in the 
nitration of tyrosine residues and the formation of 3-nitrotyrosine, which could 
potentially lead to vascular damage (Amirmansour et al., 1999). At the molecular level, 
the nitration of tyrosine may alter protein function, initiating protein damage. Thus, the 
presence of 3-nitrotyrosien has been used as a marker for ONOO- (van der Vliet et al., 
1995). 
1.4.2 The antioxidant System     
All aerobic organisms possess a complex antioxidant defence system, which can 
be divided into two main components: a group of antioxidant enzymes and organic 
compounds. The first group consists of a coordinate enzymatic cascade, which includes 
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the superoxide dismutases (SOD), catalase (CAT) and glutathione peroxidise (GpX) 
(Fig. 1.5). The second group is a non-enzymatic group, which includes the vitamins C, 
(ȕUHGXFHGJOXWDWKLRQHDQGRWKHUFRPSRXQGV 
The first enzyme to be activated in the enzymatic cascade is SOD, which is able to 
convert O2.- to a the less reactive form H2O2 (O2.- + O2.- +ĺ+2O2 + O2) (Gardner & 
Fridovich, 1992). There are three SOD isoforms in mammals: cytosolic Cu/Zn SOD, 
mitochondrial Mn-SOD and extracellular EC-SOD (Mates et al., 1999) and all these 
enzymes are able to neutralise O2.- at very high reaction rate (Meier et al., 1998). At a 
cellular level, there are two main sources of O2.-: one is the respiratory chain in the 
mitochondria and the other is the activation of NADPH by cytokines or RAS (Chen et 
al., 2004b). SOD in endothelial cells has a protective role, attenuating the effects of 
induced superoxide anion by cytokines, such as TNF-Į7KHVHUHVXOWVVXJJHVWWKDW62'
has anti-inflammatory properties and may play an important role in the reduction of the 
inflammatory response (Lin et al., 2005a). Moreover, EC-SOD has an important role in 
maintaining the extracellular oxidant/antioxidant equilibrium, thus regulating the 
adaptation of several tissues, including the kidneys, to a low oxygen environment 
(Suliman et al., 2004). The by-product of the neutralisation of O2.- by SOD is H2O2. This 
molecule, unlike O2.-, can diffuse across membranes (Antunes & Cadenas, 2000) and is 
also a highly reactive free radical. Two enzymes, CAT and GpX, are involved in the 
neutralisation of H2O2. CAT transforms H2O2 to water and molecular oxygen (2 H2O2 
ĺ&$7ĺ  +2O + O2) very efficiently. There are five GpX isoforms expressed in 
mammals, and the abundance of each type varies according to the tissue. All of them are 
found in the kidneys (de Haan et al., 1998). Although GpX shares the substrate with 
53 
 
CAT, these enzymes also have the capacity to reduce lipoproteins and other 
hydroperoxides to their corresponding hydroxylated compounds, using glutathione as a 
K\GURJHQ GRQRU 522+  *6+ ĺ*S;ĺ52+  *66*  +2O). Furthermore, the 
GpX enzymes are able to neutralise 95% of the total H2O2, being the major source of 
protection against low levels of OxS (Sies et al., 1997). 
 
 
 
 
 
 
 
Figure 1.5  Superoxide neutralisation by superoxide dismutase family (SOD) 
 
1.4.3 Vascular endothelial cells and nitric oxide production 
Vascular endothelial cells have a number of important functions. They provide a 
natural barrier between the vessel wall and the lumen and maintain vascular tone by 
secreting a number of mediators. Thus, the dysfunction in the endothelium induces 
several processes, including platelet aggregation and coagulation, involved in 
cardiovascular health. Endothelial cells produce a large number of compounds, which 
mainly induce vasoconstriction, including endotheilin-1 or vasodilatation, such as nitric 
oxide (NO).  
A number of observations demonstrate that endothelial NO production is induced 
by insulin-receptor pathways and the uptake of glucose (Montagnani et al., 2002; Chen 
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et al., 2003a). By this action, insulin stimulates the endothelial cells to produce NO, 
which is a potent vasodilator and anti-thrombotic mediator. Additional metabolic 
components, such as adiponectin, also have vascular actions by stimulating the 
production of NO in endothelial cells (Chen et al., 2003a). Furthermore, insulin NO 
mediated stimulation can be suppressed by IL-6. In vitro exposure to IL-6 results in 
impaired IRS-1 phosphorylation and in a reduction of NO production in endothelial cells 
(Andreozzi et al., 2007). Additional evidence indicates that ANG II is also able to 
interfere in NO generation through the insulin pathway (Andreozzi et al., 2004). Finally, 
the anti-diabetes drug, metformin, restores the NO insulin mediated synthesis (Davis et 
al., 2006). These observations suggest a link between obesity-insulin resistance and NO 
secretion.  
1.4.3.1 Nitric oxide synthase (NOS) 
Nitric oxide (NO) is a key biological messenger and one of the few known 
gaseous signalling molecules. This molecule plays a major role in several biological 
processes, such as vasodilatation and the inhibition of platelet aggregation. NO, also 
known as the endothelium-relaxing factor (EDRF), is biosynthesised endogenously by a 
family of enzymes called nitric oxide synthase (NOS).  
There are three major isoforms of NOS: inducible (iNOS), neural (nNOS) and 
endothelial (eNOS). In addition, the activation of each of these enzymes can be induced 
by four other cofactors to produce NO, including flavinmononucleotide (FMN), 
calmodulin, bihydrobiopterin (BH4) and flavin adenine dinucleotide (FAD).  
The most common reaction used in the production of NO involves the oxidation of 
the nitrogen atom of L-arginine, which is catalysed by all three isoforms of NOS. ROS 
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can consume NO in a series of reactions that leads to a reduction in its vasodilatation 
properties (Nathan, 1992). Exposure to ROS can transform NO to other forms of 
reactive nitrogen species such as nitorsonium cation (NO+), nitroxyl anion (NO-), or 
peroxynitirtite (ONOO-). Oxygen reacts with NO to produce ONOO-, which may 
dissociate into NO and OH. ONOO oxidises the zinc-thiolate centre of NOS, producing 
a decrease in NO generation. Furthermore, H2O2 reacts with several renal proteins 
containing iron, producing hydroxyl radical (HO.), which in turn produces biologically 
inactive forms of NO, such as nitrite NO2 and nitrate NO3 (Haber-Weiss reaction) 
(Beckman et al., 1990). Thus, a decrease in NO activity is associated with OxS and 
hypertension. 
In rats with induced chronic myocardial infarction, an increased production of NO 
by eNOS was observed. However, the increased formation of O2.- inactivated most of 
the NO and this process was only reversed by treatment with exogenous superoxide 
dismutase (SOD). This observation demonstrated that the affinity between NO and O2.- 
is higher than the affinity of O2.- by SOD and this accelerated its degradation 
(Bauersachs et al., 1999).  
An additional modulation in the production of NO is a decrease in substrate, 
cofactors or toxins (Shimokawa et al., 1991; Pou et al., 1992). For instance, pertussis, a 
toxin associated with porcine artery injuries, is able to alter the cell signal of eNOS 
leading to a reduction in NO production (Shimokawa et al., 1991). Diet can also 
regulate NO production. Ren et al. have shown, during low NaCl intake in rabbits, that 
nNOS function alters renal afferent arteriole diameter in the macula densa. This data 
indicates that macula densa nNOS is activated by low NaCl, suggesting that NO brings 
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the glomerular filtration rate to an appropriate level during renin secretion, a result of 
low sodium intake (Ren et al., 2001). Increased NO production by nNOs can also 
reverse OxS and hypertension through improved parasympathetic activity in 
spontaneously hypertensive rats (SHR) (Heaton et al., 2007). The oxidation of cofactor 
BH4 reduces its capacity to be used in the production of NO. The absence of BH4 leads 
eNOS to produce O2.- instead of NO, starting a process called NO uncoupling, which 
leads to an increase in OxS (Kerr et al., 1999). Thus, NO has important roles in the 
kidney, including the regulation of tubular NaCl transportation, modulation of renal 
sympathetic nerves and cell antioxidants.  
1.4.3.1.1 Production of NO 
As reviewed by Higashi et al., mechanical forces, such as laminar and oscillatory 
shear stress, lead to alterations in endothelial function mediated through changes in NO 
bioavailability. Several studies observed that laminar shear stress, through an increase in 
physical activity, increased NO production and had an important role in the regulation of 
vascular tone (Higashi et al., 2002). In vitro data indicates that shear stress in 
endothelial culture cells stimulates the gene expression of eNOS and the production of 
NO (Uematsu et al., 1995). In dogs, shear stress induced by 10 days of exercise 
increased the expression of eNOS mRNA and protein abundance in epicardial coronary 
arteries, leading to acetylcholine induced release (Sessa et al., 1994). Oscillatory shear 
stress results in increased production of ROS via NADPH (Vaziri et al., 2003). 
Although there is a large body of evidence about the effects of these forces in vascular 
tissues, less is known about the kidney. In vitro studies in podocytes demonstrate that 
mechanical stress can lead to glomerulosclerosis through a re-organisation of the actin 
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cytoskeleton, elevating the probability of podocyte detachment (Friedrich et al., 2006). 
Furthermore, exposure to continuous shear stress leads to an activation of ATR1 mRNA 
expression in cultured podocytes and in turn to cell apoptosis (Durvasula et al., 2004).  
An additional pathway that contributes to the production of NO is the 
insulin/IGF1. The activation of this pathway promotes vasodilatation by activating the 
insulin receptor through PI3-Kinase/AKT that leads to the activation of eNOS, starting 
the secretion of NO (Montagnani & Quon, 2000). Thereby, IGF-1 and insulin decrease 
vascular contraction. The local mechanisms by which these hormones may decrease 
vascular reactivity include the partial release of nitric oxide (NO) (Hayashi et al., 1997). 
An increase in NO generation is observed in early stages during streptozotocin treatment 
in diabetic rats, which show signs of glomerular hyperfiltration, due to greater 
expression of glomerular endothelial nitric oxide synthase (eNOS) (Veelken et al., 
2000). In addition, insulin also promotes vascular contraction by inducing an increase in 
cytosolic calcium. Thereby, the contractive actions of ANG II in mesangial cells might 
be attenuated by an increase in insulin resistance. Thus, insulin and IGF-1 are active in 
promoting vascular relaxation and contraction, in part via increases in NO 
bioavailability and ANG II activity (Kreisberg, 1982; Standley et al., 1991). 
1.4.3.2 NADPH oxidase family and HIF system 
Several studies demonstrate that the different isoforms of NADPH are the main 
source of ROS, thereby having an important role in the development of renal and 
vascular dysfunction (Zafari et al., 1998). The first member of the NADPH family to be 
discovered was the phagocyte Gp91phox (phagocyte oxidase), presumed to be activated 
DV SDUW RI WKH YHVVHOV¶ response to injury and inflammation. Additional studies have 
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shown the existence of different Gp91phox isoforms, which are expressed in other cell 
types, including: fibroblast, endothelial cells and smooth muscle cells. To avoid 
confusion, the enzymes in these cells are called Nox (non-phagocyte NADPH oxidase) 
(Touyz et al., 2002; Chamseddine & Miller, 2003).  
NADPH oxidase is a multiple protein electron transport system that includes the 
membrane-bound flavocytochrome b559 (formed by gp91phox and p22phox) and three 
cytosolic proteins (p47phox, p67phox and Rac 1 or 2). Flavocytochrome b559 bears the 
NADPH binding site and a redox centre (FAD and heme). Electrons flow through the 
redox centres, where NADPH transforms oxygen to superoxide (Koshkin et al., 1997). 
Shiose et al. have reported a novel NADPH homologue, Nox 4 that is abundant in adult 
and fetal kidneys (Shiose et al., 2001). Later tissue and cell analysis revealed the 
expression of all additional members of the Nox family, including Nox 1, Nox 2, Nox 3 
and Nox 5, in renal tissues (Suh et al., 1999; Cheng et al., 2001; Shiose et al., 2001).  
ANG II regulates these enzymes by phosphorylating the p47phox unit, inducing the 
subsequent activation of NADPH oxidase and the generation of ROS (Touyz et al., 
2002). It is well established that the ROS produced from Nox by over-exposure to ANG 
II has hypertrophic and proliferative effects on mesangial cells and fibroblasts 
(Chamseddine & Miller, 2003; Gorin et al., 2003). Infusion of ANG II for 7 days in rats 
(1mg/Kg/d) causes endothelial dysfunction by raising vascular superoxide production 
and increasing the expression of NADPH oxidase subunit p22phox, Nox1 and gp91phox. 
The infusion also led to eNOS uncoupling, which may further enhance oxidative stress 
in vascular tissue, thereby decreasing NO bioavaibility (Mollnau et al., 2002).  
59 
 
In acquired forms of hypertension in rodents, such as surgical nephrectomy, there 
was a rise in oxidative stress markers (lipid and protein oxidation), followed by a 
reduction in cellular SOD isoforms. These alterations were possibly induced by the 
significant elevation of Nox activity and expression in renal tissues (Vaziri et al., 2003). 
The abundant expression of Nox 4 protein and mRNA in the proximal convoluted tubule 
may suggest that it has a function as oxygen sensor (Geiszt et al., 2000). It is appropriate 
to presume that function exists because these cells are the major regulators of renal 
oxygen consumption and are sensitive to hypoxia (Bernhardt et al., 2007). 
The key mediators of cellular adaptation to low oxygen levels are the hypoxia 
inducible factors (HIFs), HIF-1 and HIF-2. They consist of two subunits: an oxygen-
sensitive unit-ĮRU+,)-ĮDQGDFRQVWLWXWLYHO\H[SUHVVHGȕ-unit, also known as HIF-ȕ
During hypoxia, the activation of HIF is dependent upon stabilisation of the HIF-Į
subunit and its translocation to the nucleus, where it forms a functional complex with 
additional co-activators (CBP/p300). Under normal levels of oxygen, HIF-Į LV
degradated after binding to the von Hippel-Lindau tumour suppressor protein (Jaakkola 
et al., 2001). This interaction requires iron, oxygen and 2-oxogutarate for the 
hydroxylation of the proline residues within the HIF-Į VXEXQLW (Jaakkola et al., 2001; 
Elkins et al., 2003). However, in vascular smooth muscle cells, ANG II is able to 
activate HIF-1 by over expressing HIF-ĮSURWHLQ 
The activation of HIF-ĮE\$1*,, LVGLIIHUHQW IURPK\SR[LF LQGXFWLRQ8QGHU
aerobic conditions, the protein induction of HIF-ĮE\$1*,,LVWKUough the activation 
of two different pathways. One activates the IGF-1 receptor for HIF-Į WKURXJK WKH
PI3K pathway for protein translation. The second mechanism involves the tyrosine 
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kinase receptor activation by ANG II, essential in both the induction and activation of 
HIF-1 (Lauzier et al., 2007). Thereby, the activation of HIF 1 and 2 influences genes 
that play important roles in cell metabolism in adaptive responses to hypoxia, including 
the angiogenic gene VEGF and the glucose transporter GLUT-1 (Warnecke et al., 
2003). 
In several in vivo animal models of kidney disease, these reno-protective effects of 
the HIF system were identified by cobalt chloride preconditioning, producing an 
inhibition of prolyl-hydroxylation  (Matsumoto et al., 2003). These observations 
emphasise the importance of the stabilisation of HIF-ĮEHIRUHWKHRQVHWRIUHQDOLQMXU\
On the other hand, deletion of the pVHL gene from glomerular cells in rats is sufficient 
to induce a rapid proliferation of podocytes, resembling glomerular disease (Ding et al., 
2006). Moreover, Higgings et al. demonstrated that the activation of renal epithelial 
HIF-Į ZLWKRXW FKHPLFDO SUHFRQGLWLRQLQJ SURPRWHG H[FHVVLYH ILEURVLV ZKHUHDV WKH
inhibition of HIF-Į LQKLELWHG WKH GHvelopment of tubulointersititial fibrosis. This 
protective effect was associated with a decrease in collagen deposition and cell 
infiltration (Higgins et al., 2007). These results demonstrate the fragile balance between 
the activation of oxygen sensing and oxidative stress. 
1.5 Conclusions and future perspectives 
Overall, the data collected from human and animal studies has expanded our 
understanding of how the early nutritional environment affects growth. The inclusion of 
additional studies that focus on the effects of obesity adds to our knowledge of the basic 
pathways and morphological changes that contribute to the development of renal 
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dysfunction. However, our understanding of the interaction between the kidneys, the 
obesogenic environment and early nutritional manipulation is incomplete.  
In recent years, our laboratory has made considerable progress in the 
characterisation of the metabolic outcomes resulting from a compromised intrauterine 
environment during organogenesis. Using sheep as an animal model, the predominant 
responses to a reduction in fetal nutrient supply, between early to mid-gestation, were 
changes in insulin sensitive tissues (i.e. muscle, liver and adipocyte) (Sharkey et al., 
2009; Chan et al., 2009; unpublished observations). It is important to note that these 
sheep, at adolescence, showed considerable weight gain. Furthermore, it was also 
observed that, at one year of age, regardless of maternal diet during gestation, exposure 
to an obesogenic environment, produced an increase in visceral adipose tissue 
deposition and dysfunction characterised by perturbed insulin signalling, an abundance 
of crown-like structures and activation of pro-inflammatory genes (Sharkey et al., 
2009). In parallel, obesity in this animal model led to hyperinsulemia, hyperleptemia 
and a considerable increase in plasma FFAs concentration (Sebert et al., 2009). Of 
further note, there was evidence of renal structural changes, such as glomerular 
hypertrophy, which appeared before the onset of hyperglycemia (Williams et al., 2007). 
In sheep, at one year of age, exposure to an obesogenic environment produced renal 
VWUXFWXUDOFKDQJHVZKLFKLQFOXGHGJORPHUXORPHJDO\ZLWK%RZPDQ¶V capsule expansion 
and glomerulosclerosis (Williams et al., 2007; Sharkey et al., 2009). These markers of 
renal dysfunction were particularly exacerbated in obese sheep not exposed to maternal 
nutrient restriction.  
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Stimuli from the surrounding environment, in addition to alterations induced by in 
utero nutrition, also contribute to the renal adaptation to the obesogenic environment. 
The induction of oxidative stress by certain metabolic pathways, such as RAS and 
insulin axis, and their influence in renal development and function provide good tools to 
understand the interaction between the kidneys and different tissues. Finally, 
discrimination between, and identification of, early changes induced in utero and 
obesogenic adaptation may lead to new reno-protective interventions and improved 
maternal and offspring health outcomes.  
1.6 Main hypothesis 
The main hypothesis of my study was that the relative structural renal 
amelioration observed in those obese offspring previously exposed to maternal nutrient 
restriction is a product of post-injury responses, inducing scarring and other adaptations 
to obesity. In addition, the severity of the renal dysfunction is at a similar stage to that 
observed in other tissues of this animal model, including the adipose tissue of both 
obese groups. The following chapters were designed for these aims: 
1. Description of the effects induced by maternal nutrient restriction in renal and 
adipose tissue in early postnatal life prior to exposure to an obesogenic 
environment. 
2. Identification of structural renal alternations and their molecular markers and 
whether these exhibit different progression in the renal disease induced by 
obesity when offspring have previously been exposed to maternal nutrient 
restriction compared to those who were born to control fed mothers. 
 
63 
 
3.  Due to the interaction between the adipose tissue maturation and renal health, 
the last aim was to identify a potential alteration induced by maternal nutrient 
restriction in adipose tissue, which may affect differentially the progression of 
renal disease between both obese groups. 
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Chapter 2 - Materials and Methods 
 
2.1 Study Protocols 
The laboratory procedures were all conducted at the School of Clinical Sciences, 
Division of Human Development, Academic Child Health, and University of 
Nottingham. The animal research was conducted with the approval of the Home Office 
and performed according to the terms of the Animals Act. In addition, all experimental 
protocols were followed according to national legislation, with the ethical approval of 
the University of Nottingham. 
All the laboratory protocols were followed, under the United Kingdom Control 
Substances Hazardous to Health (COSHH: SI No 1657, 1988) code of laboratory 
practice, and administered by the University of Nottingham. Unless otherwise stated, all 
the chemicals and reagents were obtained from Sigma-Aldrich Company (Gillingham, 
UK) and equipment was obtained from Laboratory Supplies. Details of all suppliers and 
the standard solutions used can be found in the Appendix. 
2.2 Animal Study 
Welsh Mountain ewes of similar age and body composition were selected for this 
VWXG\7KURXJKRXWWKHH[SHULPHQWDQLPDOVZHUHNHSWDWWKH8QLYHUVLW\RI1RWWLQJKDP¶V
Joint Animal Breeding Unit at the Sutton Bonington Campus. The ewes were mated 
with Texel rams. At 30 days of pregnancy, the ewes were scanned by real time 
ultrasound to determine fetal number. Only mothers pregnant with twins (n=26) were 
selected for this study.        
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 Ewes were randomly allocated to either a nutrient restricted group (NR or NR-O, 
n=12), fed at 50% of metabolic energy requirements (3,5MJ/day) from day 30 to 80 of 
gestation, a control fed group euthanased at seven days of age (C, n=7), an obese group 
(O, n=7) or lean group (L, n=8). Both the latter groups were fed to 100% of the 
requirements (7MJ/day).  After day 80 of gestation until term, the diet of all the groups 
was restored to 100% of the calculated metabolic need (12-13MJ/day)(Clarke et al., 
1998).  
Throughout the period of experimentation, the animals were fed daily between 
8.00 am and 9.00 am and all feed intake was recorded.  The metabolic requirements 
during the period of pregnancy were based on the Agricultural and Food Research 
Council recommendations (1980)(Council, 1980). The diet for the mothers consisted of 
1kg of chopped hay per day and an increasing proportion of barley (200-500g per day), 
depending on nutritional group and period of pregnancy. In addition, each group had 
free access to water and was given adequate minerals and vitamins. 
Twenty-two newborn (12 female and 10 male) sheep, which were born from 
control fed mothers, were randomly assigned to the Lean or Obese control groups. This 
was undertaken irrespective of gender, because previous observations in 1 year old 
sheep demonstrated no difference in metabolic responses (Gardner et al., 2005). The 
maternal nutrient restricted group was composed of twenty-two newborns, in which 6 
were born male and 18 were females.             
At 7 days after birth, one offspring from each mother from the groups C and NR 
were humanly euthanased and their tissues were immediately taken for molecular 
measurements and preservation at -80oC until further analysis (Fig. 2.1) (Council, 1992). 
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The remaining offspring from all the groups were kept with their mother during 
lactation for 10 weeks. During this period, all mothers were fed a diet to fully meet the 
metabolic needs during lactation. Then, between the 4th and the 12th month of postnatal 
life, the physical activity of the offspring of O and NR-O groups was restricted (by 
housing at a stocking rate of 17 animals per 50m2) and they were fed hay and 
concentrated pellets to promote obesity (Williams et al., 2007). Lean offspring remained 
at pasture, and exhibited a four-fold increase in physical activity compared to the other 
groups (Williams et al., 2007). This increase was confirmed by accelerometry 
µ$FWLZDWFK¶/LQWRQ ,QVWUXPHQWLRQ8.HYHU\VHFRQGVRYHU DKRXUSHULRG All 
the groups had free access to water during the experimentation. 
At one year of age, the sheep were humanely euthanased, using an electric shock. 
The tissue samples, including the kidney and perirenal adipose tissue (PAT), were 
collected and snap frozen in liquid nitrogen and stored at -80oC until further analysis. 
Prior to preservation, all vital organs, including the kidneys, were weighed and 
dissected. From this tissue, some samples were extracted for immunochemistry analysis  
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OBESE
(n=7)
* * *
NR-Obese
(n=12)
* NR *
* * *
LEAN
(n=8)
30 80 1450
*
Low physical activity 
fed to promote obesity
6 120-3
* Normal activity
*
Low physical activity 
fed to promote obesity
Birth MonthsDays (sheep gestation)
Prenatal Lactation Postnatal
(*) fed to meet 100% of the metabolic 
requirement
(NR) fed to meet 50% of the metabolic 
requirement
7 day group
C (n=7)
NR(n=12) 
1 year group
L(n=8)
O(n=7)
NR(n=12) 
and were preserved in 10% formol saline (10% (v/v) formaldehyde in 0.9% (v/v) 
sodium chloride) (Fig. 2.1). 
Figure 2.1 Schematic diagram describing the animal model used in this study 
 
In this study, in addition to Welsh mountain flock, Border Leicester cross 
Swaledale sheep were also used for the perirenal fat ontogeny of the DNA 
methyltransferase (DNMT)-1. Previous studies had established that there were no 
distinguishable differences in molecular development between these breeds 
(Gnanalingham et al., 2005). All mothers included in this study were fed to nutritional 
levels stipulated by the Agricultural and Food Research Council throughout gestation (7 
MJ/day). Randomly selected animals were euthanased either at birth (n=7) or at 30 
(n=9) days after birth, and their organs dissected following similar procedures as 
described above. 
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2.2.1 Collection of plasma samples from lambs 
In order to collect venous blood at one year of age, all offspring were kept in a 
barn for one week prior to surgical implantation of arterial and venous catheters. During 
a period of 24 hours before surgery, food, with exception of water, was withdrawn from 
all animals. For the insertion of the catheters, an anaesthetic was applied (propofol, 
Rapinovet; 6mg.kg-1; National Veterinary Supplies Ltd.) and animals were maintained 
with 3-4% l.min-1 O2. In the area to be catheterised, the neck was shaved and cleaned. 
The incision was closed after the operation. In addition, the sheep received a dose of 
antibiotic, to prevent any infection. This included 10mg.kg-1 I.M. propcaine penicillin 
(Duphapen, Fort Dodge Animal Health Ltd, Southampton, UK) and a dose of analgesia 
2mg.kg-1 I.M. flunixin meglumine (Finadyne, Schering-Plough, Kenilworth, UK) for 3 
days after surgery. Catheter patency was maintained by a flushing 50 I.U/ml-1 of saline 
heparin per day. The normal pattern of feeding was restored 1 hour after surgery. No 
animal exhibited any signs of physical discomfort during, or after, this procedure. 
After blood sampling, and immediately after surgery, the 10 ml blood samples 
were placed immediately into heparinised tubes and kept at 4oC. Aliquots of the blood 
previously collected were used to analyse: sodium concentration [Na2+], calcium [Ca2+], 
potassium [K+], and chloride [Cl-]. In addition, haematocrit and of blood glucose and 
lactate concentrations were recorded. 
2.3 Tissue analysis 
After their removal from the ultrafreezer (-80oC), tissues selected for analysis 
were preserved in a closed polystyrene box containing dry ice. For each analysis, 
69 
 
selected amounts of kidney cortex or PAT were dissected from each sample, depending 
on the assay to be performed. Each sample received a code number (in order to blind the 
analysis) and their dissected weights were recorded on an Excel data sheet. The 
remaining tissue was returned to the ultrafreezer immediately. In addition, the selected 
samples were kept in dry ice or returned to the ultrafreezer for later use.  
2.3.1 Protein extraction from frozen tissues 
Protein extraction consists of a series of procedures to free the proteins from the 
matrix and stabilise them in a suitable working buffer of the assay of interest. The first 
step is to homogenise the tissue and release the protein content from the cell. The 
average mammalian cell, which builds the renal tissue, is approximately 10µm in 
diameter (Mathews et al., 1999). It possesses a cytoskeleton, which maintains the cell 
shape, and it is enclosed by a membrane built of a thin bilayer of amphipathic 
phospholipids. For this reason, mammalian cells lack rigidity and are easy to disrupt by 
sheer force, such as that produced by a simple homogeniser. The second consideration is 
the type of buffer to use, which depends on the analysis to be performed and the type of 
proteins to be analysed. For the study of whole cell proteins, RIPA buffer (a phosphate-
base buffer) is commonly used because it has similar properties, such as acidity and 
density, to the cell cytosol. Another important characteristic is its compatibility with a 
wide range of protease inhibitors, thereby preventing proteolysis (Wilson & Walker, 
2001) (Nevalainen et al., 1996). For that reason, RIPA buffer is the optimum medium 
for studying total protein concentrations. It is also an ionic buffer, able to denature some 
proteins and disrupt protein-protein interactions. Therefore, it should not be used in 
enzyme activity tests. Another important limitation of RIPA buffer is  that it is an ionic 
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buffer, increasing the background of some assays, such as in the detection of lipid 
peroxidation (Mathews et al., 1999).  
To study mitochondrial proteins, a dense buffer is needed to separate the 
mitochondrial fraction from the cytosol. The basic principle of this procedure is that the 
homogenisation of the tissue is followed by high speed centrifugations, producing a 
pellet, the mitochondrial fraction. The components that help in this process are: sucrose, 
tween-20 (ionic detergent), and different derivates of glycerol. The buffer has two 
important ingredients:  EDTA, which helps to prevent mitochondrial swelling by 
chelating calcium ions, and albumin, which removes free fatty acids, reducing 
respiration and preserving the mitochondria structure (Symonds et al., 1992). 
2.3.1.1  Whole cell lysate procedure 
The procedure used for the extraction of whole cell protein fractions from the 
renal cortex was an adaptation from the method published by Haimovich et al 
(Haimovich et al., 1991). To each 100 mg dissected of renal cortex were added 300 µl 
RIPA buffer containing the protease inhibitors, phenylmethylsulphonyfluore (PMSF) 
(10µg/ml), aprotinin (30 µl per ml of RIPA) and sodium orthovanadate (100 mM). Each 
sample was homogenised using a Dispomix® (GC biotech B.V., Alphen aan den Rijn, 
Holland) homogeniser at 9000 rpm for 45 seconds, until the tissue was completely 
homogenised and no clumps of tissue were present. To each lysate was added 30 µl of 
PMSF (10 mg/ml) before incubation at 4oC for 30 minutes. Following this, the 
homogenates were centrifuged at 10000 rpm for 10 minutes at 4oC and from each 
sample only the supernatants were placed in a sterile 500 µl microcentrifuge tubes in 
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aliquiots of 100 µl. These protein samples were stored at -20oC until required for further 
analysis. 
2.3.1.2 Mitochondrial cell fraction procedure 
The procedure used for the mitochondrial fraction from the renal cortex was an 
adaptation from the method published by Symonds et al. (Symonds et al., 1992). 
To each 1 g of renal cortex dissected was added 10 ml homogenisation buffer. 
Each sample was homogenised using a Dispomix® homogeniser at 9000 rpm for 45 
seconds, until the tissue was completely homogenised and no clumps of tissue were 
present. Homogenisation buffer was added to achieve a final volume of 2 ml buffer per 
100 mg of tissue. Following this, the crude homogenate was centrifuged (T-1045, 
Kontron AG, Germany) at 900 x g at 4oC for 10 minutes. The protein concentration of 
each crude homogenate was determined using a Bradford Assay (Sigma), 200 µl aliquot 
was separated from each crude sample and stored at -20oC, until further analysis. 
The remaining supernatant was filtered through two layers of surgical gauze to 
remove any lipids and centrifuged at 13000 x g at 4oC for 30 minutes. Finally, the 
mitochondrial fractions were placed in a sterile 500 µl eppendorff tubes in aliquiots of 
100 µl. These protein samples were stored at -20oC, until required for further analysis. 
2.3.1.3 Bradford protein assay 
The protein concentrations were determined by the Bradford protein assay (Sigma, 
Steinheim, Germany). This assay is based on changes in absorbance produced by the 
reaction between Coomassie dye and its binding to proteins, which shifts its colour from 
red to blue, depending on protein concentration. This change in colour occurs during the 
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formation of the complex dye and protein. The Coomassie reagent passes a free proton 
to the ionic groups found in proteins, which opens their tertiary structure. This positions 
the positive amine groups of the proteins in proximity to the negative charge of the dye. 
These changes in protein charge increase the ionic interaction, which stabilises the blue 
form of Coomassie, so that the intensity of the colour can be used to measure protein 
concentration in a linear fashion by reading absorbance (Bradford, 1976). 
The benefit of using this assay is that it is less susceptible to interference from 
chemicals that may be present in protein samples, with the exception of high or low 
concentrations of detergents such as SDS. At low concentrations (from 0.0033% to 
0.067% v/v), SDS inhibits the protein binding sites, resulting in an underestimation of 
the concentration of the protein in solution. High concentrations of SDS will produce the 
opposite effect. Therefore, thus, a period of optimisation is needed, with known 
concentrations of protein and SDS, to calculate the critical concentration (Zor & 
Selinger, 1996).  Another disadvantage is the short linear range of detection of this assay 
(from 2µg/ml to 120µg/ml), necessitating dilution of samples (1:20) before analysis. 
2.3.1.4 Bradford assay procedure 
The tissue homogenates (mitochondrial or whole cell) were diluted 1:20 with 
RIPA buffer. Bovine serum albumin (BSA) was diluted as described by the 
manufacturer (Sigma) in six dilutions (0, 0.25, 0.5, 1, 1.25, and 2 mg/ml), in order to 
establish a standard curve. The standards and the samples were placed in a 96 well plate 
in duplicate. In each well were placed 5 µl of sample and then 250 µl of Bradford 
reagent was added and briefly mixed on a shaker platform before incubation at room 
temperature for 5 minutes. Then, the absorbance of each sample was measured at 595 
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mm by a spectrophotometer (Anthos Labtec Instruments, Cambridge, UK). The protein 
concentration was calculated and corrected for the original dilution factor with a 
coefficient of variance of less than 5% between duplicates deemed acceptable 
reproducibility.  
2.3.2  Immunoblotting (Western blotting) 
Immunoblotting is an analytical technique designed for the detection and 
quantification of specific proteins expressed by the cell. This technique involves two 
steps for the detection of protein abundance: the first step being based on the use of gel 
electrophoresis to separate proteins by their molecular weight (Burnette, 1981). After 
the separation, the proteins are transferred to a membrane (usually nitrocellulose or 
PVDF) in which the proteins are detected by specific antibodies (during this project only 
polyclonal antibodies were used) (Renart et al., 1979). The second antibody is 
conjugated with an enzyme and visualised using enhanced chemiluminescence detection 
system. To prove the reproducibility of the assay, each Western blot was performed in 
duplicate for these studies. 
Sodium dodecylsulphate (SDS) is an ionic detergent which gives a negative 
charge and denatures proteins by removing their secondary and tertiary structures 
(disulphite bonds to sulphhydryl bonds), thus allowing the complete separation of 
proteins by their molecular weight. In addition, SDS binds specifically in a mass ratio of 
1.4g SDS: 1g protein confers a negative charge equal to the molecular length. It is 
usually necessary to reduce further the disulphite bonds to avoid random disulphite 
bridges. This is done by adding 2-mercaptoethanol or dithiothreitol (DDT). To ensure 
the complete denaturation, it is also necessary to boil this mix at 100oC for 10 minutes. 
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After the proteins become negatively charged, they are loaded in the wells of a 
polyacrylamide gel. Together with the samples, a reference sample and protein marker 
or ladder (Bio-Rad) are also loaded, usually at the first and second well of each gel. The 
reference sample used is a common protein sample and enables the calculation of an 
intra-assay coefficient of variance. The marker is a commercial mix of proteins, having 
a known molecular weight and is used to measure the target protein size.  
The SDS-protein complexes are then electrophoresed, as they move through the 
positive electrode at a rate inverse to their molecular weight (usually measured in kilo 
daltons, KDa). The resolution of the gel depends on the concentration of the acrylamide 
and the cross-linking bisacrylamide used in its preparation. This determines the pore 
size, which can increase the separation between lower molecular weight proteins. 
In order to facilitate the immune-detection, the separated proteins are transferred 
into a membrane made of nitrocellulose. The gel is placed on top of the nitrocellulose 
membrane and both are covered by filter paper to facilitate capillarity, which is involved 
in the protein transfer during transmission of the electric current. All of this is 
introduced into a transfer cassette, that is placed in an electroblotting tank together with 
a buffer solution (Towbin et al., 1979). By applying an electric current, the proteins are 
pulled from the gel into the nitrocellulose membrane in the same pattern as separated by 
the SDS-PAGE gel. The effectiveness of the transfer is tested by staining the membrane 
with Ponceau S dye. After this test, it is possible to distain the dye by applying water 
alone or a saline solution with a detergent.  
Since the membrane has the capacity of binding proteins non-specifically, it is necessary 
to block it with a known non antigenic protein like casein so that antibodies will not 
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react to them, preventing any false positives and noise. The detection process starts by 
incubating the primary antibody at an appropriate concentration, incubation time and 
temperature, with the membrane in constant agitation. The antibodies are diluted in a 
buffer composed of 3% milk powder and 0.2% detergent (Tween-20) in a saline solution 
(TBS). The concentration, time and temperature of incubation of the primary antibody 
depend on an optimisation process for each target protein. To reduce non-specific 
binding at the end of the incubation, the membrane is rinsed in order to remove 
unbonded or unspecific antibodies.  In order to detect the complex antibody target 
protein, the membrane is exposed to secondary antibody. These are produced from a 
different animal species and are able to bind to the heavy chains of the primary 
antibody.  In addition, the secondary antibody is commonly attached to a reporter 
enzyme, such as horseradish peroxidase (HPR). When exposed to a chemoluminescent 
agent, the reaction results in the emission of light or luminescence proportional to the 
protein abundance in the initial sample. 
The light emitted by this reaction is detected by an image detection system or 
CCD camera (Fujifilm LAS-100 cooled CCD camera, Fuji Photo Film Co. Ltd, Tokyo 
Japan) which produces a digital image of the Western blot. The image created by this 
process is analysed by densitometry (Aida version 2.0, Raytek Scientific Ltd., 
Sheffield), which evaluates the density of the bands found in the image. The intensity 
values of each band reflect abundance of the polypeptide within the initial sample. 
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2.3.2.1 Western blot procedure 
Polyacrylamide gel preparation  
Polyacylamide gels were cast, using a dual gel caster. This casting system consists 
of two glass plates: a small one sits on the top of a larger one. On the last plate, two 
silica 1 mm spacers were attached. Both plates were vertically assembled within the 
casting apparatus, DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV PLQL-PROTEAN® 3 
cell, Bio-Rad). Each 10 ml 12% of polycylamide resolving gel consisted of: 3.3 ml of 
deionised water, 4 ml of 30% acrylamide-bisacrylmide solution, 2.5 ml of ph 8.8; 1.5 M 
Tris ([hydroxymethyl] amino-methane, 0.2% (w/v) SDS), 100 µl of 10% SDS (w/v), 
 O  $PPRQLXP 3HUVXOSKDWH ZY DQG  O 111¶1¶
Tetramethylethylenediamine (Temed). The mix was poured on the top and between the 
plates to a level of 3 cm below the top. To avoid gel-oxidation 2 ml of isopropanol was 
added to top of the gel solution. The polymerisation of the resolving gel was conducted 
at room temperature for 45 minutes. After this incubation, the isopropanol was rinsed 
with deionised water.  Another gel is added on to top of the polycylamide resolving gel 
(called: stacking gel). The mix of this last gel consisting of:  6.8 ml deionised water, 1.7 
ml of 30% acrylamide-bisacrylmide solution, 1.25 ml of ph 6.8; 1 M Tris 
([hydroxymethyl] amino-methane, 0.2% (w/v) SDS), 100 µl of 10% SDS (w/v), 100 µl 
$PPRQLXP3HUVXOSKDWH ZY DQGO111¶1¶7HWUDPHWK\OHWK\OHQHGLDPLQH
(Temed). The mix was poured on the top of the resolving gel and a 10 well comb 
inserted in order to produce the loading wells and left to polymerise for 15 minutes at 
room temperature. 
  
77 
 
Sample preparation                             
The protein concentration of mitochondrial or whole cell samples was determined, 
using the Bradford assay. Aliquots of each sample were diluted to an initial 
concentration of 4.2 mg protein/ml with mitochondrial homogenisation buffer (10 mM 
Tris ([hydroxymethyl] amino-methane ph 7.4, 250 mM Sucrose and 1 mM EDTA) or 
protein homogenisation buffer (10 % (v/v) Glycerol, 2 % w/v SDS, 5 % 2-
mercaptoethanol made up to volume with 50 mM Tris (ph 6.8) to the final volume of 20 
µl. To this, 50 µl protein or mitochondrial buffer was added to each sample, followed by 
14 µl loading dye (0.00 1% Bromophenol blue, 16 % (v/v) Glycerol in deionised water). 
In order to denaturate the proteins within the diluted fractions and to expose the epitopes 
to the antibodies, 20 µl aliquot of each sample were incubated at 100oC for 10 minutes. 
This procedure was followed by incubation in ice, until the stacking gel was ready for 
use.  
Sample loading and electrophoresis 
The polymerised gels were transferred to a vertical electrophoresis unit (Bio-Rad 
Ltd., Hercules, CA, USA). The reservoir and sample wells were filled with 1 x running 
buffer (25 mM Tris [hydroxymethyl] amino-methane, 250 mM glycine, 0.1 % (w/v) 
SDS). 
Before loading the protein samples, the wells were cleansed of unpolymerised 
acrylamide, using a Pasteur pipette and the running buffer. 15 µl of protein sample was 
loaded from the second to ninth well. The first well was reserved for the protein ladder 
(Precision Plus pre-stained standards, Bio-Rad) and the last well was excluded from use 
because of its proximity to the silica spacer, which alters polymerisation. The second 
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well was reserved for the reference sample and 5 µl of loading buffer was loaded on the 
last well. 
The samples from the different animals were blinded and randomised, using a 
research randomised web site http://www.randomizer.org/ . Finally, the gels were 
electrophoresed at 200V for 45 minutes per gel. 
Electrophoresis transfer onto nitrocellulose membrane 
Proteins are transferred from the polyacrylmide gel to a nitrocellulose membrane 
(Hybond-C Super; Amersham Ltd, UK) using a Mighty Small II electrophoretic 
chamber (SE 250; Hoefer Pharmacia Biotech Inc.). The gel and the membrane are 
opposed between two layers of blotting paper soaked in transfer buffer (48mM Tris 
[hydroxymethyl] amino-methane, 39 mM Glycine 20% (v/v) Methanol, 0.037% (v/w) 
SDS). Gel and membrane were firmly placed together and air bubbles removed by light 
transverse pressure. Following this, both gel and membrane were sandwiched between 
two Scotch-Brite scouring pads (3M: Bracknell, UK) and held in position vertically in 
the cassettes within the blotting tank in the order cathode ± gel ± membrane ± anode (Fig 
2.1), to allow transfer of the negatively charged polypeptides onto the membrane. The 
tank was filled with transfer buffer and a potential difference of 80 mA applied across 
for 1 hour. A cool water stream passes throughout the high voltage transfer, so that 
proteins were not denatured by the transfer process. 
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Figure 2.2 Western blotting- graphical description of the transfer unit 
Protein staining  
Following electroblotting, the consistency of electrophoresis and blotting was 
examined by irreversible staining of the nitrocellulose membrane. The membrane was 
then incubated at room temperature with 10% diluted Ponseau S stain (2% (w/v) 
Ponseau S, 30% (w/v) Trichloroacetic acid, 30% (w/v) Sulphosalicylic acid in deionised 
water; further diluted 1:10 in deionised water) for 10 minutes and excess dye eluted with 
deionised water. Ponseau S stain reversibility binds to protein and reveals a series of 
multiple bands, arising vertically in lanes from each well (Fig 2.2). Following the 
visualisation, it was possible to distain the Ponseau S dye by applying TTBS (Tween-
Tris buffered saline (0.2% (v/v) Tween-20 in 20 mM Tris [hydroxymethyl] amino-
methane, 500mM Sodium Chloride, ph 7.5)) for 10 minutes at room temperature in 
constant agitation. The final confirmation of the efficiency of the transfer was assessed 
E\VWDLQLQJWKHJHOLQ&RRPDVVLH%ULOOLDQW%OXH6LPSO\%OXH,QYLWURJHQ&$86$
solution for 1 hour. Excess stain is removed by deionised water after 5 minutes in 
constant agitation. This procedure stains any proteins remaining on the gel after 
electroblotting, with the absence of protein staining after this procedure confirms the 
complete transfer of polypeptides. 
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Immunodetection 
In order to prevent potential non-specific binding of antibodies to the areas of 
membrane not occupied by polypeptides from the sample originally loaded, the 
nitrocellulose membranes are incubated with a protein containing solution (10% Marvel 
dried milk, PrLPLHU %UDQGV LQ 77%6 WR µEORFN¶ WKHVH VLWHV (DFK PHPEUDQH ZDV
incubated with blocking buffer overnight at 4oC. The membrane was rinsed with TTBS, 
before incubation for 1 hour at room temperature with 10 ml of primary antibody 
solution (TTBS, 3% (w/v) Marvel and antibody active against the target protein). The 
antibodies against SOD1 (Fig 2.2) and SOD2 were purchased from Abcam plc, UK; p85 
was purchased from Milliopore Ltd, USA and VDAC1 was home produced (Mostyn et 
al., 2003).  
Each antibody was validated by measuring the band that it generated against the 
protein ladder. In addition, the result of this assay was compared with the bands 
produced by non-specific immunoblots, one of which is tested with non-specific rabbit 
serum (all the antibodies used in this project were raised by rabbits) the other of which is 
exposed only to the secondary antibody. The antibody was validated only if the band to 
be tested was similar to the molecular weight of the protein of interest as published in 
the literature. Moreover, the band does not have the same molecular weight as the bands 
found in the other two non-specific immunoblots. To optimise the incubation conditions 
of the antibody, identical gels were exposed to different concentrations of primary 
antibodies, incubation times and temperatures (see table 2.1).  
At the end of the incubation of the primary antibody, the membranes were rinsed 
and washed three times for 10 minutes in 100 ml of TTBS in constant agitation. Then, 
the membranes were incubated for an extra hour with the secondary antibody (1:1000 
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dilution, PO 217; Dako Ltd. UK). This antibody was also re-suspended in 10 ml of 3% 
dried milk in TTBS. The membranes were washed again and rinsed as previously 
described.            
 
 
 
 
 
 
 
 
 
Figure 2.3  Immunoblot images. On the left Ponceau S stain test and on the right a western blot of 
SOD1. Line 1 protein standard, lines from 2 to 4 three are different samples representing each 1 
year old group (2:L;3:O;4 NR-O). 
  
Table 2.1: Technical details of the antibodies used during this project 
 
 
 
 
 
Antibody Supplier Catalogue number Protein type Protein size (Kda) Primary antibody dilution factor
Incubation time and 
temperature
p85 Upstate 06-195 Cytosol 85 1/1000 1 hour at room 
temperature
SOD1 Abcam ab13498 Cytosol 15 1/500 Overnight at room 
temperature
SOD2 Abcam ab13533 Mitochondria 25 1/1000 1 hour at room 
temperature
VDAC In house N/A Mitochondria 34 1/1500 1 hour at room 
temperature
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Enhanced chemiluminescence 
The membranes were washed in constant agitation in TBS for 30 minutes and the 
excess fluid drained. To each membrane 6 ml of Immobilom western (Millipore Ltd. 
MA, USA) was applied and the membrane incubated for 5 minutes. The excess reagent 
was drained and the membrane placed in the CDD camera to generate a digital image. 
The optimum time of exposure for all immunoblots was 30 seconds. By visualisation of 
the digital image, it was possible to determine the intensity of the antibody-target 
SHSWLGH¶VVLJQDODQGUHODWLYHEDFNJURXQG%\FRPSDULQJLQWHQVLW\RIWKHSL[HOVRIEDQGV
against the background of the immunoblot, it was possible to determine the abundance 
of the protein of interest. To confirm the reproducibility of the assay, each gel was 
performed in duplicate on different occasions. 
2.3.3  Nitric Oxide measurement 
A large number of colorimetric methods exist to determine the presence of nitric 
oxide (NO). However, the most common technique used in clinical publications is based 
on the Griess reaction (Tsukahara et al., 1997; Dobrian et al., 2001; Beltowski et al., 
2004). This technique does not directly measure the concentration of NO for a number 
of reasons. Firstly, NO is produced in trace quantities by a large number of cells, 
including neurons, endothelial cells and platelets under normal physiological conditions. 
Secondly, NO is a highly reactive free radical, able to interact with ozone, reducing its 
half life to few seconds. For these reasons, the Greiss reaction is based on the 
measurement of the final products in vivo of NO, which is Nitrite (NO2-) and Nitrate 
(NO3-) (Granger et al., 1996). It is possible to measure the relative concentration of both 
products. The remaining NO in the samples is transformed by NADPH to both final 
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products. Then, NO3- can be converted to NO2- with nitrate reductase, an enzyme 
extracted from bacteria (e.g. Escherichia Coli). The total NO2- is exposed to 
sulphanilamide and N-(1-naphthly) ethylenediamine to produce an azo dye (yellow 
colour) with the colour product being proportional to the concentration of NO2- present 
in each sample. Thus, the colour intensity is used for the measurement of NO 
concentration by absorbance reading. The absorbance spectrum of this assay is at 540 
mm, with an increase in absorbance is equal to the quantity of dye that is proportional to 
the amount of NO present in the sample (Granger et al., 1996). 
However, there are a large number of factors that may interfere with the assay, 
including reagents present in biological fluids and components from the Griess reaction. 
For that reason, there are a number of variants to this reaction, designed to reduce 
interference from such sources. Plasma or tissue homogenate assays require protein 
extraction by precipitation or by ultrafiltration. In addition, NADPH is an essential 
cofactor in the activity between of L-arginine and enzymes NO synthase (NOS), which 
interferes with the chemistry of the Griess reaction (Greenberg et al., 1995). This 
limitation is overcome by adding small quantities of sample or removing the excess of 
NADPH by the metabolic action of lactate dehydrogenase (LDH) (Tracey et al., 1995). 
The determination of nitrite and nitrate (NOx) described above is performed using a 
standard commercial kit (Nitric Oxide Synthase Assay Kit, Calbiochem Inc., Darmstadt 
Germany). 
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2.3.3.1 Nitric oxide measurement procedure 
Sample preparation  
For this procedure, one sample from renal cortex was dissected of each animal 
euthanased at 1 year of age from this study. 100 mg of tissue were added to 300 µl of 
phosphate buffered saline (PBS; 137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, ph 
7.4) and homogenised using a Dispomix® 9000 rpm for 45 seconds until complete 
homogenisation. The homogenates were then centrifuged (5810R, Eppendorf, SLS, UK) 
at 10000 rpm for 10 minutes at 4oC and the supernatant placed in sterile 1 ml eppendroff 
tubes. The samples were analysed for protein concentration by the Bradford method 
(described earlier at 2.3.1.4). The protein concentration was expressed in mg/ml. The 
tissue supernatants were ultracentrifuged (T-1045, Kontron AG, Germany) at 10000 x g 
for 15 minutes at 4oC. Later, the resulting supernatants were ultrafiltrated through two 
filters a 0.45 µm (Ministart, Sartorius Ltd., Gottingen, Germany) and 10 KDa (Vavispin 
2, Sartorius Ltd., Stonehouse, UK) to separate complete all proteins from each sample.  
Performing the assay 
The NO2- solution was diluted 5, 10, 15, 20, 25µM and a blank, to establish 
standard curve. These and the samples were placed in a 96 well plate in duplicate using 
60 µl of standard or sample. The samples were blinded and randomised using a research 
randomised web site http://www.randomizer.org/. 10 µl of freshly prepared NADPH 
solution (1mM), 10µl of nitrate reductase was then added and the sample incubated at 
room temperature for 60 minutes. Then 10 µl of cofactors solution plus 10 µl LDH 
solution, and samples incubated for another 20 minutes at room temperature. Finally, 50 
µl of Griess reagent added to each well.  The plate was left for 10 minutes at room 
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temperature for the colour reaction to occur. The intensity of the reaction was measured 
at 540 mm by a spectrophotometer. The standard data was expressed as a function of 
absorbance at 540 mm and concentration of nitrate (µM) calculated. The final NO2- 
concentration was normalised by the protein content of each sample found by the 
Bradford assay ([NO2- µM]/ [protein mg/mg]).  
In order to optimise the linear detection range, different serial renal NO dilutions 
were tested using the same protocol as described earlier. 
2.3.4 Triglyceride extraction from renal tissue 
The Folch, Less and Stanley method is a simple method for the preparation of total 
pure lipid extracts from various tissues including the kidney (Folch et al., 1957; Saito et 
al., 2005). This procedure exploits on the interaction between the buffer chloroform-
methanol-saline (8:4:3) and cellular lipids for separation of the homogenised tissue into 
two phases in which the lower phase is the total pure lipid extract. After homogenisation 
and gravity filtration, due the polarity and density of the suspension solution and the 
lipids, the cellular and tissue debris can be separated simply by adding and mixing one 
fifths of water or a salt buffer (e.g. 0.9% NaCl) of the total volume. The chloroform-
methanol solution can be removed by applying a nitrogen stream and the pure lipids 
faction can be easily measure by any commercial triglyceride assay (Randox Ltd, 
Antrim, UK). 
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2.3.4.1 Triglyceride tissue deposition procedure 
Tissue preparation 
The tissue samples (500 mg of renal cortex) were minced in 10 ml (w/v) cold 
chloroform/methanol (2:1) on ice, using a dispomix® homogeniser as described 
previously (2.3.1.1), then the samples were agitated at room temperature for 15-20 
minutes. The extracts were filtered through filter (24 cm) paper (Whatman Ltd, 
Banbury, UK) into centrifuge tubes, and filtration was completed by adding 1 ml of 
chloroform. The filtrates washed by mix them with 2 ml of 0.9% (w/v) NaCl solution 
and centrifuged at low speed (2000 rpm) for 10 minutes for the separation the lipid and 
aqueous phases. The aqueous layers (upper phase) were removed with a Pasteur pipette 
and the organic phase was dried by applying a nitrogen stream and then the pellets were 
GLVVROYHLQȝORIYYWHUW-butyl alcohol/Triton X-100. 
Performing the assay 
Triglycerides were measured enzymatically by using a commercial kit (Randox 
Ltd, Antrim, UK) and the absorbance read using a plate reader at 500 mm. Triglyceride 
concentration was expressed as a ratio of triglyceride found in micrograms and weight 
in grams of the sample previously dissected (mg/g).   
2.3.5 Superoxide dismutase activity assay 
The total activity of superoxide dismutase (SOD) enzymes can be measured using 
a modified version of the method of Beauchamp and Fridovich (Fridovich, 1970). 
Measurement of the activity of total SOD utilised a tetrazolium salt for the detection of 
superoxide radicals generated by xanthine oxidase and hypoxanthine. One unit of SOD 
is defined as the amount of enzyme needed to exhibit 50% dismutation of the superoxide 
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radical. The activity test was performed using a commercial kit (Superoxide Dismutase 
Kit II, Calbiochem Inc., Darmstadt Germany). 
2.3.5.1 Superoxide dismutase activity procedure  
Sample preparation 
As described earlier, 100 mg of dissected renal cortex was added to 1 ml of 
suspension buffer (20mM HEPES buffer ph 7.2, 1mM EGTA, 210 mM Mannitol, 70 
mM Sucrose), homogenised  and centrifuged at 1500 x g for 5 minutes at 4oC and the 
supernatant removed for the assay and stored at -80oC. The samples were analysed for 
protein concentration by the Bradford method (described at 2.3.1.4).    
Performing the assay  
Standards for the assay at 0, 0.025, 0.05, 0.1, 0.15, 0.2 and 0.25 U/ml were 
prepared and placed together with the samples in a 96 well plate in duplicate, blinded 
and randomised, as previously described. In each well, 200 µl of the diluted radical 
detector was added plus 20 µl of diluted xanthine oxidate was added and incubated at 
room temperature in constant agitation for 20 minutes. The absorbance was read using a 
plate reader at 450 mm. The activity of SOD was expressed as a function of total SOD 
activity U/ml.   
To fully validate and optimise this methodology, different, serially diluted 
homogenate samples were measured to find the protein concentration detection range of 
the assay. The detection range of this assay varied from a protein concentration of 0.02 
to 0.1 mg/ml. All the samples were diluted to the mid detection range equal to 0.05 
mg/ml. 
 
88 
 
2.3.6 Thiobarbituric acid reactive substances (TBARS) 
The thiobarbituric acid reactive substances (or TBARS) method has been used 
extensively in food manufacturing for the last 50 years and is the gold standard method 
to measure global oxidative stress a well-established mechanism of cellular injury. 
Originally, this technique was based on the ability of thiobarbituric acid (TB) to react 
with malondialdehyde (MDA) and used as an index of lipidperoxidation (Armstrong & 
Browne, 1994; Yagi, 1994). MDA is the stable byproduct of the decomposition by free 
radical of polyunsaturated fatty acids (Tappel, 1973).  
The assay starts by heating the sample with TBARS at low pH.  Then, the reaction 
with TB and MDA produces a pink chromogen, which is possible to measure at 532 mm 
(Kosugi et al., 1987). However, previous findings have demonstrated that TB might 
react with other components. This acid is also able to react with aldehydes and other 
components associated with oxidative stress induced by obesity, producing similar 
colour dye (Fogelman et al., 1980). Moreover, MDA is a reactive compound able to 
bind to different cell components such as lysine, albumin and DNA. For that reason, it 
can be overestimated four to five fold when TB is used just to determine MDA 
(Gutteridge, 1986). Therefore, many authors have suggested that the results need to be 
termed TBARS and not MDA concentration (Csallany et al., 1984; Draper et al., 2001). 
This procedure is still the most wildly employed assay to determine lipid peroxidation 
(Armstrong & Browne, 1994; Draper et al., 2001; Kim et al., 2001; Ece et al., 2006). 
7KH7%$56DVVD\ZDVSHUIRUPHGXVLQJDFRPPHUFLDONLW 2[L6HOHFW7%$56DVsay 
Kit, Cell Biolabs Inc., CA, USA). 
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2.3.6.1 Thiobarbituric acid reactive substances (TBARS) procedure 
Sample preparation 
100 mg of dissected renal cortex were resuspended in 1 ml of lysis buffer (Cell 
LyticTM MT mammalian tissue lysis, Sigma, Steinheim, Germany) and 10 µl of protease 
inhibitor cocktail was added (Sigma). Each sample was homogenised as described 
previously (2.3.1.1) and centrifuged at 1600 x g for 10 minutes at 4oC before the 
supernatant was removed for the assay and stored at -80oC. The samples were analysed 
for protein concentration by the Bradford method (Section 2.3.1.4).  
Performing the assay 
Each standard and sample was prepared in duplicate and randomised as described 
previously (see 2.3.3.1). The standard curve solution was diluted from 0 to 250 µM of 
MDA and 100 µl of sample or MDA standard was added. 100 µl of SDS lysis solution 
was then added and incubated for 5 minutes at room temperature. 250 µl of TB reagent 
was added, immediately incubated at 95oC for 1 hour and then cooled in ice for 5 
minutes, followed by centrifugation for 15 minutes at 3000 rpm. All the samples were 
read spectrophotometerically at 540 mm excitation and 590 nm emission. The 
concentration of MDA calculated and was expressed as: [MDA µM]/[Protein mg/ml]. 
To validate this methodology, firstly the lysis buffers and the protein inhibitors 
were tested for any interference with the assay. Optimal results were obtained by using 
the Sigma lysis buffer and its inhibitor cocktail. The detection range was between 0.3 to 
7.5 mg/ml of protein with all the samples diluted to a range of 3 mg/ml. To test a 
possible inference of lipids with a higher degree of unsaturated bonds and lipoprotein, 
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homogenate samples from of both one year old obese groups were tested at different 
protein concentrations against the one year old lean group. 
2.3.7 Histology 
2.3.7.1 Immunohistochemistry 
Immunohistochemistry (IHC) is a technique used to locate specific proteins in a 
cell and exploits the interaction between antibody-antigen. The visualisation of these 
interactions can be accomplished by the use of  a dye, enzyme, radioactive element or 
conjugated antibody, as are used in other techniques, such as Western bloting (Mason & 
Sammons, 1978; Ramos-Vara, 2005). 
Tissues were preserved as described in Section 2.3 and were then paraffin wax 
embedded. These techniques permit the preservation of the morphological structures of 
the tissues with a high visual resolution. Formaldehyde preserves the majority of 
peptides and the general structure of cellular organelles because it is able to bind to and 
preserve amino acids (Lysine, Tyrosine and other) stopping the process of protein 
degradation. Five µm serial sections, optimal for antibody binding and light microscopy, 
were prepared from the paraffin wax tissue blocks using a sledge microtome.(Eltoum et 
al., 2001). 
Following slicing and mounting onto microscopy slices, the sections were 
deparaffinised  with xylene and brought to water and then peroxidase blocked to prevent 
exogenous peroxidases being detected by the horseradish peroxidase (HRP) conjugated 
antibody.  Epitope retrieval  was performed by citrate buffer at 95oC for 15 minutes (Shi 
et al., 2000). Sections were then incubated with the primary antibody, followed by the 
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secondary antibody, which binds specifically to the primary antibody and is conjugated 
with HRP enzyme and, after applying a DAB substrate, allows the localisation of the 
protein of interest  (Merz et al., 1995 ; Kiernan, 2000). 
2.3.7.2 Immunohistochemistry procedure  
Tissue processing 
Samples of 1 year old sheep kidneys were fixed in 10% formol saline (10% (v/v) 
formaldehyde in 0.9% (v/v) sodium chloride) and embedded in paraffin wax and 
sectioned using a microtome (Sledge microtome, Anglia Scientific, UK) into 5 µm 
sections, floated out onto warm water (45oC), these were then placed onto Superfrost 
plus glass microscope slides (Mezel-Glazer Inc., Braunchweig, Germany) and baked on 
a hot plate for 15 minutes. The slices were dried overnight at 37oC. 
In total, 130 slides from kidney sections (NR-O (n=10 x 5); O (n=8 x 5); L (n= 8 x 
5)) and 26 from PAT (NR-O (n=10); O (n=8); L (n=8)) were prepared for this assay and 
for subsequent procedures conducted in these studies. Identification of samples was 
double blinded as previously described (2.3.2.1) before any further experimentation was 
carry out. 
Performing the assay 
The Bond-Max automated slide processor (Bond software version 3.4A) and Bond 
Polymer Refine Detection System (Vision Biosystems, Mount Waverley, Australia) was 
used for the immunhistochemical processing with proliferative cell nuclear antibody 
(PCNA). The rabbit PCNA antibody was purchased from Abcam PLC (ab18197). 
Twenty six sections, including a positive control (sheep placentome) and two 
negative controls (a section of sheep kidney and another placentome section) were 
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placed in random order in a Bond-Max tray. The slides were dewaxed with toluene, 
incubated in citrate buffer at 95oC for 15 minutes and then peroxide blocked for 5 
minutes at room temperature. Each slide was incubated with 150µl of rabbit anti PCNA 
primary antibody (1:2500 dilutions) for 15 minutes. The sections were washed twice 
with Bond Wash solution and with deionised water after which they were incubated 
with 100 µl of secondary antibody for 8 minutes and rewashed.  The section were then 
LQFXEDWHGZLWK¶'LDPLQREHQ]LQGLQH'$%IRUPLQXWHVIROORZHGE\PLQXWHV
incubation with haematoxylin and again washed with water.  
Slides were imaged using a Leica DM RB microscope and images captured using 
the OpenLab software (Improvision OpenLab 4.0.2) and analysed blinded using 
Volocity 4 (v4.2.1, Improvision Ltd, Coventry, UK) quantification software. 
In order to ensure that the optimum PCNA antibody concentration was used, serial 
antibody dilutions were performed as described in table 2.2, prior to the assay: 
 
Table 2.2 PCNA antibody dilution series used to optimise to immunohistochemical 
staining 
 
 
The optimum dilution is that which produces good staining but with the majority 
of positive staining loss after the next more dilute antibody is used (see Fig. 2.3) 
(Stevens & Lowe, 2005). The loss should be dramatic and not gradual. Gradual loss will 
indicate non-specific bind of the antibody (Table 2.3).  
Optimization 
number Antibody Dilution 1 Dilution 2 Dilution 3 Dilution 4 Dilution 5
1st PCNA 1./250 1./1000 1./2000 1./4000 1./8000
2nd PCNA 1./2500 1./3000 1./3500 1./3500 1./4500
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1/500 1/1500 1/2500 1/3500 1/4500
Grade of 
staining
High
Low
PCNA Dilution factor
Table 2.3  Graph illustrating the optimum PCNA antibody dilution factor. Note 
that the red line symbolises the optimum dilution found during the optimisation 
 
 
 
Figure 2.4 First and second renal section stained with PCNA assigned for the optimisation of the 
immunostaining (20X magnification). Antibody dilution: A 1/250; B 1/1000; C 1/2000; D 1/4000; E 
1/2500; F 1/3000; G 1/3500; H 1/4500. Optimal dilution: 1/2500. 
 
 
B CA D
E F G H
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Semi-quantification of PCNA stained sections 
From each section, three pictures were taken, which represented random fields of 
renal cortex using a magnification of x 1:20.  Prior to any analysis, each section was 
viewed microscopically to recognise and identify the main structures of the renal cortex 
and specific cells that were positive stained, after which the numbers of positive stained 
cells were counted. 
The mean number of positive cells in each individual random field was estimated 
by using quantification software (Volocity 4, Improvision, Coventry, UK).  
2.3.7.3 Histochemistry  
Histochemistry refers to a series of techniques that exploit specific reactions 
between chemical dyes and components within the tissue. Some commonly performed 
KLVWRFKHPLFDO WHFKQLTXHVDUH3HUOV¶3UXVVLDQEOXHXVHG WRGHPRQVWUDWH LURQGHSRVLWLRQ
and Masson trichrome, which is a three-colour staining protocol for the observation of 
collagen, keratin and cells within the tissue (Ishizaka et al., 2002; Bharwan et al., 2009).  
Prussian blue staining 
3HUOV¶3UXVVLDQEOXHDOORZVHVWLPDWLRQRIWKHGHSRVLWLRQRIQon-haemoglobin iron 
in formalin fixed, wax embedded sections by staining erythrocytes, normoblasts, 
macrophages and other cells containing particulate iron. Biologically active iron is 
normally attached to protein as haemosiderin and ferritin, which are impossible to 
detect. However, treatment with dilute mineral acid releases the ferric (Fe+3) form in the 
presence of cyanide ions and iron is seen as small blue or blue-green granules. This 
technique has recently been used to demonstrate iron deposition in mice renal tissue 
(Ishazaka et al. 2005; Saito et al., 2005).  
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Performing the assay 
For the assessment of iron deposition, 26 paraffin-embedded renal sections and 
their controls (positive, liver; negative, placenta and a renal section without exposure to 
potassium ferric ferrocyanide) were prepared as described in Section 2.3.6.1. The 
sections were deparaffinised and hydrated. The slices were immersed in freshly prepared 
3HUOV¶ 3UXVVLDQ EOXH VROXWLRQ  K\GURFKORULF DFLG PL[HG ZLWK  SRWDVVLXP
ferrocyanide) for 20 minutes. The samples were washed three times in distilled water for 
2 minutes and then counterstained with nuclear fast red stain (0.1 g nuclear fast red, 5% 
V/V aluminium sulphate, 100 ml distilled water; Sigma (N3020)) for 5 minutes. After 
staining, the sections were dehydrated in 95% alcohol and two changes of absolute 
alcohol the slices were cleared in xylene and mounted in a resinous medium (DPX). All 
analysis was performed independently by two assessors using reference slides to access 
consistency of grading assessment. For assessment of iron deposition, the slides were 
analysed in a blinded fashion using a semi-quantitative index (1-4) as described by 
Wintour et al.. Grade 1= no staining, 2= 1-10 granules 3= 10-20, 4= 20 and more.  
Twelve random fields were chosen per kidney section and were evaluated at x 20 
magnification.  
Masson trichrome 
Masson's trichrome is frequently used to differentiate collagen from other fibres, 
particularly keratin and to identify increased collagenous tissue in disease as seen in 
renal dysfunction (Bharwan et al.7KHWLVVXHVHFWLRQVZHUHVWDLQHGZLWK+DUULV¶
haematoxylin, a nuclear stain. The sections then were treated with acid fuchsin solution 
(0.5 g of acid fuchsin; 0.5 ml glacial acetic acid; 100 ml distilled water). As result of the 
exposure to acid dye, all the acidophilic components including the cytoplasm and 
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collagen will stain after this stage. The sections then were treated with phospmolybdic 
acid (25g phosphomolybdic acid; 20 ml water) to facilitate the diffusion of the acid 
stains into the cytoplasm, which is less permeable than collagen. Chemical compounds 
such as phosphomolybdic acid has numerous acidic groups that most likely act as 
mediator between collagen and light green, which is the collagen dye. Finally, the pH of 
the phosphomolybdic acid also increases the colour intensity of the collagen green light 
dye. A quality control is not required for this technique as every tissue has an internal 
control due the presence of collagen and other components. Both this technique and 
Prussian blue are suitable for formalin fixed tissue sections. The expected results are: 
collagen green-blue, nuclei black, cytoplasm and keratin red. 
Performing the assay 
Twenty-six slides from renal tissue and PAT were dewaxed by immersion in two 
changes of xylene each for three minutes, followed by two changes of absolute alcohol 
each for two minutes and other three minutes in 70% alcohol before washing in distilled 
water for three minutes. The trichrome was applied by immersion of the fixated sample 
LQWR+DUULV¶KDHPDWR[\OLQDQGWKHQWKHVOLFHVZHUHLQFXEDWHGLQWKUHHGLIIHUHQWVROXWLRQV
A (acid fuchsin; 5 minutes), B (phosphomybdic acid; 5 minutes), and C (light green SF 
yellowish; 5 minutes). In between each solution the samples were rinsed in water. 
Finally, the sections were immersed in 1% acetic acid for two minutes, two changes of 
absolute alcohol each for two minutes, followed by two changes of xylene each for 3 
minutes. The sections were then mounted in a resinous medium (DPX). All analysis was 
independently performed blind by two assessors using reference slides to access 
consistency of grading assessment.  
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For assessment of fibrosis, the slides were analysed using a Nikon Eclipse 90i 
microscope with CCD high speed camera and analysed in a blinded fashion using a 
semi-quantitative index (0-4) as described by Wintour et al. Grade 0= no positive green-
blue (collagen) staining, 1= 25%, 2=26-49%, 3= 50-74% and 4=75-100%.  Twelve 
random fields were chosen per kidney section and were evaluated at x 20 magnification. 
2.3.8 RNA extraction 
The total RNA was isolated from renal tissues and perirenal adipose tissue 
sampled at 7 days and 1 year of age using Tri-reagent (Sigma Chemical Co. Poole, 
UK)(Chomczynski & Sacchi, 1987) and a RNA extraction kit (RNeasy, Qiagen Ltd., 
Crawley, UK), which included a DNAse digestion step. Tri-reagent contains guanidine 
thicyanate and phenol, which dissolves RNA during tissue homogenisation. The 
addition of chloroform separates the aqueous phase containing the RNA, which is 
passed to an RNeasy mini column for further purification. 
The RNeasy columns are designed for a rapid and effective isolation of up 100 µg 
of total RNA for frozen tissues. These columns contained a RNA nucleotide selective 
silica membrane to enable the combination of reagents to enhance the quantity and 
quality of the purification.  
Once extracted, the quantity and preliminary integrity evaluation of the RNA was 
determined spectophotomerically (Nanodrop® Technologies, Wilminton, USA), 
calculating the concentration of RNA at 260 mm (1 OD unit= 40 µg RNA/µl) (Wilson 
& Walker, 2001). By also calculating the absorption at 280nm, it is possible to estimate 
the presence of protein contaminants. The optimum 260/280 absorbance ratio for RNA 
is 1.8 to 2.0 (Wilkinson, 1995; Wilson & Walker, 2001). 
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To further ensure the quality of the total RNA, samples were checked using the 
Agilent 2100 Bioanalyser (Agilent Technologies Inc., Santa Clara, USA). This 
spectrophotometer uses 1ng of RNA and is able to give an extremely accurate readout 
showing the 18S and 28S peaks, along with the degradation of any kind (Bustin & 
Nolan, 2004; Fleige & Pfaffl, 2006).   
In order to avoid any contamination and degradation of RNA, all the materials 
were autoclaved and the working areas were cleansed of ribonucleases using 
RNaseZAP® (Sigma Chemical Co., Poole, UK). In addition, all the reagents, including 
the water, were RNAse and ribonuclease free. All the procedures were conducted with 
filter tips while wearing gloves and a laminar flow cabinet was used to set up the 
reactions. Moreover, all the stages of the reaction were performed on ice, to minimise 
RNA degradation. After preparation, the samples were stored at -80oC until further use.    
2.3.8.1 RNA extraction procedure  
RNA was extracted from 100 mg renal cortex or 1 g PAT 7 days and 1 year old 
sheep in random order as described previously. Samples were fully homogenised at 
9000 rpm for 45 seconds and left to stand at room temperature for 5 minutes to ensure 
complete dissociation of nucleoprotein complexes. Following this, 200µl of chloroform 
per 1 ml of tri-reagent was added, briefly mixed by vortex and then incubated for 15 
minutes at room temperature, followed by a centrifugation (Microcentaur, Sanyo, SLS 
LTD; UK) at 13000 rpm for 10 minutes at 4oC. The objective of this centrifugation was 
to separate the top aqueous phase (from the phenol phase), which was transferred to a 
sterile 1.5 ml microcentrifuge tube. Then, to each sample, an equal volume (to the 
separate aqueous phase) of 70% ethanol was added and mixed well by pipetting. All of 
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the mixture was transferred to an RNAeasy spin mini column and centrifuged 
(Microcentaur, Sanyo, SLS LTD; UK) at 10000 rpm for 15 seconds at room 
temperature.  
To each sample, 350 µl of RW1 buffer (contains Guanidine Isothiocyanate and 
70% ethanol) was added and centrifuged for 15 seconds at 10000 rpm (Microcentaur, 
Sanyo, SLS LTD; UK). After this step, 80µl of DNAase I solution it was added directly  
to the RNAeasy column membrane and incubated for 15 minutes at room temperature. 
Another 350 µl of RW1 was added, centrifugated. 500µl of RPE buffer (contains 
Guanidine Isothiocyanate) was then added and centrifuged. The empty columns were 
spun at 13000 rpm for 1 minute. All the columns were placed in a new 1.5 µl collection 
tube and the RNA was eluted by adding 30 µl of RNAse free water and centrifuged at 
10000 rpm.  
The RNA concentrations from these extractions were determined by 
spectrophotometer analysis. One µl was pipetted from each RNA preperation and placed 
on the Nanodrop® spectrophometer. 
2.3.9 Reverse Transcriptase polymerase chain reaction (RT-PCR)  
RT-PCR is a molecular biology technique that allows the amplification of a 
defined sequence of RNA and is used for the detection of a low copy number messenger 
RNA (mRNA). It is widely used in the diagnosis of genetic diseases and as a first step in 
the cellular determination of gene expression (Baumforth et al., 1999).  
Firstly, the RNA strand is treated with the reverse transcriptase enzyme that 
transcribes its complementary DNA (cDNA). The most common sources of reverse 
transcriptases are extracted from avian myeloblastosis virus (AM) or Moloney murine 
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leukaemia virus. Throughout my thesis, the reverse transcriptase used was extracted 
from the AM virus, which is able to synthesis cDNA at 42oC preserving the RNA 
secondary structure (Sambrook & Russel, 2001). The product of this reaction is that the 
cDNA can be used as a platform using other techniques such as, amplification by 
polymerase chain reaction (PCR) or quantification of mRNA expression by real-time 
polymerase chain reaction (QPCR).   
2.3.9.1 RT-PCR procedure 
Total RNA isolated previously was diluted to 1µg/µl in a final volume of 5µl in a 
0.5 ml microcentrifuge tube and labelled with an individual sample ID. Following, 8µl 
RT mix was added to all the tubes. This master mix consisted of 4 µl of reverse 
transcriptase buffer (100mmol/l dithrithreitol), 0.5µl  RNAse inhibitor (final 
concentration 1.0IU/µl) and 2µl deoxyribonucleotide triphosphate (dNTP; final 
concentration 10nmol/l), 1µl of random hexamers primers (Roche Co. Basel, 
Switzerland) and RNAse free water (Ambion, Applied biosystems, Warrington, UK) to 
the final volume of 17µl. The reaction mixtures were heated to 25oC for 5 minutes and 
then 1µl of reverse transcriptase was added (Roche Co. Basel, Switzerland). Reverse 
transcription was allowed to proceed for 10 minutes at 25oC, then for 1 hour at 42oC. 
The reaction was stopped and then cooled to 8oC. 
2.3.10  Primer design  
Oligonucleotide primers are sequences of nucleic acids essential for the first step 
of DNA replication by any type of polymerase reaction. They are required because their 
binding to the genome marks the point where the DNA polymerase starts or finishes the 
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imprinting of the new DNA sequence7KH'1$SRO\PHUDVHVWDUWVUHSOLFDWLRQDWWKH¶
end of the primer, and then copies the opposite strand. The oligonuclotides primers 
replace the novo RNA strand which starts the DNA replication or synthesis in nature 
(Sambrook & Russel, 2001; Gibson & Muse, 2004).  
One of the parameters for the correct design of the primers is the similar melting 
temperature (Tm) of both primers. This is importance as the reaction, annealing to the 
DNA in PCR occurs for both primers at the same time. A significant differance between 
temperatures may result in an incorrect sequence of DNA or failure to extend at all.  In 
addition, a correct Tm avoids that the primers annealing with other primers during the 
reaction, producing primer dimmers.  
A common method in the design of primers is the use of software such as Beacon 
Designer, which is able to produce specific primers. This software can avoid the 
formation of primers loops or mishybridisation, by reducing the addition of 
mononucleotide repeats. This effect occurs when the primers anneal with themselves as 
internal hairpins or loops, hindering the annealing with the template DNA. For efficient 
results in real-time PCR (QPCR), the amplificon sizes should not exceed 250 bp.   
In addition, to ensure the effectiveness of the DNA amplification, the primer 
sequences are designed from a unique DNA sequence. An online BLAST search engine 
was used that searches and compares all known DNA sequences that have similarity to 
the primers and identifies the boundaries between exon/introns on the DNA sequence, 
avoiding any amplification of possible genomic DNA. Therefore, it is possible to 
eliminate primers that may yield non-specific DNA amplifications (Wilson & Walker, 
2001; Bustin & Nolan, 2004; Bustin et al., 2005; Fleige & Pfaffl, 2006).  
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2.3.10.1 Primer design for QPCR procedure  
The primers for QPCR used during this research were designed using the Beacon 
Designer 4.0 (Premier Biosoft, Palo Alto, USA). All the primers were designed 
specifically for QPCR reactions. To minimise nonspecific primer annealing, the melting 
temperature for the primers was set at 60oC. The lengths of the primer were 15-30 bases 
each. The cytosine (C) and guanine (G) content (the number of Gs and Cs in the primer 
as a percentage of the total bases) was around 30-80% to avoid the formation of loops or 
mishybridisation of the primers. 
The design of the primers was based on known mRNA sheep sequences published 
on the National Center for Biotechnology Information (NCBI) online database 
(http://www.ncbi.nih.gov). To ensure that the primer sequences would not cross 
hybridise with other sequences within the genome, the target sequence was tested using 
the BLAST search engine from the NCBI (http://www.ncbi.nlm.nih.gov/BLAST). To 
avoid amplification of contamination genomic DNA, primers were designed to include 
cross exon/intron boundaries wherever possible.  
The oligonucleotides primers were purchased form Sigma-Genosys (Sigma 
Chemicals Co. St. Lous, USA) and were resuspended in RNA free water to achieve a 
stock concentration of 100µmol/l. Table 2.4 describes the sequence and annealing 
temperature of each primer use during this project: 
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Table 2.4 QPCR sequences use in this thesis  
 
2.3.11 Polymerase chain reaction (PCR) 
Polymerase chain reaction or PCR is widely used for the amplification of a chosen 
region of the DNA molecule. PCR as RT-PCR involved the use of two primers, which 
are complementary to opposite strands of the double stranded DNA sequence to be 
amplified (Zheng et al., 2006). The key to this reaction is the use of the Tag polymerase 
enzyme (extracted from the bacteria Thermus aquaticus), which maintains its activity 
for long periods of time at high temperatures (>105oC) (Saiki et al., 1988). The high 
temperatures are essential for the reaction allowing the separation of the double strand 
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60oCTCA CTG GCC CAG GAA ATG TC
CCC CAA GCT CTA CAC TTC CA
60oCACA GGA GAG TTC CAC CAG GA
Insulin-like growth factor-1 Receptor 3,4 IGF-1R Ovis aries AY162434.1 TCT AAC TTT GTC TTT GCA AGA ACC A
endothelial Nitric Oxide synthase 4,5 eNOS Ovis aries MN00603 AAC CAT CCT GTA CGC CTC TG
ATT CCC AAA GGT GCT GGT C
CTG CAC CAT CAT CAA CGG AA
60oCCGTAAC TTC CGG AAG AAG GA
60oC
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GCA GGA GAT GAA GGA GGA GAG C
60oCGCA GCA CCA CGG AAA TGA G
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GCC TTG CCT TGC TGC TCT AC
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CGG GAT CTG GGT TCA CTT GTC
57oCAAC AGG TGC TCA CGA TAT AGG C
CGG GTG GAA GGG AAT TTA CGC
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DNA and the binding of the primers to it. During this reaction, the polymerase enzyme 
synthesises the new DNA strand from the DNA basic components, the nucleotides, and 
by adding them after the binding of the primers on the template DNA.       
The basic PCR reaction is a sequence of several cycles (approx 40 cycles) of 
denaturation, hybridisation and synthesis resulting in the exponential amplification of 
the DNA target sequence (Wilkinson, 1995; Sambrook & Russel, 2001; Wilson & 
Walker, 2001). The product of each PCR reaction was tested using an Aragose gel for 
DNA genomic contamination, optimisation of the amplification process (Tm), and each 
PCR product was sent for DNA sequencing for the validation of the primers using the 
QMC sequence service. The resulting chromatogram were then analysed by using 
Chromas Lite computer software (http://www.technelyium.com.au) and checked for the 
correct genes by BLAST. 
A sample from each PCR reaction was used to measure the concentration using 
the Nanodrop® spectrophotometer. The results of this measurement were used to set the 
standard of the QPCR reaction. 
2.3.11.1 PCR procedure 
As previously described, the PCR reaction was performed by keeping the cDNA 
in an ice box, working with gloves and filter tips. The reaction was performed in a final 
volume of 20µl using 1µl of cDNA, 10µl of PCR master mix (ABgene Ltd. Epson, UK), 
1µl forward and 1µl reverse primers at a final concentration of  100µmol/l in 7µl of 
RNA free water. PCR conditions are described in Table 2.5: 
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Table 2.5  PCR standard programme 
 
 
The cDNA was run in an electrophoresis agarose gel (3%) and gel extracted using 
QIAquick gel extraction kit (Qiagen).   
2.3.12 Aragose gel electrophoresis 
DNA molecules carry a negatively charge, which enable their separation in an 
electric field, with the shorter molecules moving faster and migrating farther than the 
longer ones in the direction of the cathode. The matrix in which the proteins move is 
built up of a material called agarose (3% (w/v) aragose pH7), which is dissolved in TAE 
buffer ( 2M Tris ([hydroxymethyl] amino-methane, 0.2% (w/v) SDS, 1 M Glacial acetic 
acid , 0.5M Na2 EDTA ph8, deionsate water up to 1000ml) by heating.  After a short 
period cooling 0.01% of ethidium bromide is added, a dye which fluoresces under ultra 
violet (UV) light when intercalated into DNA. 20µl of PCR product was mixed with 5µl 
of 5x gel loading buffer (0.0016% (v/v saturated bromophenol blue, 0.15% (w/v) 
Time Temperature Step
4 Minutes 105oC Initaition
15 Minutes 96oC Enzyme activation
Number of cycles 45
30 Seconds 94oC Denaturation
30 Seconds 60oC Annealling
60 Seconds 72oC Extension
7 Minutes 72oC Final extension
One single step
Indefinitely 8oC Hold 
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EDTA, 20% (v/v) Glycerol) and 5 µl of 1Kb sizes marker (ABgene) were loaded in 
different lines. The electrophoresis was then performed at a constant 120 V for 1 hour. 
For the visualisation of the DNA, the gel was exposed to a UV transilluminator CCD 
camera (Fuji film luminescent image analyser LAS-1000 V1.0). 
2.3.13 DNA extraction from agarose gel  
The gel extraction was performed using a gel extraction kit (QIAquick®, Qiagen, 
West Sussex, UK) that combines spin-column technology with the selective binding 
properties of a silica membrane which absorbs the DNA in the presence of a high 
concentration of salt, while allowing contaminants to pass through. After further 
purification steps, the purified DNA can be eluted. 
The PCR products were run on a 3% aragose gel for 1 hour at 120 V. After 
visualisation, the bands were cut and transferred to a 1.5 ml microcentrifuge tube. For 
each 100 mg of aragose gel, 300 ml of QG was added, and incubated at 50oC for 10 
minutes with vortexing at intervals of 3 minutes to facilitate the dissolution of the gel. 
Once the gel was completely dissolved, 100 µl of Isopropanol was added per 100 mg of 
gel, for precipitation of the DNA. The mix was transferred to a sterile spin column and 
centrifuged at 13000 rpm for 1 minute. The resulting flow was discarded and another 
500 µl of QG buffer was added, to eliminate any traces of agarose. Again, the column 
was centrifuged as previously described and the flow was discarded. 
Next, 750 µl of PE buffer was added and centrifuged for 1 minute at 13000 rpm. 
The empty column was centrifuged again at full speed to eliminate any traces of PE 
(contain ethanol). Finally, the column was transferred to a clean microcentrifuge tube to 
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which 30µl of RNA free water was added and incubated for 1 minute at room 
temperature. The DNA was eluted by centrifugation at 13000 rpm during 1 minute.  
2.3.14 Real-Time polymerase chain reaction (QPCR) 
Real time PCR (QPCR) is a kinetic reaction that monitors the increases of a signal, 
normally fluorescent, as an indicator of amplicon production during each PCR cycle 
(Lee et al., 1993). This signal increases in direct proportion to the amount of PCR 
product in a reaction and is detected when it rises above a set background and detection 
correlated with an initial amount of target template (Higuchi et al., 1992; Higuchi et al., 
1993; Bustin, 2000).  
The signal is normally measured at a fixed threshold level by the operator and is 
called the cycle point (Cp) (Wittwer et al., 1997). This parameter is defined as the cycle 
number at which the signal exceeds the fixed threshold. During the reaction, the 
monitoring of the signal creates a sigmoid line until it reaches a plateau. During the 
linear log face, this signal can be compared with other samples in the reaction (Higuchi 
et al., 1993). Normally, the QPCR reactions are performed in a 96 well plate, in which 
the samples can be compared with the standard curve of known concentrations of DNA 
and curve is also used to calculate the efficiency of the reaction (Bustin et al., 2005). 
These known concentrations of DNA are a series of dilutions usually extending from 10-
1 ng/µl to 10-9 ng/µl. The plotting of the Cp values versus the log of the cDNA 
concentration of the standard curve creates a slope, which reflects the amplification 
efficiency (E). E can be calculated by the formula (Lekanne Deprez et al., 2002; Fleige 
& Pfaffl, 2006): 
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Equation 2.1 Mathematical model proposed by Pfaffl for the equation of QPCR efficiency. 
The efficiency of the QPCR reaction should be 90-100% (-3.6> slope >-3.1 or 
 (  +RZHYHU D QXPEHU RI YDULDEOHV FDQ DIIHFW WKH HIILFLHQF\ RI WKH 43&5
including length of the amplification, secondary structure of the product and primer 
quality (Bustin & Nolan, 2004; Yuan et al., 2006).  
The fluorescent signal emitted by a DNA binding agent like SYBR green, which 
attaches specifically to double stranded DNA, increases proportionally with the amount 
of double stranded DNA produced in each cycle during the length of reaction. The 
disadvantage of SYBR is the requirement for extensive optimisation because it is unable 
to discriminate its binding to any double stranded DNA (Ririe et al., 1997; Morrison et 
al., 1998).       
As mentioned in previously (Section 2.3.9), the specificity of the reaction is 
determined by the quality of the primers. The specificity of reaction can be measured by 
creation of a melting curve that allows the visual comparison between different melting 
temperatures of specific products. This allows a search for any suspected nonspecific 
products. The melting temperature is a function of the length and sequence of the final 
product and this will be observed as different peaks on the graph. The specificity of the 
reaction will be marked as a single peak or similar melting temperature (Ririe et al., 
1997; Morrison et al., 1998). 
The quantity of gene expression between different samples needs to be normalised 
against housekeeping gene expression of the same sample, thereby normalising any 
possible variation between different samples. A housekeeping gene is one with a 
 
E= 10
[-1/slope]
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constant mRNA abundance during the cell life cycle, i.e 18S gene which was tested 
under a range of physiological conditions in comparison to other housekeeping genes, 
such as GAPDH (Sabek et al., 2002; Schmid et al., 2003; Bustin & Nolan, 2004).  
The most efficient way to analyse QPCR results is by using the mathematical 
model for relative quantification developed by Pfaffl (Pfaffl, 2001) (equations 2.1 and 
2.2). 
 
 
 
 
Equation 2.2  Mathematical model also proposed by Plaff for the relative gene expression by QPCR 
procedures under constant reference gene expression. CP values in the sample and the control are 
equal and represent ideal housekeeping expression and condition. 
2.3.14.1 QPCR procedure 
In all the runs, all the unknown and standard curve samples were placed in a heat 
sealled 96 well plate (ABgene) in duplicate. For each gene, DNA that made up the 
standard curve was obtained from DNA extracted from Aragose gels. The internal 
controls used in each reaction were: no primer control (NPC, containing all reaction 
reagent minus primers) amd no reverse transcriptase control (NRT), which is a mock 
reverse transcription containing all the RT-PCR reagents except the reverse 
transcriptase. The latterallows testing the presence of genomic DNA (Bustin et al., 
2005). 
As mentioned in the previously (Section 2.3.13), a period of optimisation is 
needed for the correct use of SYBR green (Thermo, ABgene Ltd. Epson, UK). This 
Ratio=   (E target ) 
ȟ
Target
 (control-Sample) 
         Ratio      =
(E target ) 
ȟ
Target
 (control-sample)
(E ref )
0
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consisted of the monitoring of nonspecific products, such as primer dimmer (melting 
curve graph) and efficiency of the reaction. For improving reaction conditions, at least 
three different primer conditions (100, 300 and 500 nmol/l) and three different annealing 
temperatures (58, 60 and 62oC) were tested. 
The QPCR reactions were carried out in a final volume of 20 µl, which included 
1µl of both forward and reverse primers, 10 µl of SYBR green master mix with ROX 
passive reference, and 7 µl of free RNA water. Once the plates were loaded with all the 
reactions they were heat sealed and placed in a PCR machine (Techne Quantica®, 
Staffordshire, UK). Table 2.6 describes the temperature and conditions used for the 
QPCR of the housekeeping gene 18s: 
Table 2.6  QPRC standard programme 
 
 
Time Temperature Step
4 Minutes 94oC Denaturation
Number of cycles 45
10 Seconds 94oC Denaturation
25 Seconds 60oC Annealling
15 Seconds 72oC Extension
15 Minutes Ramp from 75 to 72oC Melt Curve
One single step
Indefinitely 8oC Hold 
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The data collected from the QPCR reaction was exported to an Excel datasheet. 
Each sample Cp was tested for coefficient of variance and its mean was normalised 
against the 18S housekeeping gene of the same sample.  
2.3.15 8-Hydroxy 2-deoxy Guanosine elisa assay 
8-hydroxy 2 deoxy Guanosine (8-OHdG) is a byproduct of the reaction between 
reactive oxygen and nitrogen species. Excessive concentrations of 8-OHdG is a well 
established marker of oxidative stress (Spencer et al., 1995) . The generation of 8-OHdG 
is a response to both normal metabolic processes and of other environmental factors. 
Rising levels of 8-OHdG are associated with tissue injury due to oxidative stress as well 
as with a number of pathological conditions including cancer, diabetes and 
hypertension. In tissues, plasma and cell lysates 8-OHdG may be found as a free 
nucleoside or attached to DNA (Hirai et al., 2006; Shen et al., 2007; Tomohiro et al., 
2007).  
This assay is based on a competitive ELISA where 8-OHdG, conjugate binding 8-
OHdG protein and an anti conjugate 8-OHdG goat antibody compete for a limited and 
fixed amount of anti-goat monoclonal HRP conjugated antibody. The amount of 8-
OHdG monoclonal antibody is inversely proportional to the concentration of 8-OHdG 
attached to the well. The plate is washed to remove any unbound reagents and then 
(OOPQD¶V 5HDJHQW ZKLFK FRQWDLQV WKH VXEVWUDWH WR +53 LV DGGHG WR WKH ZHOO 7KH
product of this enzymatic reaction produces a yellow colour and can be detected at 
absorption of 450 nm. The intensity of the colour, is inversely proportional to the 
amount of free 8-OHdG present in each sample (Hempelmann et al., 1987; Chou et al., 
2007). For a schematic explanation of this assay see Figure 1.4. 
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The determination of 8-OHdG described above was performed using a 
FRPPHUFLDONLW2[L6HOHFW-OHdG assay kit, Cell Biolabs Inc., CA, USA). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 graphical explanation of the 8-OHdG competitive elisa 
 
2.3.15.1 8-Hydroxy 2 deoxy Guanosine elisa procedure 
Sample preparation   
1g of renal cortex was homogenised using a Dispomix® homogeniser at 9000 rpm 
for 45 seconds in 5 ml buffer (0.1 M phosphate buffer, pH 7.4, 1 mM EDTA) and 
centrifuged at 1000 x g for 10 minutes. From the resulting supernatant, the DNA was 
extracted using a commercially available extraction kit (DNeasy®, Qiagen, West Sussex, 
UK). The concentration of each sample was verified using Nanodrop® spectrophotomer 
Then the DNA was digested using nuclease P1 (Sigma) for 2 hours at 37oC in 20 mM 
Sodium acetate, followed by incubation with 1 unit alkaline phosphatase at 37oC for 30 
minutes per 100µl of DNA. After this incubation, the samples were heated at 100oC for 
10 minutes. The reaction mixture was centrifuged for 5 minutes at 6000 x g. Finally, the 
= Blocking proteins
= Conjugate 8-OHdG binding protein
= Goat anti-8-OHdG binding protein antibody
= Secondary antibody
= Free 8-OHdG
Plates are coated with conjugate 
binding 8-OHdG protein and blocked . 
Second step, it is an incubation with 
standard or unknown sample, 
immediately followed by adding the 
anti-conjugate goat antibody.    
Wash to remove all unbound reagents.
Develop the colour with Ellman's
Reagent
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supernatant DNA samples were determined spectrophometrically and stored at 4oC until 
use. 
Performing the assay 
Each standard and sample to be analysed was prepared in duplicate and 
randomised as described in previously (Section 2.4.4.1).  The first step was the coating 
of the plate: 1mg/ml of 8-OHdG conjugate was diluted to 10µl/ ml with 1 time PBS. To 
each well 100 µl of 8-OHdG conjugate solution was added and incubated overnight at 
4oC. Next day, the unbound 8-OHdG conjugate was removed by washing each well with 
300µl of dionased water. The plate was blotted in paper towels to remove excess fluid. 
Then, 200 µl of assay diluent buffer was added to each well and blocked for 1 hour at 
room temperature. 
The standard curve solution was diluted with the assay diluent in a concentration 
range of 0 ng/µl to 20 ng/µl 8-OHdG. Then, 50 µl of unknown sample or 8-OHdG 
standard was added to the wells of the conjugated plate. The plate was incubated for 10 
minutes on an orbital shaker. Next, 50 µl of diluted (1:1000) anti-8-OHdG antibody was 
added to each well and the plate was incubated was 1 hour on an orbital shaker at room 
temperature. Following, each well was washed by applying three times 250 µl of wash 
buffer thorough aspiration. After the last wash, the plate was emptied by taping on a 
paper towel to remove the excess of wash buffer. Then, 100 µl of the diluted secondary 
antibody was added to all the wells, followed by 1 hour of incubation at room 
temperature in constant agitation. The plate was washed three times. Immediately, 100µl 
RI(OOPQD¶V5HDJHQWZDVDGGHGWRHDFKZHOOLQFOXGing the blank and control wells. The 
plate was incubated for 5 minute on an orbital shaker at room temperature. To stop the 
reaction, 100µl of Stop Solution was added into each well. Finally, the absorbance was 
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read by the spectrophotometer using 450 nm as the primary wave length. The 
concentration of 8-OHdG was expressed as: [8-OHdG ng/µl]. 
To validate this methodology, firstly the standard curve was tested, and each 
dilution was repeated in duplicates to guarantee the reproducibility of the assay. The 
parameters tested were coefficient of variance between same concentration, absorption 
value of the blank and R2 value. In addition, different concentrations of DNA sample 
were tested by serial dilution and finding the detection range of this assay as described 
in previous sections (Section 2.4.4.1). The detection range of this assay was between 25-
100 ng/ml of DNA. All the samples were diluted to 50 ng/ml in deionised water.  
The controls used for this assay were: 
 
 
 
 
 
 
 
 
 
 
 
 
 
List of control used
Blank:           +            +           -
Non-Specific Binding 1:           - +            +            
Non-Specific Binding 2:            +             - +
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2.4  Statistical analysis 
To assist in the study design and to limit the sample sizes that would be required 
in each group and not erroneously accept (type II error) or reject (type I error) the null 
hypothesis, a power calculation was performed. Sample size was calculated to assess the 
effect of measured variables (such as weight) obtained from an intervention (NR or 
obesity) or group at 80% power. The sensitivity of the power calculation is a function of 
the group sizes, statistical controls and reliability of the measures. Therefore, by 
increasing sample sizes it is possible to increase the statistical power. In the research 
literature, it is generally accepted that a power of 80% is needed as a standard for 
DGHTXDF\ 3RZHU FDOFXODWLRQV ZHUH SHUIRUPHG XVLQJ 6DPSOHSRZHU  6366 ,QF., 
Chicago, Illinois, USA).  
Previous to any statistical analysis, all the values collected in each assay were 
transferred up to an Excel datasheet. Then, the coefficient of variance (CV) of all the 
duplicate values were analysed and for which a CV  0.95% confirmed low variation 
between duplicates and the reproducibility of the assay. The data points that fulfil this 
requirement were used for the analyses.  
The distribution of the data collected in each assay was the main factor for the 
chosen statistical test to perform. For testing normal distribution, the data collected of 
each group were subjected to the Kolmogorov-Smirnov test for which a P  0.05 
confirmed that the data was normally distributed. Depending on the significance of this 
analysis, parametric or nonparametric tests were utilised for the analysis of the data. For 
consistency, the data in these studies are presented as mean and standard of error (SEM). 
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During the length of this study, the NR-O group and L group are considered to be 
exposure to more than one intervention (e.i maternal nutrient restriction and exposure to 
an obesogenic environment). For that reason, to obtain a biological meaningful analysis, 
the L group was compared only with the O group, who was exposed only to one 
intervention (obesogenic environment). Subsequently, the means of the two obese 
groups (NR-O and O) were compared independently of the L group. Thus, depending on 
their type of distribution based on the significance of the Kolmogorov-Smirnov test, 
either an independent parametric (T-test) or non-parametric test (Mann Whitney U) was 
assigned to compare these two groups. When an independent T-test was applied ,it was 
IROORZHGE\D/HYHQH¶VWHVWWRHYDOXDWHHTXDOYDULDQFHV,IWHVWUHVXOWZDVp> 0.05, equal 
variances between the groups could be assumed. More specific tests are detailed 
throughout the results chapter and further explanation is given when relevant. The 
statistical tests were performed using SSPS software (version 14.0). 
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Chapter 3 - The effect of maternal nutrient restriction 
between early to mid gestation on renal and perirenal 
adipose tissue at seven days of age 
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 Chapter 3 - The effect of maternal nutrient restriction between early to mid 
gestation on renal and perirenal adipose tissue at seven days of age 
 
3.1 Introduction 
3.1.1 Early effects of maternal nutrient restriction 
The thrifty phenotype hypothesis suggests that low birth weight compromises 
adult health and well being by increasing the risk of the development of metabolic, 
endocrine and cardiovascular diseases (Hales & Barker, 2001). However, the causes of 
low birth weight are complex and many retrospective studies have shown that maternal 
health and nutritional status play a part in the programming of future health outcomes, 
irrespective of birth weight (Hales & Barker, 2001, Olson et al., 2008). These findings 
are supported by evidence collected from offspring exposed to the Dutch Famine 
(Roseboom et al., 2001). Moreover, another important conclusion from this cohort is 
that outcomes in later life depended on the trimester of gestation in which there was 
exposure to famine. For instance, offspring exposed during the second trimester were 
not smaller or lighter than non-exposed newborn but they had an increased prevalence 
of renal disease and other metabolic alterations in later life (Painter et al., 2005). 
Furthermore, evidence obtained from large animal models of maternal nutrient 
manipulation shows that the only examples that lead to a reduction in birth weight are 
those offspring exposed to severe undernutrition throughout pregnancy, or during, the 
last third of gestation (Whorwood et al., 2001; Oliver et al., 2002; Budge et al., 2004).  
It is important to note that the majority of studies describing the development of 
renal tissue influenced by the maternal nutritional environment were conducted in 
118 
 
singleton offspring, which may differ from the present study that utilised twin bearing 
mothers. Previous studies have shown that twin and singleton ovine offspring have 
different insulin metabolic responses, which may affect the patterns of renal and adipose 
tissue development (Bloomfield et al., 2004; Rumball et al., 2008).       
As in humans, a reduction in maternal nutrition during early to mid gestation in 
sheep (30 to 80 days of 145 day pregnancy) produced offspring of similar weight to 
those born from standard fed mother but with significant alteration in fat mass, blood 
pressure and renal structure (Whorwood et al., 2001; Bispham et al., 2005; 
Gopalakrishnan et al., 2005). Near term singleton IHWXVHV§GD\VRIH[KLELWed a 
rise in fat deposition in conjunction with an increase in mRNA abundance for IGF-1 and 
-2 receptors (Bispham et al., 2003). This effect was accompanied by an increase in 
mRNA abundance of other key regulatory components of fat metabolism, including 
UCP-2 and PPAR-Į (Bispham et al., 2005). Additional alterations in mRNA gene 
expression of critical pathways in renal and adipose tissue development included the 
glucocorticoid and angiotensin 1 receptors (Whorwood et al., 2001). In another similar 
cohort, at six months of age, the nutrient restricted offspring showed a reduction in 
blood pressure in conjunction with a decrease in nephron number (Gopalakrishnan et al., 
2005). These results suggest that maternal nutrient restriction during early-to-mid 
gestation potentially alters the gene expression of key physiological and endocrine 
pathways, affecting the normal patterns of renal and adipose tissue development and 
subsequently altering the risk of cardiovascular disease in later life (Tchoukalova et al., 
2004; Gopalakrishnan et al., 2005). 
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3.1.2 Changes in the growth hormone (GH)-IGF axis in renal and adipose tissue 
Linear growth is unique to childhood and growth hormone (GH) is a key 
endocrine regulator of postnatal growth (Low et al., 2001). However, during early 
childhood, the normal GH production and release is mainly nutritional dependent 
(Ogilvy-Stuart et al., 1998). One of the mechanisms by which maternal nutrient 
restriction modulates postnatal growth may be through alterations in the GH-IGF axis, 
that has a major role in kidney and adipose tissue development (Brennan et al., 2006). 
During the neonatal period, the receptors of this axis are detectable at very high levels in 
developing renal and adipose tissue (Ymer & Herington, 1992; Holzenberger et al., 
2001). IGF-1 and its homolog IGF-2 are both involved in embryonic development, 
whereas only IGF-1 maintains a role in growth regulation after birth. In small animals, 
IGFs play an essential role in renal development by inducing metanephric 
differentiation, thereby modulating nephron number (DeChiara et al., 1990; Liu et al., 
1993). In addition, IGF-1 production is GH dependent (Tannenbaum et al., 1983). IGFs, 
by binding to IGF-1 receptors (IGF-1R), play a role in the negative feedback regulation 
of GH in juvenile animals and, to a lesser degree, in adults (Tannenbaum et al., 1983). 
 In vitro, GH appears to regulate the number of IGF receptors in adipocytes by 
modulating the stimulatory effects of IGF (Lonnroth et al., 1987). Genetically induced 
IGF-1R deficient mice are seen to have disproportionate postnatal growth, particularly 
in adipose tissue, characterised by a reduction in adipocyte number per fat pat and a 
raised lipid content (Holzenberger et al., 2001). A possible explanation for these effects 
has come from cell culture studies, which indentified IGFs as important regulators of 
adipocyte development (Deslex et al., 1987).  
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As well as having a role in adipose and renal tissue development, several 
observations indicate an additional role for the IGF-GH axis in mature kidney function. 
Infusion of GH into healthy adults causes an increase in glomerular filtration rate (GFR) 
and renal plasma flow (RPF). Hirshberg et al. have demonstrated that renal IGF-1 is the 
main component for GH regulation of kidney function (Parving et al., 1978; Hirschberg 
& Kopple, 1989). Thus, alterations in the IGF-GH axis by reducing prenatal nutrition 
could compromise the early development of renal and adipose tissues, thereby 
increasing the risk of metabolic and renal dysfunction in adulthood.   
3.1.3 Common factors in cell maturation in renal and adipose tissue 
In newborn sheep, brown adipose tissue represents the main adipose tissue depot, 
particularly around the kidneys. Over the first two weeks of postnatal life, the majority 
of brown adipocytes in this depot completely disappear and are replaced by white 
adipose tissue (Finn et al., 1998). Comparative microarray analysis of pre-adipocytes 
and white adipocytes revealed the involvement of DNA methyltransferases (DNMT) as 
one of the key regulators of the differentiation process (van Beek et al., 2008). One of 
these proteins, DNMT-1, is associated with the maintenance of methylation patterns 
during replication and de novo DNA methylation. 
It is known that, during the cell differentiation process, DNMT-1 interacts with the 
retinoblastoma protein, an important developmental protein with a role in the regulation 
of energy expenditure (Robertson et al., 2000; Hansen et al., 2004). DNA methylation 
has the potential to affect the expression of other essential genes that are active during 
cell differentiation, such as IGF-2 and its receptor (Kaneda et al., 2004). A decrease in 
the expression of IGF-2 has been linked with a reduction in muscle mass and an increase 
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in fat deposition in pigs (Nezer et al., 1999). Recent findings have demonstrated that 
lactogens are able to control the differentiation and growth of brown adipose tissue in 
neonatal mice through the up-regulation of IGF-2 (Viengchareun et al., 2008).  
In addition, DNMT-1 activity and alterations in DNA methylation patterns have 
been implicated in gene expression and morphologic changes in renal tissues, induced 
by a suboptimal maternal environment (Pham et al., 2003). For instance, exposure to 
uteroplacental insufficiency in rats decreased the methylation in specific areas of the p-
53 promotor. This triggered excessive apoptosis, altering the process of organogenesis 
and potentially reducing nephron numbers. Interestingly, this effect was associated with 
a reduction in DNMT-1 mRNA expression in the renal cortex, followed by a reduction 
in IGF-1 gene expression (Pham et al., 2003). Thus, the enzymatic activity and 
expression of DNA methyltransferases, such as DNMT-1, may be critical factors for 
postnatal growth of the kidney.  
3.1.4 Scientific rationale, aim and hypothesis 
Previous human and animals studies have indicated an association between the 
maternal environment in utero and an increased risk of later renal disease. It has also 
been postulated that the development of adipose tissue during embryogenesis and early 
fetal life may play a role in the modulation of kidney function in adulthood. 
Furthermore, as a key endocrine organ, alterations of adipose tissue function, caused by 
later exposure to an obesogenic environment, may increase susceptibility to kidney 
disease. The hypothesis to be examined in this chapter was whether a targeted reduction 
in maternal nutrition over the period of early organogenesis in sheep affected early 
postnatal maturation of adipose and renal tissues. In addition, it was postulated that 
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exposure to maternal nutrient restriction will result in an altered pattern of expression of 
key developmental genes involved in postnatal development, such as cell cycling, 
glucose utilisation and DNA methylation. Therefore, the effects of maternal nutrient 
restriction during this period of postnatal development on the gene expression of 
components of the IGF-GH axis, IR, HK-1, GLUT-1, DNMT-1, eNOS, iNOS and p-53 
in renal tissue and IGF-1, IGF-1R, IGF-2, IGF-2R and DNMT-1 in perirenal adipose 
tissue of seven-day-old sheep, were investigated.  
3.2 Methods and materials 
A full description and details of all methods, including animal experimentation, 
gene expression analysis used in this chapter can be found in Chapter 2, with the 
exception of the estimation of nephron number assay that was kindly carried out and 
supervised by Dr. David S. Gardner with the collaboration of Prof. Michael E. Symonds. 
In addition, all statistical tests utilised are also explained in Chapter 2 or in the results 
section of this chapter. 
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3.3 Results 
3.3.1 The effects of maternal nutrient restriction between early to mid gestation 
on birth weight, parameters of renal development and fat mass 
As expected, there was no difference in body weight at birth between groups and 
this relationship persisted until the time of dissection at seven days of postnatal age. In 
addition, there were no effects of maternal nutrient restriction on kidney or perirenal 
adipose tissue weights. However, the ratio between kidney and body weight was lower 
in offspring exposed to maternal nutrient restriction (p<0.01; Fig. 3.1.B). Nephron 
numbers per group were similar. Importantly, the mean increase in total body weight 
was directly related with the increase in fat in each group during this first week of 
neonatal life (p<0.01; Fig. 3.2).   
In addition, NR offspring exhibited a trend towards greater pancreas weight 
compared to the controls (p= 0.053; Fig 3.1.A). Finally, no difference was recorded 
between the groups in the relative mass of the remaining tissues dissected or body 
dimensions measured at seven days of age (Table 3.1). 
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Ratio total fat body weight at 7 day 
(g/g)
Total fat (g)
Peririnal adipose tissue weight (g)
NS
NS
24.29 ± 1.90
NS
NS
 13.74 ± 0.97
 1.81 ± 0.16 
 193.29 ± 31.29 
 12.44 ± 1.25
 1.35 ± 0.35 
 159.14 ± 31.29 Mean increase weight per day (g/d)
53.25 ± 7.47  65.75 ± 7.24 
40.19 ± 7.18 49.50 ± 5.45
Ratio perirenal adipose tissue 
kidney weight (g/g)
3.19 ± 0.25 3.18 ± 0.15
Kidney Depth (mm) 
Nephon numbers per kidney
Weight at birth (kg) 
Weight at 7 day (g) 
Crown-rump length (mm)
Total kidney weight (g)
Kidney length (mm)
Kidney breadth (mm)
Growth Parameter  NR Group
26.50 ± 1.94 
Control Group P
NS
4.58 ± 0.25
43.11 ± 0.72 
27.28 ± 1.49 
4.24 ± 0.29 NS
42.43 ± 1.00 NS
NS
38.86 ± 0.86
25.57 ± 2.49
29.42 ± 1.10
39.25 ± 0.85 NS
27.28 ± 1.49 NS
NS
NS
NS
5.25 x 105 ± 2.34 x 104  5.36 x 105 ± 1.04 x 105  
Table 3.1  Physiological characteristics at birth and at dissection time (adapted 
from Williams et al., 2007)  
 
 
 
 
 
 
 
(n=12) (n=7) 
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Figure 3.2  Linear association between the mean of weight increase and the total fat 
mass in both nutrition groups at seven days.  
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Figure 3.1 (A) Effect of maternal nutrient restriction on pancreatic weight (p=0.053) 
and (B) ratio of kidney weight to body weight at seven days of age (*p<0.05). Values 
are mean ± SEM.  
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3.3.2 Effects of maternal nutrient restriction between early to mid gestation on 
the renal IGF-GH axis 
3.3.2.1 Renal IGF-1, IGF-2, IGF-1R and IGF-2R gene expression in seven-day-old 
offspring 
There was no difference in IGF-1 mRNA abundance in the kidneys between 
groups but, interestingly, it was negatively correlated to total fat mass (p<0.01: Fig. 3.3) 
and to body weight at seven days of age (p<0.001; Fig. 3.4).  There was no difference 
between the groups in renal IGF-1R, IGF-2 and IGF-2R mRNA expression (Table 3.2).  
 
Table 3.2 Renal mRNA expression of IGF-1, IGF-2 and their respective receptors 
at seven days of age 
 
 
 
 
 
 
 
 
 
NS
Gene NR Group Control Group P
IGF-1 (2ǻ&7) 0.95 ± 0.14 1.00 ± 0.13 NS
IGF-2R (2ǻ&7) 0.86 ± 0.11  1.00 ± 0.11 NS
IGF-2 (2ǻ&7) 2.50 ± 0.71 1.00 ± 0.16 NS
IGF-1R (2ǻ&7) 0.81 ± 0.12 1.00 ± 0.24 
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Figure 3.3 Scatter plots illustrating the negative relationship between IGF-1 renal gene 
expression and total fat mass at 7 days of age  
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Figure 3.4 Scatter plots illustrating the negative relationship between renal IGF-1 gene 
expression and body weight at 7 days of age  
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3.3.2.2 Renal gene expression of growth hormone receptor (GHR) and 
measurement of renal oxidative stress 
Seven days after birth, GHR was the only renal gene tested in this study to show a 
decrease as a result of maternal nutrient restriction (p<0.05; Fig. 3.5). To evaluate the 
effect of reduced GHR mRNA expression, concentrations of thiobarbituric acid reactive 
substances (TBARS) were measured in the kidney cortex and were found to be 
significantly decreased (p<0.01; Fig. 3.5.B) in the offspring of nutrient restricted 
mothers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 (A) Renal GHR mRNA abundance and (B) TBARS concentration observed in 
NR and control offspring at one week of age. Values are expressed as means ± SEM. 
Significant differences between NR and control offspring *(p<0.05). 
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3.3.3 Renal gene expression for glucose sensing factors 
Maternal nutrient restriction in early to mid gestation did not influence the mRNA 
abundance in the renal cortex of glucose sensing factors, such as glucose transporter 1 
(GLUT-1) or hexokinase 1 (HK-1). Furthermore, there was no difference in the renal 
mRNA abundance of the renal insulin receptor between nutrition groups (Table 3.3). 
3.3.4 Renal mRNA gene expression of DNMT-1, the pro-apoptotic gene p-53, 
iNOS and eNOS 
Maternal nutrient restriction did not influence the mRNA expression of renal 
DNMT-1, p-53, iNOS and eNOS (Table 3.3). 
Table 3.3 Renal gene expression of glucose sensing factors, p-53, DNMT-1, iNOS 
and eNOS at 7 days after birth   
 
 
 
HK-1 (2ǻ&7) 1.21 ± 0.20 1.00 ± 0.21 NS
IR (2ǻ&7) 0.89 ± 0.45 1.00 ± 0.13 
eNOS (2ǻ&7) 1.07 ± 0.18  1.00 ± 0.23 NS
iNOS (2ǻ&7) 1.70 ± 0.39  1.00 ± 0.18 NS
DNMT-1 (2ǻ&7) 1.10 ± 0.19  1.00 ± 0.18 NS
p-53 (2ǻ&7) 1.44 ± 0.39  1.00 ± 0.16 NS
NS
Gene NR Group Control Group P
GLUT-1 (2ǻ&7) 0.75 ± 0.23 1.00 ± 0.39 NS
130 
 
3.3.5 IGF-1, IGF-2, IGF-1R and IGF-2R and DNMT-1 mRNA expression in 
perirenal fat of seven-day-old offspring 
There was no difference in the expression of IGF-1, IGF-1R mRNA between 
groups (Table 3.4), but, IGF-2 gene expression was significantly lower (p<0.05; Fig. 
3.6.A) in perirenal adipose tissue from maternal nutrient restricted offspring. This was 
associated with a similar trend in IGF-2R mRNA abundance (p= 0.075; Fig. 3.6.B). In 
the perirenal adipose tissue of early to mid gestation maternal nutrient restricted 
offspring, at seven days of age, there was a two-fold greater abundance of DNMT-1 
mRNA (p<0.05; Fig. 3.7) compared to controls. 
 
 
Table 3.4 IGF-1 and IGF-1R mRNA expression in perirenal adipose tissue in 7-
day-old offspring 
 
 
 
 
 
 
 
IGF-1R (2ǻ&7) 0.88 ± 0.10 1.00 ± 0.21 NS
Gene NR Group Control Group P
IGF-1 (2ǻ&7) 1.08 ± 0.13 1.00 ± 0.13 NS
131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Gene expression of 
perirenal adipose tissue DNMT-1 in 
seven-day-old offspring born from 
maternal nutrient and control fed 
mothers. Values are expressed as 
means ± SEM. Significant 
differences between NR and control 
offspring* (p<0.05)    
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Figure 3.6 (A) Gene expression of IGF-2 (significant control vs. NR offspring *p<0.05) and 
(B) abundance of IGF-2R mRNA in neonatal perirenal adipose tissue in NR and control 
offspring at seven days of age (p< 0.075). Values are expressed as means ± SEM.  
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3.4 Discussion 
In the present study, exposure to maternal nutrient restriction between early and 
mid gestation had little effect on the kidney in terms of weight and size, as measured at 
seven days after birth, although a reduction in the ratio of kidney-body weight was 
observed. The few significant changes noted in these renal tissues included a decrease in 
GHR mRNA expression and a reduction in oxidative stress. In contrast, perirenal 
adipose tissue of these offspring exhibited significant changes in gene expression, 
associated with the process of adipocyte differentiation (van Beek et al., 2008; 
Viengchareun et al., 2008). Thereby, following early exposure to maternal nutrient 
restriction, adipose tissue is characterised by a decrease in gene expression of IGF-2, 
IGF-2R and an increase in the methyltransferase DNMT-1.  
3.4.1 Effects of maternal nutrient restriction on body weight, renal and adipocyte 
development 
Consistent with previous studies, weight at birth was not affected by exposure to 
maternal nutrient restriction during early to mid gestation (Whorwood et al., 2001). 
However, epidemiological studies of the Dutch Famine offspring survivors have shown 
that, despite there being no significant effect on birth weight, exposure to famine during 
early gestation predisposed offspring to metabolic disorders in adult life (Ravelli et al., 
1976). In addition, throughout their first week of postnatal life and regardless of 
maternal nutrition during gestation, both groups of offspring showed similar increases in 
total body weight and in other parameters of physical development. These results 
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support the view that endocrine regulation of postnatal growth, which is nutrient 
dependent, may act in a similar manner in both groups.   
As demonstrated in previous studies, maternal nutrient restriction during early to 
mid gestation did not alter additional parameters of renal composition, such as nephron 
number or total weight (Whorwood et al., 2001; Brennan et al., 2005). However, in my 
study, the only change in renal composition influenced by reduced nutrition in utero was 
a decrease in the ratio of kidney to body weight, whilst previous studies in newborn 
ovine singletons had shown an increase (Whorwood et al., 2001; Brennan et al., 2005). 
These findings suggest that maternal nutrition has different consequences for renal 
development depending on whether the offspring are singleton or twins (Whorwood et 
al., 2001; Brennan et al., 2005). 
It has previously been proposed that exposure to maternal glucocorticoids during 
early nephrogenesis can alter renal physiology. As demonstrated by Dodic et al., an 
infusion of dexamethasone (a cortisol analogue), administered to sheep mothers from 26 
to 28 days of gestation, decreased nephron numbers in offspring, followed by renal 
dysfunction and hypertension in later life (Dodic et al., 2002). However, exposure to 
moderate undernutrition in mothers bearing singleton or twins resulted in a rapid 
decrease in cortisol secretion. These results may explain the different effect on renal 
composition in response to a suboptimal maternal nutritional environment compared 
with those offspring exposed to dexamethasone during gestation (Dodic et al., 
2002;Bispham et al., 2003; Jaquiery et al., 2006; Rumball et al., 2008). Interestingly, in 
twin pregnancies, maternal cortisol remained low for at least 20 days after returning to a 
standard maternal diet. On the other hand, in the plasma of mothers bearing singletons, 
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the concentration of cortisol is normalised in parallel to the increase in food intake 
(Bispham et al., 2003; Jaquiery et al., 2006). Possibly due to this slow increase in 
maternal cortisol levels, the twin fetal environment may produce a different maturation 
pattern of the kidneys, affecting renal composition and also generating different 
endocrine responses, as compared with singleton offspring exposed to maternal nutrient 
restriction (Whorwood et al., 2001; Bloomfield et al., 2004; Brennan et al., 2005). 
Another important observation in pregnant sheep bearing twins is that undernutrition led 
to a constant decrease in maternal glucose and insulin plasma concentrations until the 
end of gestation (Rumball et al., 2008). These parameters were unaffected by the 
increase in food intake during the re-feeding period, an effect not seen in singleton 
pregnancies exposed to nutritional manipulation (Bispham et al., 2003). Thereby, an 
absence of change in total fat mass or renal composition observed in both groups of 
offspring at seven days after birth may, in part, reflect the maternal compensatory 
response to a reduction in food intake during twin pregnancy.  
3.4.2 The effect of maternal nutrient restriction on renal endothelial function 
Nephrogenesis is affected not only by the actions of glucocorticoids, but also 
depend on additional endocrine components, including elements of the renin-angiotensin 
system (RAS) (Hall, 2003; Moritz et al., 2004). For example, in rats, inhibition of the 
angiotensin 1 receptor (AT1R) during postnatal nephrogenesis is associated with a 
reduction in nephron number and renal mass (Woods & Rasch, 1998). The hypertensive 
effects of angiotensin are mediated through AT1R by the up-regulation of the NADPH 
protein complex, which contributes to the generation of oxidative stress and subsequent 
endothelial dysfunction (Zafari et al., 1998).  
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In previous studies, it has been found that exposure to maternal nutrient restriction 
in singleton sheep offspring between early to mid gestation resulted in a significant 
increase in the expression of renal AT1R, suggesting an activation of the RAS in renal 
tissue leading to possible early endothelial dysfunction (Whorwood et al., 2001).  
The oxidative stress analysis (i.e.TBARS) of renal tissues at seven days of age, in 
the present study showed a reduction in lipid peroxidation in the maternal nutrient 
restricted group. In addition, renal gene expression of nitric oxide synthase enzymes, 
eNOS and iNOS, were not affected by maternal NR, suggesting similar endothelial 
function regulation between nutrient groups, an observation reinforced by similar 
mRNA expression of p-53 and DNMT-1. Overall, the reduction in oxidative stress and 
the gene expression of markers associated with endothelial function may suggest that the 
RAS in twin offspring exposed to maternal NR is down regulated, another possible 
difference in renal development compared with singletons. 
3.4.3 Gene expression for renal cellular glucose uptake and utilisation 
Previous findings have suggested that important long term changes in metabolism 
and the endocrine system may be induced by exposure to maternal nutrient restriction, 
independent of fetal number or birth weight (Oliver et al., 2002). Nutrient restriction, 
confined to early gestation, negatively impacts on offspring glucose-insulin 
homeostasis. Oliver et al. reported increased pancreatic insulin release in offspring, at 5 
and 30 months of age, exposed to severe undernutrition from 60 days before conception 
to 30 days of gestation (Oliver et al., 2002). Raised insulin can induce endothelial 
vasodilatation, which could contribute to glomerular hypertension, leading to a slow 
process of renal dysfunction (Brands et al., 2009). Numerous enzymatic systems in the 
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kidney are affected by plasma insulin concentration , including the hexokinase family 
(HK1-3), which plays a central role in cellular glucose uptake and utilisation (Robey et 
al., 2002; Henningsen et al., 2003). Previous observations have demonstrated that 
exposure to high concentrations of insulin can induce mRNA expression of HK-1 in the 
glomeruli of obese rodents (Henningsen et al., 2003). In addition, insulin itself is also 
able to regulate IGF production with high IGF-1 concentrations suppressing insulin 
action in mesangial cells (Abrass et al., 1988). Unfortunately, we were unable to collect 
plasma to measure insulin concentration during the neonatal period.  
However, offspring exposed to maternal NR had a heavier pancreas, which may 
be possible sign of a different pancreatic development influenced by the in utero 
environment (Fowden et al., 2005). Further exploration of pancreatic function and 
structure is needed to understand the biological relevance of these differences in weight.  
3.4.4 The renal IGF-GH axis 
The IGF-GH axis has a key role in the maintenance of kidney structure and 
function (Doi et al., 1988). Although most actions of GH are mediated by IGF-1, both 
share common functions; but over-exposure to IGF-1 or GH has different consequences 
for the kidney. Infusion of GH or IGF-1 in mice causes renal hypertrophy, 
glomerulosclerosis and lipid accumulation, leading to an increase in kidney weight (Doi 
et al., 1988; Quaife et al., 1989; Berfield et al., 2006). 
Increases in the gene expression of IGFs and their receptors in several tissues, 
including the kidney, have also been observed in singleton fetuses exposed to similar in 
utero nutritional manipulation during different periods of gestation (Bispham et al., 
2003; Brennan et al., 2005; Hyatt et al., 2007). Furthermore, changes in activation of 
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this axis may be the main mechanism by which maternal nutrient restriction is 
associated with impaired glucose tolerance and future alterations in renal functioning in 
offspring (Hyatt et al., 2007; Bridgewater et al., 2008). However, evidence collected in 
this study indicates that a reduction in maternal diet between early to mid gestation in 
twin offspring had no influence with respect to renal gene expression of the IGFs. In 
addition, as stated previously, no changes in kidney composition and endothelial 
function between the groups were observed. Furthermore, the identical gene response of 
renal IGF-1 to increased body weight or fat mass, regardless of maternal nutrition, may 
indicate a similar regulation of this hormone in both offspring groups. My results might 
therefore suggest that the factors governing normal body growth during this period of 
life, such as neonatal nutrition, also regulate the gene expression of renal IGF-1, thus 
emphasising the similarities in renal endocrine responses in both groups.  
Another important element in the regulation of this axis is the hormone ghrelin. 
Predominantly produced by the stomach, ghrelin is a potent inducer of GH secretion, 
glucose oxidation and food intake (Arvat et al., 2000; Wren et al., 2001). As previously 
shown, a period of nutrient restriction in early to mid gestation resulted in an 
appreciable decrease in NPY mRNA abundance in the hypothalamus at 7 days of age 
(Sebert et al., 2009). This component of appetite regulation is able to reduce the activity 
of ghrelin, inducing a decrease in cellular metabolic activity and indirectly reducing 
oxidative stress in the kidney (Kalra & Kalra, 2004). Consequently, the functional 
alteration associated with the regulation of appetite through the actions of NPY, 
observed in the hypothalamus, may be the most likely factor influencing the reduction in 
oxidative stress and GHR seen in the kidneys of the maternal nutrient restricted 
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offspring. Further studies are needed to explore the influence of appetite regulation by 
the hypothalamus in neonatal renal function. 
3.4.5 Possible factors altering the perirenal fat maturation in maternal nutrient 
restricted seven-day-old offspring 
It has been shown previously that the maturation of brown fat cells in mice, 
induced by lactogens, occurs through the prolactin receptor and is characterised by an 
increase in IGF-2 and UCP-1 gene expression in adipose tissue at birth (Viengchareun et 
al., 2008). Cell culture experimentation using prolactin receptor deficient pre-adipocytes 
demonstrated that the process of differentiation can be triggered by introducing 
exogenous IGF-2, which stimulated glucose uptake (King et al., 1980; Sinha et al., 
1990; Viengchareun et al., 2008). Importantly, GH, at least in vitro, regulates IGF-2 
receptor abundance (Lonnroth et al., 1987). The results of the present study show that 
my model of maternal nutrient restriction decreases the gene expression of IGF-2 and its 
receptor during the neonatal period. It is possible that this reduction in mRNA 
abundance may have consequences for the stimulation of energy use and the 
differentiation of perirenal adipose tissue. This hypothesis is reinforced by other 
observations, including reduced NPY mRNA expression in the hypothalamus, which is 
linked to adipocyte hyperplasia that might subsequently increase gene expression of 
DNMT-1 on perirenal fat, as observed in NR neonatal offspring (Kalra & Kalra, 2004; 
van Beek et al., 2008; Sebert et al., 2009). At the molecular level, DNMT-1 is 
associated with cell differentiation and proliferation in pre-adipocytes through 
interaction with the retinoblastoma protein (pRb) (Hansen et al., 2004; van Beek et al., 
2008). For instance, the inactivation of this complex leads to an inhibition of the 
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adipocyte differentiation process, whilst obese pRb deficient mice show an increase in 
energy expenditure, resulting in weight loss (Hansen et al., 2004). 
It has been suggested that an irregular pattern of adipocyte differentiation may 
lead to insufficient capacity to store and assimilate increased nutrition intake (Miyoshi et 
al., 2009). Ultimately this failure might lead to adipocyte dysfunction and necrosis, 
associated with insulin resistance in later life (Salans et al., 1973; Cinti et al., 2005; 
Spalding et al., 2008). Sharkey et al. have recently reported that adipose tissue 
dysfunction and inflammation  in one-year-old offspring born to maternal nutrient 
restricted (28-80 gestation days) mothers, following exposure to a post-weaning 
obesogenic environment (Sharkey et al., 2009). There was an increase in markers 
associated with necrosis in adipocytes, such as crown-like structures. In addition, the 
perirenal adipose tissue of these obese offspring showed clear signs of inflammation and 
macrophage infiltration (Sharkey et al., 2009). They also displayed increased ectopic 
lipid storage in cardiac tissue and raised plasma insulin, in comparison with obese 
controls (Chan et al., 2009; Sebert et al., 2009). In maternal nutrient restricted neonatal 
sheep, IGF-2 and its receptor mRNA expression was decreased in perirenal fat, whilst 
there was no effect on IGF-1 and its receptor. Given that gene regulation of IGF-1 and 
its receptor in adipose and other  peripheral tissues is related to nutrition intake, these 
similarities in gene expression are not surprising in this animal model (Wren et al., 
2001; Giovannuci et al., 2003). However, I further propose that changes in gene 
expression of IGF-2, IGF-2R and DNMT-1 may indicate a cellular phenotypic 
alteration, which may ultimately limit the lipid storage capacity of the adipocyte, 
becoming critical only after exposure to an obesogenic environment. 
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3.5 Summary 
Offspring exposed to nutrient restriction during the period of early organogenesis, 
compared with those born to mothers fed to appetite throughout gestation, showed a 
reduction in the expression of GHR in conjunction with a decrease in oxidative stress 
within the kidney. However, the greatest differences between gestational nutrition 
groups were found in the adipose tissue surrounding the kidneys. The gene expression of 
IGF-2 and its receptor were decreased, accompanied by an increase in DNMT-1 mRNA 
abundance. All these effects may be a consequence of the alterations on gene expression 
of the appetite control elements in the hypothalamus, such as NPY, possibly 
programmed by their in utero nutritional experience. Owing to the role of these genes in 
adipose tissue development and energy metabolism, there may be long term implications 
for the storage capacity of this tissue and its response to increased nutrition 
consumption. These mechanisms could explain, in part, the process of adipocyte 
hypertrophy and other effects associated with extreme obesity seen when the siblings of 
these offspring are exposed to an obesogenic environment (Sharkey et al., 2009).  
 
 
 
 
141 
 
 
Figure 3.8 Summary of findings  
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Chapter 4 - Effects of obesity on renal tissue of young sheep exposed to 
maternal nutrient restriction between early to mid gestation 
 
4.1 Introduction 
4.1.1 The effects of leptin on renal function  
It was observed in several human cohorts that an adverse uterine environment may 
induce permanent functional changes within the kidneys, leading to hypertension and 
subsequent cardiovascular and renal dysfunction in later life (Barker et al., 1990; Law et 
al., 2002; Hughson et al., 2003). Analysis of renal autopsies have demonstrated a strong 
relationship between birth weight and nephron number in both the infant and adult 
kidney (Hughson et al., 2003). However, the authors of this report noted a substantial 
variation in adult nephron number in the lower range of birth weights, suggesting an 
innate ability of the kidney to develop correctly, even in a suboptimal maternal 
environment (Hughson et al., 2003). As described in chapter 3, birth weight and kidney 
development, including nephron number, was not influenced by maternal nutrient 
restriction in early to mid gestation. However, this manipulation in maternal nutrient 
supply affected the expression of genes associated with adipose tissue development. 
Thus, the influence of maternal nutrient restriction on renal tissue is possibly limited to 
alterations in metabolic and hormonal responses associated with lipid storage and 
appetite control in these offspring (Chapter 3; Sebert et al., 2009). As previously 
observed, the model of maternal nutrient restriction I have adopted has produced 
different renal responses when these offspring experienced an excessive  increase in 
weight gain after weaning, such as a reduction in renal apoptosis and gene expression of 
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elements of the RAS (Williams et al., 2007; Sharkey et al., 2009; Chan et al., 2009; 
Sebert et al., 2009). 
In recent years, it has been suggested that leptin, a hormone secreted by  adipose 
tissue, is partly associated with obesity-induced hypertension (Rahmouni et al., 2005). 
Importantly, a short isoform of the leptin receptor is  highly expressed in the kidney, 
potentially influencing renal function and structure (Serradeil-Le Gal et al., 1997). 
Previously it was observed that acute or chronic exposure to leptin influenced blood 
pressure and renal function by altering the synthesis of nitric oxide (NO) (Beltowski et 
al., 2002; Beltowski et al., 2004). Acute infusion of human leptin (1 mg/Kg) into rats 
resulted in increased NO synthesis, through the stimulation of NO synthase enzymes, 
but did not induce activation of the vascular-sympathetic nerve activity system or 
produce renal sodium retention (Beltowski et al., 2002). However, long term leptin 
administration (7days-0.25mg/Kg), as observed during hyperleptinemia, decreased NO 
synthesis, followed by abnormal sodium retention and vasoconstriction (Beltowski et 
al., 2004). As expected, in obese mice obesity, a peripheral or cerebroventricular 
administration of leptin produced increased renal sympathetic nerve activity of similar 
intensity to that found in controls (Rahmouni et al., 2005). However, the increase in 
arterial blood pressure following an infusion of leptin was more than 10 mmHg higher 
in obese compared with lean mice (Rahmouni et al., 2005). Furthermore, the strong 
correlation between body weight and leptin serum abundance suggests the development 
of a leptin-resistant mechanism in obesity (Considine et al., 1996). This adverse 
response can be set  in utero following severe undernutrition in rats (a 30% reduction 
compared with ad libitum energy intake) throughout gestation, resulted in elevated 
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leptin concentrations in adult life, which was also associated with an increase in 
adiposity and food intake (Vickers et al., 2000). In addition, human adipocytes exposed 
in vitro to angiotensin II secreted leptin in a dose dependent fashion (Skurk et al., 2005). 
These observations may explain, in part, the abnormalities in renal function induced by 
obesity (Skurk et al., 2005). 
4.1.2 Renal dysfunction and angiotensin II 
The activation of the RAS has been associated with renal injury, mediated in part 
by an increase in reactive oxygen species and pro-inflammatory cytokines, through 
impairment to  endothelium-dependent vasodilatation (Hasdan et al., 2002; Higashi et 
al., 2002; Luchtefeld et al., 2003). Angiotensinogen is the precursor of ANG II and is 
mainly synthesised by two tissues: the liver and the adipose tissue (Lynch & Peach, 
1991). However, unlike the liver, adipose tissue not only expresses angiotensinogen, but 
also expresses all of the enzymes involved in its conversion to ANG II. Observations in 
vitro and ex vivo demonstrated that ANG II is an important component in adipose tissue 
development (Massiera et al., 2001a). Comparative studies of angiotensinogen adipose 
deficient mice showed that the lack of expression of this gene generates a phenotype 
unable to increase weight in response to a high fat diet  (Massiera et al., 2001b). The 
opposite genetic manipulation in mice results in increased adiposity, plasma leptin and 
insulin concentrations, together with  increased  abundance of renal ATR1 protein (Kim 
et al., 2006). Long term infusion of ANG II in rats promotes abnormal accumulation of 
lipids and iron in renal tissue, which may play a crucial role in the development of renal 
damage, causing free radical injuries, such as lipid peroxidation in the proximal tubules 
(Kawabata et al., 1997 ; Ishizaka et al., 2002; Saito et al., 2005). Finally, exposure to 
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maternal nutrient restriction (i.e 50% of total metabolic requirements) during early to 
mid gestation (28-77 days) is also associated with an increase in ATR1 gene expression 
in several tissues, including kidney, liver, adrenal and lungs in newborn sheep 
(Whorwood et al., 2001). 
4.1.3 Mechanism of apoptosis and proliferation in renal tissues 
It has been suggested that both apoptosis and cell proliferation play a major role in 
the development of renal disease. In the kidney, RAS assumes an important role by 
inducing both processes (Cao et al., 2000; Bhaskaran et al., 2003). After binding to one 
of its receptors, ANG II induces cell apoptosis in renal tubular cells through the 
activation of Fas, a member of TNF cytokine receptor (Muller et al., 1998; Bhaskaran et 
al., 2003). Interestingly, gene expression of Fas is under the control of p-53, which is the 
major regulator of the cell cycle and whose activation is associated with DNA damage 
(Bouvard et al., 2000). For the subsequent development of the intracellular apoptotic 
pathway, p-53 targets the activation of another gene called Bax, a pro-apoptotic member 
of Bcl2. In response to stress, Bax forms a homodimer and binds to a mitochondrial pore 
called the voltage-dependent anion channel (VDAC). These actions allow the release of 
cytochrome c from the mitochondria, which results in cell death (Shimizu et al., 1999). 
Aizawa et al. found that the protein abundance of Bax in renal tissues of rats rises after 
an infusion of ANG II, in a dose and time dependent manner and was followed by  
apoptosis (Aizawa et al., 2001). ANG II also stimulates cell proliferation or hypertrophy 
in the rat kidney and this effect is possibly mediated by several angiogenic factors, such 
as vascular endothelial factor-A (VEGF-A) (Kitayama et al., 2006). Although its role in 
renal disease is controversial (Flyvbjerg et al., 2002; Advani et al., 2007). Recently, in 
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transgenic (mRNA-2)27 rats that over-express renin, VEGF mRNA expression 
increased two fold and the administration of different VEGF blockers resulted in severe 
glomerulosclerosis (Advani et al., 2007). In contrast, treatment with VEGF antibodies in 
db/db mice was able to reduce the renal injury associated with diabetes, such as 
increased kidney weight, glomerular volume, mesangial matrix expansion and creatinine 
clearance (Flyvbjerg et al., 2002). It is therefore possible that the different effects of 
VEGF-A reflect the complexity of the factors involved in the adaptation of renal tissue 
to obesity.  
4.1.4 Scientific rationale, aim and hypothesis 
Previous epidemiological observations reported a link between maternal nutrition 
during gestation and subsequent changes in metabolic responses in offspring later in life 
(Ravelli et al., 1976; Painter et al., 2005). In addition, it was postulated that obesity per 
se can modulate the kidney, leading to a slow process of structural and functional 
deterioration (Rea et al., 2001; Henegar et al., 2001). Williams et al. observed a 
reduction in the number of apoptotic renal cells linked to obesity as a unique feature of 
the development of glomerulosclerosis in offspring exposed to maternal nutrient 
restriction during early to mid gestation (Williams et al., 2007). Later work conducted 
by Sharkey et al., who applied the same model of maternal manipulation, observed a 
rise in the unfolded protein response in the kidney as a possible adaptation to obesity 
(Sharkey et al., 2009). However, the extent to which further molecular changes in the 
kidney may have been influenced by the endocrine status of these offspring has not been 
fully investigated. Furthermore, none of the previous studies has established a possible 
mechanism that would explain the reduction in cell apoptosis seen in these offspring. 
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My study was designed to identify the possible reasons for the reduction in renal 
apoptosis observed in this model of nutrient restriction. It is hypothesised that the 
reduction in apoptosis observed in the kidneys of the juvenile sheep exposed to maternal 
nutrient restriction, compared with those offspring born to mothers fed to appetite, is 
associated with the post-injury responses such as cell proliferation, which may be an 
additional degenerative adaptation to obesity in renal tissue (Nangaku & Eckardt, 2007). 
Therefore, several cellular responses induced by obesity and associated with renal 
dysfunction in this tissue were investigated. 
4.2 Methods and materials 
A full description and details of all methods, including animal models and gene 
expression analysis used in this chapter, can be found in Chapter 2, with exception of 
angiotensin II challenge assay and the analysis of cysteine concentration in plasma. 
These were kindly carried out and supervised by Drs. David S. Gardner with the 
collaboration of Prof. Michael E. Symonds. In addition, all statistical tests are also 
explained either in Chapter 2 or in the appropriate section of this chapter. 
4.3  Results 
4.3.1 Body composition, renal and metabolic status 
The results of this section (4.3.1) have been reported previously by Williams et al. 
and are summarised in table 4.1  (Williams et al., 2007; Sharkey et al., 2009). 
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4.3.1.1 Body composition 
After nine months of exposure to an obesogenic environment (65% reduction in 
physical activity and 30% increase in food intake), there was no difference in body 
weight between both in utero nutrition groups. However, the combined postnatal 
nutritional intervention and relative physical inactivity influenced the body weight and 
composition of these sheep in relation to the lean group, who remained in an 
unrestricted field environment. Finally, the weight of the kidneys and the adipose tissue 
was influenced only by obesity and not by the previous maternal nutritional environment 
(Williams et al., 2007). 
 
Table 4.1 Morphometry in one-year-old lean and obese sheep (Williams et al., 
2007). 
 
* Statistical significance in lean group vs. both obese groups, regardless of maternal diet 
 
 
 
 
1422.00±513.80 7242.71±349.32* 6614.68±333.30* P<0.01
Perirenal fat (g)
Viseral fat (g)
82.50±8.64 328.43±29.36* 232.60±105.80* P<0.05
NSKidney depth (mm) 28.57±1.49 26.57±1.99 29.56±2.79
Omental (g)
553.88±93.48 2692.14±294.33* 2783.23±197.92* P<0.05
Kidney lenght (mm) 73.38±5.26 75.71±2.45 75.71±2.45 NS
Total kidney weight (g) 117.27±9.20 155.70±6.68* 164.86±7.16* P<0.01
Body weight (kg) 58.58±2.46 88.71±2.67* 85.83±4.57* P<0.01
Parameter Lean Obese NR-Obese group P
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4.3.1.2 Metabolic status 
At one year of age, there was no difference in plasma leptin between those obese 
groups of offspring, although exposure to the obesogenic environment had elevated the 
concentration of this hormone, relative to the lean group. Similar trends were recorded 
in other plasma hormones, such as IGF-1, cysteine and free fatty acids (Table 4.2) 
(Williams et al., 2007). The concentration of glucose was similar between the three 
groups, but plasma insulin concentration increased with obesity, a response that was 
amplified in offspring born to nutrient restricted mothers (Fig. 4.1) (Sebert et al., 2009). 
 
 
Table 4.2  Mean plasma concentrations of hormones and metabolites at one year of 
age in lean and obese sheep, either exposed to maternal nutrient restriction or fed 
to appetite throughout pregnancy  (Sebert et al., 2009)  
 
*Statistical significance in lean group vs. both obese groups, regardless of maternal diet 
 
 
 
 
 
 
 
Parameter Lean
Glucose (mmol/liter)
3.0±0.5 18.9±1.4*
0.31±0.05
4.47±0.58
Leptin (ng/mg)
IGF-1(ng/ml)
&\VWHLQHȝ0
Free fatty acids (mmol/liter) 0.64±0.16*
5.77±0.62
Obese
6.31±0.48 16.92±3.55* 13.09±1.06*
127.9±11.7 183±10.9* 180.1±16.3*
0.56±0.06*
5.17±0.51
P
P<0.01
P<0.05
P<0.05
P<0.05
NS
NR-Obese group
22.3±1.5*
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4.3.1.3 Glomerular filtration rate (GFR), blood pressure and angiotensin II 
challenge 
Glomerular filtration rates were similar in both obese groups but the values 
obtained shown a tendency be to higher than the lean group (Table 4.3). In addition, 
there were clear differences in baseline systolic and diastolic blood pressure between the 
obese group and those obese offspring previously exposed to maternal nutrient 
restriction. Following a similar trend, the infusion of angiotensin II resulted in a similar 
rise in arterial blood pressure in both obese groups, as compared to the lean group 
(Table 4.3) (Williams et al., 2007; Sharkey et al., 2009).     
 
 
 
 
 
 
 
Figure 4.1 Insulin concentration in 1 
year old lean and obese sheep born to 
mothers exposed to nutrient restriction 
or fed to appetite (*p<0.05) (Sebert et 
al., 2009) 
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Table 4.3 Glomerular filtration rate, basal blood pressure and systolic blood 
pressure response to angiotensin II infusion in lean and obese offspring, either 
born from mothers exposed to nutrient restriction during early to mid gestation or 
those fed to appetite throughout pregnancy (Williams et al., 2007; Sharkey et al., 
2009)  
 
*Statistical significance in lean group vs. both obese groups, regardless of maternal diet 
 
4.3.2 ,URQ VWDLQLQJ 0DVVRQ¶V WULFKURPH VWDLQ OLSLG 7%$56 DQG -OHdG 
concentrations in renal tissues 
Iron deposits in renal tissues were observed using Prussian blue staining. A 
significant reduction in iron deposition was seen in both obese maternal nutrient 
restricted (NR-O) and lean (L) groups, compared with the obese (O) group. The 
different levels of iron deposition were estimated semi-quantitatively (for more details 
see chapter 2, page 93) (p<0.05; Fig. 4.2.B). More distinct deposits of iron were 
observed in both obese groups in the cortical regions and, to a lesser degree, in the 
medulla (Fig. 4.3). Further analysis revealed that iron deposition occurred occasionally 
in glomerular cells, but was predominantly seen in the tubular structures. In contrast, 
exposure to an obesogenic environment significantly increased the lipid abundance in 
those sheep exposed to maternal nutrient restriction (p<0.05; Fig. 4.2.A). Analysis of 
0DVVRQ¶VWULFKURPHVWDLQHGNLGQH\VHFWLRQVUHYHDOHGWKDWWKHrenal cortex and medulla in 
Blood pressure-diastolic (mmHg) 78.1±1.5 88.6±2.3* 86±2.2* P<0.01
Blood pressure-systolic (mmHg) 105±2 116±3* 119±3* P<0.01
Parameter Lean Obese NR-Obese group P
Glomerular filtration rate (ml/min) 93.5±9.9 138±15* 114±17* P<0.08
Angiotensin II challenge- systolic 
blood pressure (mmHg/Sec) 849.3±55.07 1174±94.72* 1019±84.98* P<0.05
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lean sheep exhibited a low abundance of collagen compared with both obese groups. 
The most striking characteristic of this histological measurement from sheep exposed to 
an obesogenic environment, independent of maternal nutrition during pregnancy, was a 
marked presence of collagen in the renal cortex (Fig. 4.3). The data was analysed in a 
semi-quantitative manner (for more details see chapter 2, page 95). Finally, exposure to 
an obesogenic environment raised the abundance of renal TBARS / 8-OHdG associated 
metabolites to similar concentrations in both obese groups, without modulation by in 
utero nutrition supply (Table 4.4). 
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Table 4.4  &ROODJHQ DEXQGDQFH REVHUYHG XVLQJ 0DVVRQ¶V WULFKURPH LQ NLGQH\
sections and TBARS/8-OHdG concentration in renal tissues of lean and obese 
sheep, born either to mothers exposed to nutrient restriction during early to mid 
gestation or fed to appetite throughout pregnancy  
 
* Statistical significance in lean group vs. obese group, regardless of maternal diet 
 
 
 
 
 
 
 
 
8-OHdG>2+G*QJȝO@>3URWHLQ
ȝJȝO@ 0.74±0.05 1.02±0.08* 0.99±0.05* P<0.05
Parameter Lean Obese NR-Obese group P
Collagen (arbitrary units) 2.51±0.21 3.32±0.26* 3.57±0.15* P<0.05
TBARS >0'$ȝ0@>3URWHLQȝJȝO@ 3.91±0.12 4.50±0.14* 4.30±0.25* P<0.05
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Figure 4.2 (A) The effect of prenatal nutrient restriction and postnatal obesity on 
triglyceride content in renal and (B) on renal iron deposition as assessed by Prussian blue 
staining tissues of lean, obese or prenatally nutrient restricted obese offspring. (*P<0.05) 
Data is expressed as mean± SEM. 
A B 
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Figure 4.3 5HSUHVHQWDWLYH UHQDO 0DVVRQ¶V WULFKURPH VWDLQ DQG LURQ VWDLQLQJ LQ UHQDO FRUWH[ DQG
medulla of lean, obese or prenatally nutrient restricted obese offspring. The sections A to F were 
VWDLQHGZLWK0DVVRQ¶VWULFKURPHVWDLQLQJIRUWKHGHWHFWLRQRIFROODJHQDQG*WR/ZHUHVWDLQHGZLWK
Prussian blue for the observation of iron deposition in the kidneys. Renal sections C, F, I and L 
were obtained from lean sheep, B, E, H and K belong to the obese group and finally A, D, G and J 
were generated from prenatally nutrient restricted obese sheep. The colours red, dark brown or 
EODFNREVHUYHGRQWKHUHQDOVHFWLRQVVWDLQHGZLWK0DVVRQ¶VWULFKURPHDUHFHOOQXFOHLDQGNHUDWLQ
whereas blue to green are collagen peptides. A predominant green-blue staining was observed in the 
renal cortex and with less intensity in medulla of both obese groups independent of maternal 
nutrition during pregnancy (A, B, D, and E). In contrast, the cortex and medulla sections obtained 
from the lean group were usually stained dark brown or red and green (C and F).  Although no 
visible iron depositions were observed in the renal cortex and medulla of the lean (I and L) or obese 
nutrient restricted sheep (G and J), iron deposits, indicated by blue dots, were seen in the medullary 
ray (K) and cortical proximal tubules (H) in sheep belonging to the obese group (Magnification X 
10).     
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4.3.3 Renal nitric oxide (NO) 
The analysis of Nitrite (NO2-) and Nitrate (NO3-) showed that the production of 
NO was higher in those obese offspring born from standard fed mothers compared to the 
nutrient restricted obese group (p<0.05; Fig. 4.4). Finally, the gene expression of renal 
iNOS and eNOS was similar among the three groups (Table 4.5). 
 
Table 4.5 Renal mRNA abundance of iNOS and eNOS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
eNOS (2ǻ&7) 1.00±0.28 1.56±0.43 1.70±0.26 NS
Parameter Lean Obese NR-Obese group P
iNOS (2ǻ&7) 1.00±0.26 1.35±0.39 1.23±0.25 NS
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Figure 4.4  NO3- abundance in renal 
tissue. Values are expressed as 
means ± SEM. Significant 
differences between lean and obese 
groups (*p<0.05) and between obese 
and maternal nutrient restricted 
obese group (*p<0.05).    
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4.3.4 Regulation of genes associated with apoptosis 
Real time PCR analysis showed that renal expression of the pro-apoptotic gene 
Fas was increased with obesity, although this response was not observed in those obese 
offspring born to nutrient restricted mothers (p<0.05; Fig. 4.5). In addition, gene 
expression of Bax and p-53 increased in both obese groups compared with lean animals 
(Table 4.6). 
 
Table 4.6 The effect of prenatal nutrient restriction and postnatal obesity in renal 
tissues on the gene expression of Bax and p-53 
 
* Statistical significance in lean group vs. obese groups, regardless of maternal diet  
 
 
 
 
 
  
 
 
 
 
Parameter Lean Obese NR-Obese group P
Bax (2ǻ&7) 1.00±0.15 2.68±0.21* 2.67±0.46* P<0.05
p-53 (2ǻ&7) 1.00±0.34 3.61±1.05* 1.94±0.48* P<0.05
Figure 4.5  mRNA abundance of the 
pro-apoptotic receptor Fas. Values 
are expressed as means ± SEM. 
Significant differences between lean 
and obese groups* (p<0.05) and 
between obese and maternal nutrient 
restricted obese group*(p<0.05).    
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D E F
4.3.5 Renal markers of cell survival 
4.3.5.1 Immunohistochemical analysis of proliferating cell nuclear antigen 
(PCNA) 
PCNA positive immune-stained cells are used as a marker for cell proliferation as 
this protein is mainly expressed during the DNA synthesis phase of the cell cycle 
(Leonardi et al., 1992). In the renal cortex, the PCNA staining was, in general, detected 
in tubular cells and with less intensity around the Bowman capsule and glomerulus. 
Exposure to an obesogenic manipulation in the offspring of mothers fed to requirements 
throughout gestation resulted in an increase of PCNA both in the tubular cells and 
around the Bowman capsule to a moderate degree, as well as inside the glomerulus. 
Similar results were recorded in the obese and in the obese nutrient restricted groups 
(Fig. 4.6). 
Figure 4.6 Immuno-VWDLQHGSDUDIILQHPEHGGHGȝPVHFWLRQVRIVKHHSNLGQH\IRUSUROLIHUDWLQJFHOO
nuclear antigen (PCNA). The renal section A (cortex) and D (Medulla) were generated from 
maternal nutrient restricted obese sheep. Figures B and E represent the renal cortex and medulla of 
obese group and in the same order C and F sections were produced from the lean group 
(magnification x 10).    
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4.3.5.2 Regulation of genes associated with cell proliferation, angiogenesis and 
hypoxia 
All genes linked with the cell replication machinery, such as VEGF-A, DNMT-1 
Bcl-2, Glut-1 and IGF-1R, showed a statistically significant elevation in mRNA 
abundance by exposure to an obesogenic environment, compared with the lean group. 
However, maternal nutrient restriction did not influence the mRNA abundance of this 
group of genes (Table 4.7). 
Although gene expression of HIF-Į LQFUHDVHG ZLWK REHVLW\ WKLV UHVSRQVH ZDV
amplified in offspring born to NR mothers (p<0.05; Fig 4.7). 
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Table 4.7 Abundance of proteins and genes associated with cell proliferation and 
angiogenesis at 1 year of age in lean and obese sheep born to mothers that were fed 
either a control diet throughout pregnancy or nutrient restricted at early and mid-
gestation 
 
* Statistical significance in lean group vs. obese groups, regardless of maternal diet  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Lean Obese NR-Obese group P
VEGF-A (2ǻ&7) 1.00±0.29 3.01±0.88* 3.44±0.544* P<0.05
PCNA  (arbitrary units) (fig.4.7) 1.17±0.44 3.23±1.01* 2.54±0.70* P<0.05
Bcl2 (2ǻ&7) 1.00±0.36 3.67±0.57* 2.77±0.52* P<0.05
Glut-1 (2ǻ&7) 1.00±0.21 2.59±0.57* 2.04±0.22* P<0.05
DMNT-1 (2ǻ&7) 1.00±0.24 3.42±0.40* 2.44±0.44* P<0.05
IGF-IR (2ǻ&7) 1.00±0.35 4.31±0.79* 2.74±0.47* P<0.05
Figure 4.7  mRNA abundance of 
HIF-ĮDW\HDURIDJHLQOHDQDQG
obese sheep, regardless of maternal 
diet. Values are mean ± SEM. 
Significant differences between lean 
and obese groups (p<0.05) and 
between obese and NR-obese groups 
(p<0.05).  
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4.3.6 Expression of proteins associated with mitochondrial function 
Changes in expression of proteins associated with the release of mitochondrial 
superoxide or detoxification can be use as reliable markers of cell function (Wilcox, 
2005). The antioxidant proteins measured were the mitochondrial SOD-2 and its 
cytosolic isoform SOD-1. In addition, the abundance VDAC-1 was analysed, which has 
been shown to control the flow of metabolites and ions from the mitochondria (Tan & 
Colombini, 2007). After exposure to an obesogenic environment, the only renal protein 
analysed in this thesis that increased in expression as a result of maternal nutrient 
restriction, is the mitochondrial pore VDAC-1 (p<0.05; Fig. 4.8.A). There was no 
difference in SOD-2 protein expression between obese groups, although its abundance 
was significantly higher than in the lean group. Finally, the SOD-1 renal content was 
similar in the three groups (Table 4.8). However, the total SOD enzymatic activity was 
higher in those obese sheep exposed to maternal nutrient restriction in relation to the 
obese group born from control fed mothers (p<0.05; Fig. 4.8.B).  
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Table 4.8 Protein abundance of SOD-1 and SOD-2 in renal tissue at 1 year of age in 
lean and obese sheep born from mothers that were fed either to appetite during 
gestation or nutrient restricted during the period of nephrogenesis  
  
* Statistical significance in lean group vs. obese groups, regardless of maternal diet  
 
 
 
 
 
 
 
 
 
 
 
SOD-2 (% reference) 10.46±0.65 12.79±0.85* 11.97±0.65* P<0.05
SOD-1 (% reference) 23.69±5.76 32.57±6.95 29.99±2.01 NS
Parameter Lean Obese NR-Obese group P
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Figure 4.8 (A) The effect of prenatal nutrient restriction and postnatal 
obesity on renal abundance of the mitochondrial pore VDAC and on renal 
total SOD enzymatic activity (B). Statistics are expressed as Mean ± SEM 
(*p<0.05). 
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4.3.6.1 Renal gene expression of glucose sensing factors 
Maternal nutrient restriction followed by exposure to an obesogenic environment 
had no influence on the mRNA abundance of glucose sensing factors such as, HK-1 and 
IR. However, the obese group showed a significant increase in gene expression of 
glucose sensing factors, compared with the lean group (Table 4.9). 
Table 4.9 mRNA abundance of genes associated with glucose sensing 
  
* Statistical significance in lean group vs. obese groups, regardless of maternal diet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IR (2ǻ&7) 1.00±0.47 2.68±0.72* 2.80±0.59* P<0.05
HK1 (2ǻ&7) 1.00±0.20 2.26±0.43* 1.70±0.23* P<0.05
Parameter Lean Obese NR-Obese group P
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4.4 Discussion 
The main findings of this study are that in utero nutrient restriction, followed by 
post-weaning exposure to an obesogenic environment in juvenile sheep, results in a 
differential regulation of the proliferative-apoptotic pathways in renal tissue. The 
potential cell survival effect seen in the NR-O group was characterised by an increase in 
abundance of the mitochondrial pore VDAC-1. However, unexpectedly, similar levels 
of oxidative stress and the expression of additional pro-apoptotic and proliferative 
factors were found in renal tissue of both obese groups. Further analysis of the renal 
cortex of those sheep exposed to maternal nutrient restriction indicated an increase in 
lipid deposition, which may be the main source of oxidative stress. Activation of the 
apoptotic pathway with obesity, but not seen in NR-O animals was characterised by an 
increase in mRNA abundance of the cell death receptor, Fas. This is associated with a 
rise in oxidative stress and cell damage, possibly catalysed by the presence of iron 
(Bouvard et al., 2000; Ishizaka et al., 2002). Thus, maternal nutrient restriction during 
early to mid gestation, followed by a period of accelerated weight gain, may affect the 
sequence of cell proliferation, hypertrophy and apoptosis, which are linked to a 
progressive decline in renal function. 
4.4.1 Evidence of cell proliferation on renal tissue induced by obesity    
Results obtained in this study show that a common characteristic of both obese 
groups was an increase in mRNA abundance from genes such as VEGF-A and GLUT-1, 
that are associated with angiogenesis, in conjunction with a rise in cell proliferation 
factors, including IGF-1R and IR mRNA in renal tissue (Nangaku & Eckardt, 2007). 
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These changes in gene expression are possibly influenced by the increased plasma 
insulin concentration, a response amplified in offspring born to NR mothers (Hiromura 
et al., 2002; Sebert et al., 2009). On the basis of other ex-vivo observations in the early 
pathogenesis of renal damage in obese fa/fa rats, the onset of hyperinsulemia was 
associated with glomerular and tubular cell hyperplasia, followed by other forms of 
renal dysfunction, such as cell hypertrophy and lipid accumulation (Coimbra et al., 
2000). The changes in plasma insulin and IGF-1, in addition to the changes in gene 
expression of their renal receptor, possibly indicate similar responses in my sheep model 
(Sebert et al., 2009; Williams et al., 2007). A combination of these factors may induce 
the expression of several proteins involved in cell survival, proliferation and 
intracellular energy consumption homeostasis (Warnecke et al., 2003; Advani et al., 
2007). Furthermore, several in vitro observations have indicated the ability of insulin 
and IGF-1 to induce cell proliferation through increased expression of HIF-ĮDQDFWLRQ
mediated by the activation of IGF-1R and by an increase in the generation of ROS, 
leading to hypoxia (Page et al., 2002; Mori & Cowley, 2003; Lauzier et al., 2007). 
However, HIF-ĮSOD\VDQLPSRUWDQWUROHLQWKHUHJXODWLRQRIILEURVLVin vivo, increasing 
cell motility and invasiveness, indicating a link between the activity of this 
transcriptional factor and the development of renal injury (Higgins et al., 2007).  
Due to differences in the oxygen tension between the renal cortex (30 to 50 
mmHg) and medulla (10 to 25 mmHg), certain renal structures, such as the proximal 
tubule or the thick ascending limbs, are more vulnerable to hypoxia insults (Lubbers & 
Baumgartl, 1997; Chen et al., 2009). Consequently, an obesogenic environment, due to 
a rise in cellular metabolic activity, may increase the kidneys sensitivity to changes in 
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oxygen delivery and thus its susceptibility to hypoxic insults (Mollnau et al., 2002; Page 
et al., 2002). Further evidence of mitochondrial dysfunction, associated with hypoxia 
and the reduction in oxygen delivery, is indicated by the rise in protein abundance of 
SOD-2, detected in both obese groups (Hussain et al., 2004).  
A reduction in oxygen delivery may explain the presence of proliferative factor 
PCNA in areas susceptible to hypoxic insults, such as the tubules themselves. In 
addition, PCNA immunostained cells were also found in the Bowman capsule and 
golmerulus on the kidney cortex of both obese groups of sheep, irrespective of the 
maternal in-utero environment. One explanation for the increase in PCNA abundance 
may be that it represents the first stage of a compensative cell-division response to a 
non-lethal hypoxic insult, commonly associated with exposure to an obesogenic 
environment (Flyvbjerg et al., 1989; Johnson et al., 1992; Raz et al., 2003). Thus, 
increased exposure to anabolic hormones, such as IGF-1, insulin and leptin that are 
stimulated by the obesogenic environment, might be responsible for accelerated 
abnormal abundance of PCNA, as observed in the kidney of this model of juvenile 
obesity.  
My study suggests a significant increase in proliferative response, or at least a rise 
in the abundance of factors involved in the first stage of a mitotic response in both obese 
groups. An additional sign of the activation of the cell division mechanism was the 
increase in mRNA abundance of DNMT-1, detected in both obese groups. DNMT-1 acts 
in conjunction with PCNA during specific phases of the cell division cycle (Leonhardt 
et al., 1992). Importantly, a previous publication observed a reduction in molecular 
markers of apoptosis in the renal cortex, which might result in hyperplasia or 
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hypertrophy, which may possibly indicate a different development of vascular 
dysfunction between those obese offspring exposed to maternal nutrient restriction, 
compared with the obese group  (Williams et al., 2007). Finally, in the present animal 
model, Williams et al. found that juvenile-onset obesity per se led to an increase in 
kidney size, which may be a result of cell hyperplasia. However, this was accompanied 
by similar increases in GFR and blood pressure, which are important markers of early 
kidney disease (Henegar et al., 2001; Williams et al., 2007).  
4.4.1.1 The VDAC role in the mitochondria with obesity in the maternal nutrient 
restricted group 
The success of cellular adaptation to hypoxia by HIF-Į GHSHQGV RQ WKH
coordinated expression of gene products that facilitate glucose and oxygen uptake for 
the completion of the cell cycle in order to increase oxygen delivery by an increase in 
vascularisation  (angiogenesis)  (Jaakkola et al., 2001; Warnecke et al., 2003; Advani et 
al., 2007).  
A family of enzymes known as hexokinases are key mediators of glucose uptake 
and utilisation at the cellular level (HK1-3). Robey et al. have suggested that increases 
in glucose metabolism and exposure to fibrosis are capable of simulating HK mRNA 
abundance in mesangial cells (Robey et al., 1999; Robey et al., 2000). An important 
property of these enzymes is their ability to interact with the mitochondrial pore, 
VDAC-1, that facilitates kinase access to ATP, thereby increasing glucose uptake 
(Viitanen et al., 1984; Chang et al., 1996). Furthermore, this interaction can improve 
mitochondrial activity and it reduces the induction of apoptotic effects by growth factor 
withdrawal (Gottlob et al., 2001). In vitro, cells expressing low abundance of VDAC-1 
  
167 
 
showed a reduction in ATP synthesis capacity and a substantial reduction in cell 
proliferation (Abu-Hamad et al., 2006). In vivo, the absence of VDAC-1 leads to 
impaired glucose tolerance (Anflous-Pharayra et al., 2007). An increased abundance in 
this ionic channel, through its binding to HK-1, may be a temporary adaptation in cells 
undergoing mitosis to overcome the energetic mitochondrial deficits induced by hypoxia 
(Tanaka et al., 2003). A comparable adaptation may be occurring in the renal cortex of 
obese maternal nutrient restricted offspring. 
An increased concentration of intracellular glucose-6-phosphatase, which is 
associated with normal cellular oxygen diffusion, interrupts the mitochondrial-
hexokinase by inducing structural changes in both proteins, allowing other factors to 
bind to this channel (Mulichak et al., 1998). Bcl2 is one of a number of proteins that 
associate with VDAC-1 at normal cellular oxygen tension. Essential to this interaction is 
ATP availability and low cytosolic abundance of pro-apoptotic proteins, such as Bax 
(Shimizu et al., 1999; Gottlob et al., 2001). Abu-Hamad et al. showed that over-
expression of VDAC-1 in vitro, without a rise in protein abundance of HK-1 or Bcl2, 
induces cell apoptosis (Abu-Hamad et al., 2006). For that reason, an increase in glucose-
6 phosphate, in conjunction with a rise in abundance of the Bax protein, leads to the 
formation of the complex Bax-VDAC-1 and subsequent cytochrome C release, 
initialising the apoptotic cascade (Vyssokikh et al., 2004). Therefore, I propose that the 
decrease in the presence of molecular markers of renal apoptosis, in conjunction to an 
increase in VDAC-1 abundance and total SOD enzymatic activity observed in NR obese 
sheep, might indicate an improvement in cellular oxygen metabolism (Williams et al., 
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2007). These molecular changes possibly lead to cell division, a sign of an advanced 
adaptation to a hypoxic environment.  
 
Figure 4.9  The proposed interaction between VDAC-1 and HK1 in the transportation of ATP, 
which potentially might improve the mitochondrial function under hypoxic conditions (Adapted 
from Vander Heiden et al., 2009).    
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4.4.2 Evidence for cell-arrest and cell-hypertrophy in the renal tissue in both 
obese groups  
Histological examination of renal biopsies from non-proteinuric overweight 
patients has indicated an increase in the glomerular surface and tubular dilatation, 
compared to lean controls. These results suggest that inflammation may be one of the 
early events in renal dysfunction, possibly preceding the appearance of other symptoms, 
such as increased serum creatinine or changes in blood pressure (Rea et al., 2006). In an 
attempt to examine renal functional and morphological changes linked to early onset 
obesity, Henegar et al. exposed dogs to a high fat diet intake. After 7 to 9 weeks, their 
body weight, GFR and mean arterial pressure was higher compared with lean controls. 
In addition, the high fat diet caused hyperinsulinemia, hyperliptemia and activation of 
RAS. These hemodynamic alterations were accompanied by  further renal structural 
changes, which included expansion of the %RZPDQ¶VFDSVXOH IROORZHGE\DQLQFUHDVH
in glomerular cell proliferation and mesangial matrix expansion (Henegar et al., 2001). 
In my study, using juvenile sheep, exposure to an obesogenic environment also induced 
similar alterations in plasma concentration of several hormones, such as leptin, and an 
increased sensitivity to ANG II, which may influence renal functional and structural 
changes, as observed in this model (Williams et al., 2007; Sharkey et al., 2009). 
In obese patients, high serum concentration of leptin is associated with obesity and 
reflects the increased amount of adipose tissue (Considine et al., 1996). This hormone is 
able to affect renal structure and function directly, mainly through the short form of its 
receptor (Ob-Ra), which is highly abundant in the kidneys (Gal et al., 1997; Wolf et al., 
1999; Rahmouni et al., 2005). Furthermore, short term exposure to leptin may affect 
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kidney structure and functionality through increased production of NO. However, 
chronic hyperliptinemia leads to an increase in intrarenal oxidative stress, producing NO 
deficiency (Beltowski et al., 2004). Thereby, the changes in the amount of NO detected 
in renal tissue of both obese groups suggests the existence of different degrees of leptin 
resistance. Release of NO by leptin can modify the activities of angiogenic factors, such 
as VEGF-A, inducing endothelial cell proliferation. For that reason, when this hormone 
is infused into naive rats, it induces cell division of glomerular endothelial cells, 
followed by fibrosis (Wolf et al., 1999; Nakagawa et al., 2006).  
The action of leptin in cell proliferation may be mediated by an increase in 
glucose uptake, increasing the activity of other factors, including elements of the renal 
RAS (Han et al., 2001; Vidotti et al., 2004). Subsequent activation of the RAS induces 
different acute effects on renal tissue, including hyperplasia and hypertrophy. In first 
instance, exposure to ANG II  induced a pronounced proliferation of vascular smooth 
cells, which are followed by tubulointerstitial fibrosis injury (Johnson et al., 1992). 
However, long term exposure to ANG II in renal tissues leads to the activation of the 
cell arrest mechanism (Hannken et al., 1998). This is a direct consequence of the 
vasoconstricting action of ANG II, which takes place through the generation of reactive 
oxygen species, inducing DNA damage and triggering the activation of pro-apoptotic 
proteins, such as the tumour suppressor p-53 and Bax (Hannken et al., 1998; Mori & 
Cowley, 2003). Furthermore, cell arrest induces a rise in RNA and protein content, 
leading to an increase in cell size or cell-hypertrophy, possibly reflected in our obesity 
model by the increase in kidney mass (Fine & Norman, 1989; Williams et al., 2007). 
Cell hypertrophy is associated with a slow, degenerative process, commonly linked with 
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podocyte loss of function and glomerulosclerosis (Wiggins et al., 2005). The increased 
sensitivity to ANG II, seen in both groups of obese juvenile sheep, may be an indicator 
of a similar proliferative-hypertrophy process. Therefore it is likely that obesity per se, 
independent of in utero nutrition, appears to induce those genes involved in processes 
such as proliferation and apoptosis, to activate cell arrest or hypertrophy in renal tissue 
(Fig. 4.10).  
4.4.3 Characterisation of the apoptotic process observed in the obese groups 
After the initial compensatory proliferative-hypertrophic stage, the progression of 
renal insufficiency associated with obesity involves inflammation, leading to 
glomerulosclerosis and tubuleinterstitial fibrosis, both part of the renal scarring process 
(Cao et al., 2000; Coimbra et al., 2000; Henegar et al., 2001). As metabolic disease 
develops, the ensuing hyperinsulemia and renal injury leads to a slow but progressive 
reduction in glomerular and tubular cell numbers, inducing deterioration in renal 
structure and function (Chagnac et al., 2000; Praga et al., 2001; Wiggins et al., 2005). 
Various models of prenatal diet have shown the potential and ability to modulate 
renal structure and function (Whorwood et al., 2001; Gopalakrishnan et al., 2005; 
Williams et al., 2007). In the absence of obesity, maternal nutrient restriction between 
early to mid gestation in young sheep, reduced the nephron number associated with 
increased cytochrome C abundance in the kidney, at 6 months of age (Gopalakrishnan et 
al., 2005). A previous study, which analysed renal dysfunction in year old obese sheep 
exposed to maternal nutrient restriction, showed an apparent reduction in certain 
markers associated with inflammation and apoptosis, compared with the obese group 
(Williams et al., 2007). The main difference that I observed from the previous findings 
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of Williams et al., was an equal increase in expression of the gene, Bax, which is 
regulated directly by p-53, suggesting perhaps that the pathways associated with renal 
injury are in progress in both obese groups, although the developmental pattern of renal 
dysfunction differs. 
Cell death by apoptosis, unlike necrosis, is an ATP dependent cellular pathway 
that is genetically controlled by a transcriptional factor p-53, which in turn, depending 
on the cellular stimuli, activates a series of other genes, including Bax and Fas. This 
process includes rapid changes in cellular morphology, such as contraction of the 
cytoplasm, nucleus and DNA degradation (Yonish-Rouach et al., 1991; Bouvard et al., 
2000). Exposure to ROS activates the main regulator of cell apoptosis, p-53 due to 
increased cellular and DNA damage (Muller et al., 1998). Data obtain from the TBARS 
and 8-OHdG tests indicate similar levels of oxidative stress, possibly explaining the 
equally high gene expression of p-53 and Bax in both obese groups.  
Possible differences in the intensity of apoptosis between obese groups may be 
based on the stage of development of the metabolic disease, which may be altered by 
exposure to metabolites, hormones and cytokines, particularly those secreted by the 
surrounding adipose tissue (Hotamisligil et al., 1995; Massiera et al., 2001a; Sharkey et 
al., 2009). Sharkey et al. have demonstrated, using this animal model, much more 
advanced adipocyte dysfunction with increased formation of crown-like structures in 
those obese offspring exposed to maternal nutrient restriction compared with the obese 
group (Sharkey et al., 2009). Several studies have demonstrated that adipose tissue, 
especially in obese individuals, is able to secrete hormones and cytokines, including 
ANG II and TNF-Į SRWHQWLDOO\ LQIOXHQFLQJ LQIODPPDWion and healing in renal tissue 
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(Hotamisligil et al., 1995; Giacchetti et al., 2002; Kim et al., 2006). Thereby, the 
evolution of the fibrotic process depends heavily on apoptosis (Verrecchia et al., 2002). 
Interestingly, it has been shown that exposure to TNF-Į  LQIOXHQFHV WKH VHFUHWLRQ RI
collagen, affecting the fibroblast contractile activity, thus demonstrating that the balance 
of cytokines influences the outcome of the wound healing process (Goldberg et al., 
2007). After the inflammatory-fibrotic stage, the myofibroblasts undergo apoptosis or 
differentiation to vascular cells, leading to complete tissue re-epithelialisation, as 
characterised by a total inhibition of cell death (Desmouliere et al., 1995). 
%\VWDLQLQJNLGQH\ VHFWLRQVZLWK0DVVRQ¶V WULFKURPHDQGE\DQDO\VLVRIP51$
expression of the pro-inflammatory receptor Fas, I indirectly assessed the advance of the 
fibrotic process. Therefore, on the basis of this data and information published 
previously, I speculate that the kidneys of the NR-O animals were in a more advanced 
stage of tissue re-epithelialisation or tissue scarring compared with the (control) obese 
group. This hypothesis is further supported by evidence of a decrease in mRNA 
abundance of inflammatory or pro-apoptotic genes, the reduction in cell death and the 
excess of collagen observed in the kidneys of the prenatally nutrient restricted and obese 
animals (Williams et al., 2007).  
4.4.3.1 The role of iron and lipid accumulation in renal tissue  
As previously noted in other tissues, including the heart and liver, the effects of 
postnatal obesity in the model studied here are influenced by in utero nutrient 
restriction, which also increases ectopic triglyceride accumulation in the renal cortex, 
compared with the obese group (Chan et al., 2009; unpublished observation). Jiang et al. 
showed that obesity in mice (C57BL/6J) induced by high fat feeding caused a robust 
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lipid accumulation in glomerular and tubuleinterstitial cells. In addition, it was observed 
that this effect was accompanied by glomerulosclerosis, which resulted in a significant 
renal mRNA over-expression of collagen and fibronectin (Jiang et al., 2005). A possible 
inducer of this type of renal injury associated with obesity is the RAS. For instance, 
chronic ANG II administration is able to induce a short term increase in the 
accumulation of iron in the renal tubular and vascular cells, which is followed by lipid 
deposition (Saito et al., 2005). Importantly, when iron is exposed to a reducing 
environment, such as the cysteine-glutathione cycle or the activation of RAS, it is able 
to promote injuries in renal tissue through the production of free radicals (Mori & 
Cowley., 2003 ;Okada et al., 1993). 
Importantly, over activation of RAS, as observed in cases of severe obesity, may 
contribute to alterations in iron transport by promoting liver dysfunction through an 
increase in lipid accumulation (Bataller et al., 2005; Engeli et al., 2005; Kolak et al., 
2007). In this model, it has previously been demonstrated that chronic obesity 
influenced by maternal nutrient restriction causes an acceleration of metabolic 
dysfunction in the liver, characterised in particular by ectopic lipid accumulation. These 
changes in liver function possibly affect iron delivery, which in turn, may influence the 
lipid accumulation in other tissues, such as the heart and kidneys (Chan et al., 2009; 
unpublished observation). 
Free fatty acid accumulation per se may also result in endothelial dysfunction, 
mediated by increased production of ROS (Chen et al., 2004). However, it was 
suggested that damaged tubular cells can incorporate exogenous triglycerides, as part of 
a physiological response to injury in addition to the synthesis of fatty acids induced by 
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exposure to an obesogenic environment (Jiang et al., 2005; Zager et al., 2007). This 
combination of circumstances may rapidly increase the cellular triglyceride reserves, 
whereas the chemistry of fatty acid metabolism may have differential effects on the 
survival of cells. Listenberger et al. have suggested that triglyceride accumulation, 
particularly of unsaturated fatty acids, inhibits apoptosis by the ability to neutralise the 
toxic effects of oleic and palmitate acid in non-adipose tissues (Listenberger et al., 
2003). This may represent an initial cellular response against lipotoxicity, which may 
explain the slow progress of renal diseases associated with obesity (Listenberger et al., 
2003). In this model of juvenile obesity, renal triglyceride accumulation suggests an 
association with a reduction in cell death. Accumulation of triglycerides may be a 
temporary protection against some of the negative effects of rapid weight gain, such as 
hyperliptemia and an increase in ANG II sensitivity. However, in the long term, the 
incorporation of fatty acids raises the susceptibility to cell injuries induced by ROS and 
ATP depletion, leading to apoptosis (Chinen et al., 2007). Thus, the presence of iron and 
the accumulation of triglycerides may represent two different sources of oxidative stress 
of equal intensity, triggering different outcomes that might be different stages of the 
same overall disease process (Okada et al., 1993; Chinen et al., 2007). 
4.4.4 Summary  
As described in the literature, exposure to an obesogenic environment induced in 
sheep renal tissue results in a series of cellular events: proliferation, apoptosis and 
hypertrophy The results of my study have determined that maternal nutrient restriction 
during early to mid gestation resulted in a marked acceleration of this degenerative 
process in renal tissue, in response to juvenile obesity. 
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Activation of pro-survival and fibrogenic genes in both obese groups may be the 
biological consequences of hypoxic HIF-Į DFWLYDWLRQ VXJJHVWHG E\ XS-regulation 
angiogenic genes, such as GLUT-1 and VEGF-A. Hypoxia in the kidneys could have 
resulted from a rise in the activity of the RAS. Due the heterogenic renal cellular 
population and the length of exposure to an obesogenic environment, my results indicate 
that the three processes of proliferation, apoptosis and hypertrophy may have occurred 
simultaneously in the kidneys of both obese groups by one year of age. Renal 
dysfunction in the obese group was characterised mainly by the prevalence of apoptosis, 
associated with an outgoing inflammation catalysed by iron deposited in the renal 
tubule. Conversely, in the kidneys of the maternal nutrient restricted obese group, my 
findings suggest that, whilst there is an active pro-apoptotic response, this occurs on a 
smaller scale compared with the obese group. This reduction in cell death is in 
conjunction with a lack of expression of genes associated with the inflammatory 
process. Furthermore, the increase in abundance of the mitochondrial pore VDAC, 
combined with an increase in activity of the SOD system and the reduction in apoptosis 
may indicate that a large number of cells are dividing or becoming hypertrophic. 
Another important feature is the equal presence of collagen in all obese animals. 
However, with the reduction in apoptosis along with differences in inflammatory 
responses and the increase in lipid deposition, I propose that the NR-O group are at a 
more advanced stage of renal scarring than the obese group. This advanced stage of 
disease is in accord with additional findings from other tissues of the same animals 
(Chan et al., 2009). Maternal nutrient restriction in early to mid gestation, followed by a 
period of postnatal obesity, has a much greater impact on the liver, heart and adipose 
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tissue than on the obese offspring born from mothers fed ad libitum. Finally, these 
adaptations seen in renal tissue caused by obesity may be strongly influenced by the 
appreciable dysfunction observed in other tissues. In particular, the influence of adipose 
tissue, which is able to modify the abundance of metabolites, cytokines and hormones, 
has a significant impact on kidney health (Fig. 4.10).   
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Figure 4.10 Schematic summary of findings of this chapter. Exposure to an obesogenic environment 
induced in renal tissue results in a series of cellular events: proliferation, apoptosis and hypertrophy 
and all these processes are followed by collagen and lipid deposition. The red areas represent the 
main outgoing stage in each obese group in this study.  
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Chapter 5 - Influence of maternal nutrient restriction from early to mid gestation 
on the development of the adipose tissue in response to juvenile obesity 
 
5.1 Introduction 
5.1.1 Sensitive periods for the development of the adipose tissue 
Epidemiological and clinical studies have demonstrated that there is an association 
between early life diet, commencing in-utero and then extending over the first years of 
postnatal life, with respect to the onset of later obesity. To elucidate the potential 
influence of maternal nutrition, Ravelli et al. conducted a retrospective study of young 
males (<19 years old) prenatally exposed to the Dutch famine of 1944-5. This 
investigation indicated that the prevalence of obesity was higher in individuals who had 
suffered a reduction in nutrient supply in utero during the first trimester of gestation. 
Furthermore, exposure to the famine during the second half of pregnancy produced a 
leaner phenotype, leading the authors to conclude that early fetal nutritional deprivation 
may interfere with the normal development of the adipose tissue (Ravelli et al., 1976). 
Importantly, findings from animal models exposed to maternal nutrient restriction 
during early to mid gestation also suggested substantial metabolic alterations in the 
adipose tissue, both at birth and in early adulthood (Whorwood et al., 2001; Sharkey et 
al., 2009).  
Adipose tissue enlargement is thought to be the result of three cellular 
mechanisms: hyperplasia (increase in cell number), hypertrophy (increase in cell size) 
and or a combination of both (Jo et al., 2009). Several studies have followed the 
development of adipose cellularity in relation to fat cell morphology, in obese and lean 
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individuals throughout life and revealed the existence of critical stages on adipose tissue 
development (Knittle et al., 1979; Spalding et al., 2008). It has been suggested that one 
particularly sensitive stage for adipose tissue growth in human beings lasts from early 
childhood to puberty, during which time there is a high level of cell division (Baum et 
al., 1986). A number of studies have demonstrated that adipose tissue of infants is 
characterised by the extensive generation of new adipocytes, especially during the first 
year of life (Baum et al., 1986). In subsequent years, there is a small and temporary 
decline in the rate of cell division but a second increase in adipocyte numbers may then 
follow between 9 and 13 years of age (Salans et al., 1973; Knittle et al., 1979). After 
this second peak in cell division, there is a strong decline in new cell production, 
stabilising the number of adipocytes. The mature cell population of adipocytes them 
remains constant during adulthood, although human beings do possess a constant 
reserve of pre-adipocytes located on the connective tissue or stroma (Salans et al., 1973; 
Gimble et al., 1989; Spalding et al., 2008). Thereby, individuals who become obese 
during early childhood and remain obese after puberty, have adipose tissue with a 
tendency to be hyperplastic, but with relatively normal sized cells. On the other hand, in 
obese subjects exposed to an obesogenic environment during adulthood, the adipose 
tissue develops larger cells, though cell number remains on a par with that of lean adults 
(Knittle et al., 1979). A plausible reason for these differences in cell composition is that 
the ratio between adipocyte death and differentiation during adulthood does not exceed 
more than 10% annually. This rate is unaffected by the early onset of obesity, indicating 
the existence of a strong mechanism that regulates the generation of new fat cells 
(Spalding et al., 2008). However, this modest increase in new adipocytes can be 
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compromised by an increase in adiposity, reducing further the capacity of stroma cells to 
differentiate and leading to cell hypertrophy (van Harmelen et al., 2003). Thus, the size 
of adipocytes, particularly those belonging to upper-body depots, are the strongest 
determinants of metabolic abnormalities, due to the expansion of abdominal fat 
(Tchoukalova et al., 2008).    
5.1.1.1 Mechanisms of adipocyte differentiation  
Adipocyte differentiation involves the coordinated activation of a large number of 
genes and transcriptional factors that are heavily influenced by hormones, cytokines, 
nutrient and signalling molecules. These factors in turn regulate the characteristics of the 
mature adipose tissue depot including cell size and number (Massiera et al., 2001a; 
Farooqi et al., 2002; van Beek et al., 2008).  
Recent observations have begun to elucidate the molecular mechanisms involved 
in general pre-adipocyte differentiation, beginning with their activation in early 
postnatal life (Fu et al., 2005; van Beek et al., 2008; Viengchareun et al., 2008). One of 
the first regulators of adipogenesis is the hormone, prolactin, which stimulates IGF-2 
gene expression in brown adipocytes through its receptor, inducing early stages of cell 
differentiation, growth and the absorption of nutrients (Sinha et al., 1990; Viengchareun 
et al., 2008). Other important transcriptional factors involved in the regulation of 
adipogenesis are CCAAT/enhancer-binding proteins (C/EBP)-ȕ DQG į These in turn 
induce the expression of C/EBP-Į DQG SHUR[LVRPH SUROLIHUDWRU-DFWLYDWHG UHFHSWRU Ȗ 
(PPAR-Ȗ WKDW SOD\V D NH\ UROH LQ WKH H[SUHVVLRQ RI RWKHU WUDQVFULSWLRQDO IDFWRUV
associated with adipogenesis. In contrast to other members of this group, C/EBP-Į
promotes specific aspects of the adipocyte phenotype, including insulin sensitivity and 
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lipid accumulation (Cao et al., 1991; Wu et al., 1999). Other important factors in the 
regulation of early adipogenesis are hormones such as glucocorticoids. By binding to 
their receptor, which expressed in human pre-adipocytes, glucocorticoids induce the 
expression of C/EBP-ĮOHDGLQJWR mature cell phenotype (Joyner et al., 2000; Hausman 
et al., 2000). Notably, local activation of C/EBP-Į in adipose tissue is dependent on the 
HQ]\PHȕ-HSD-1, which transforms inert cortisone to active cortisol in humans and 
sheep (Livingstone et al., 2000; Rask et al., 2001). In addition, C/EBP-Į LV DEOH WR
mediate the activity of other components involved in cell differentiation. One such 
example is the retinoblastoma protein (pRB) that also induces the expression of UCP-1 
in brown fat cells and affects the rate of lipid accumulation in mature adipocytes (Cram 
et al., 1998; Hansen et al., 2004). Interestingly, during cell replication, pRB interacts 
with DNMT-1, a DNA methyltransferase involved in terminal differentiation in 
adipocytes and other cells types (Robertson et al., 2000; Rai et al., 2006; van Beek et 
al., 2008). As stated previously in Chapter 3, DNMT-1 is also essential for the 
maintenance of DNA methylation motifs and its deletion inhibits the process of cell 
differentiation  (Li et al., 1992). 
5.1.1.2 Factors that inhibit adipocyte differentiation 
This is a heterogenic group of molecular signals that control or repress the process 
of adipogenesis, and this includes inflammatory cytokines and hormones. Cytokines are 
important regulators of adipogenesis, the most well known of which are TNF-ĮDQG,/-
6. In obese individuals, the plasma serum concentrations of both these cytokines are 
highly elevated and is usually linked to severity of their metabolic disease (Hotamisligil 
et al., 1993; Vgontzas et al., 1997; Fried et al., 1998). For example, in obese mice 
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(ob/ob) with null mutations on both genes encoding the TNF-Į UHFHSWRU WKHUH LV D
significant improvement in insulin sensitivity (Uysal et al., 1997; Nisoli et al., 2000). 
Conversely, when TNF-Į JHQH H[SUHVVLRQ LV OLPLWHG WR RQO\ adipose tissue, in null 
mutated ob/ob mice, insulin action is normalised but does not prevent cell hypertrophy, 
which is a common feature in this animal model of obesity (Xu et al., 2002). 
Furthermore, in in vitro studies of fully differentiated 3T3-L1 adipocytes, exposure to 
TNF-ĮFDQ UHGXFH WKHP51$H[SUHVVLRQRIJHQHVDVVRFLDWHGZLWKFHOOGLIIHUHQWLDWLRQ
such as C/EBP and PPAR-ȖWKXVUHYHUVLQJ the adipocytic phenotype (Ron et al., 1992; 
Zhang et al., 1996). Treatment of adipocytes with TNF-ĮDQG,/-6 promotes lipolysis by 
increasing the activity of hormone-sensitive lipase (HSL) (Fried et al., 1998; 
Laurencikiene et al., 2007). In addition, hormones such as growth hormone (GH), also 
inhibit adipogenesis and induce lipolysis through the stimulation of HSL and the 
inhibition of adipogenic DNA transcriptional factors (Dietz & Schwartz, 1991; Huppertz 
et al., 1996; Asada et al., 2000; Chen et al., 2001). GH can promote cell differentiation. 
Its effects are mediated by IGF-1, which inhibits lipolysis through a reduction in the 
abundance of growth hormone receptor (GHR) (Bengtsson et al., 1993; Asada et al., 
2000). Therefore, hormone and cytokine activity are considered to be potential 
regulators of adipose tissue metabolism, influencing the outcome of obesity related 
complications (Clement et al., 2004; Ukropec et al., 2008). 
5.1.2 Adipocyte death, macrophage infiltration and tissue remodelling 
Recently, Sharkey et al. observed that after a period of fast weight gain, NR 
offspring exhibit signs of adipose tissue dysfunction characterised by an increase in 
crown-like structures (CLS), with similar inflammatory features, as seen in other models 
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of severe obesity (Cinti et al., 2005;  Sharkey et al., 2009). The consumption of a high 
fat diet in rodents, particularly one composed mainly of saturated fatty acids, accelerates 
the process of adipocyte hypertrophy or hyperplasia. This commonly coincides with an 
increase in the expression of immune related genes, such as TNF-Į and iNOS (inducible 
nitric oxide synthase) within the adipose tissue (Soukas et al., 2000; Strissel et al., 
2007). When adipose tissue begins to secrete these pro-inflammatory mediators, an 
infiltration of macrophages occurs in parallel, incrementing further the level of 
inflammation and also affecting insulin sensitivity (Hotamisligil et al., 1993; Clement et 
al., 2004). Cinti et al. attributed the outgoing phagocyte infiltration to an increase in 
necrosis-like cell death. This might be associated with the negative effects of adipocyte 
hypertrophy observed in humans and obese (db/db) mice models (Cinti et al., 2005). 
Dead adipocytes become surrounded by scavenging macrophages, which are postulated 
to absorb cell debris and toxic lipid droplets and form  CLS (Cinti et al., 2005; Strissel 
et al., 2007). Although CLS are commonly detected in extreme obese subjects, they are 
normally observed at a very low frequency (Cinti et al., 2005). It has been suggested 
that the macrophage infiltration is a vital mediator in adipose tissue remodelling. This is 
due to the fact that adipocyte necrosis is associated with matrix deposition, angiogenesis 
and differentiation of new adipocytes (Nishimura et al., 2007; Strissel et al., 2007). For 
instance, in the case of hypertrophic adipocytes there is a reduction in oxygen diffusion, 
leading to hypoxia in the adipose tissue. This is a potent inducer of angiogenesis, an 
essential initiator of adipogenesis. Therefore, hypertrophic adipocytes and their 
subsequent removal may create an angiogenic microenvironment in which pre-
adipocytes can potentially differentiate to mature adipocytes (Fukumura et al., 2003; 
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Nishimura et al., 2007). This is possible because new adipose cells can arise from 
progenitor cells within the adult white fat depots or the bone marrow, a process that may 
be stimulated by a high fat diet in rodents (Crossno et al., 2006; Rodeheffer et al., 
2008).  
5.1.3 Scientific rationale, aim and hypothesis 
As observed in Chapter 3, at seven days of age, offspring born from nutrient 
restricted mothers showed a different gene expression pattern within adipose tissue, 
compared to those control offspring born from mothers fed to requirements throughout 
gestation. These changes in gene expression include genes associated with adipose 
tissue growth, such as IGF-2, IGF-2 receptor and DNMT-1, linked to terminal cell 
differentiation, suggesting that there might be different mechanism involving cell 
maturation (Chapter 3). However, the extent to which those alterations persist during 
adulthood and the effect on other tissues in response to an obesogenic environment 
remains to be further established. Furthermore, whether an alteration in the nutritional 
status in utero alters susceptibility to obesity in adulthood and promotes adipocyte 
hypertrophy and cell death is still unclear. However, Sharkey et al. demonstrated that 
maternal nutrient restriction during early to mid gestation in sheep is implicated in 
increased markers of cellular stress, such as increased abundance of CLS in the adipose 
tissue, in response to juvenile obesity (Sharkey et al., 2009). Importantly, the 
appearance of these formations is linked to multiple cytotoxic stressors, including 
endoplasmatic reticulum stress, hypoxia, reactive oxygen species and the release of free 
fatty acids from the adipose tissue (Clement et al., 2004; Cinti et al., 2005; Nishimura et 
al., 2007). These cytotoxic stresses activate inflammatory pathways, thus influencing the 
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rate of ectopic lipid deposition in tissues such as the kidneys, inducing tissue 
remodelling (Kolak et al., 2007; Strissel et al., 2007). Furthermore, changes in 
adipogenesis may also potentially affect kidney function and health (Chapter 4). For that 
reason, my next study was designed to elucidate whether maternal nutrient restriction 
during the period of maximal organogenesis, in addition to an obesogenic postnatal 
environment, still affects the mechanisms of adipocyte maturation. My current 
hypothesis is that maternal nutrient restriction, during this period of gestation (e.g. early 
to mid gestation), when compared to ad libitum nutrition, would modify perirenal 
adipose tissue development. Alteration of adipocyte maturation when followed by a 
period of fast weight gain may produce additional changes in the secretion of hormones 
and metabolites. This would lead to subsequent changes in gene expression associated 
with lipolysis, angiogenesis, inflammation and terminal cell differentiation- specifically 
GHR, VEGF-A, iNOS and DNMT-1. 
5.2 Methods and materials 
A full description and details of all methods, including animal models, gene 
expression analysis in this chapter can be found in chapter 2. It is important to mention 
that the ontology of DNMT-1, the PAT of histological section using Masson trichrome 
technique and cortisol and leptin plasma quantifications were kindly carried out by Mr 
Mark Pope, Mrs Victoria Wilson and Dr David S. Gardner. Finally, all statistical tests 
are also explained in chapter 2. 
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5.3 Results 
5.3.1 Perirenal adipose tissue development over time and the influence of 
maternal nutrient restriction and obesity 
As expected, between birth and both the first week and month of postnatal life, the 
adipose tissue-body weight ratio increased equally in all animals (p<0.05; Fig. 5.1). This 
process of adipose tissue growth continued up to one year of age and was amplified by 
the exposure to an obesogenic environment irrespective of the prenatal nutritional 
environment (p<0.05; Fig. 5.1) (Williams et al., 2007). 
 
Figure 5.1 Increase in the ratio total fat-body weight at different time points from birth to one year 
old in sheep. The data are expressed as mean ± SEM. Description of statistical analysis (A) offspring 
born to control diet mothers at birth (0D) versus 7 day old siblings from the obese group (7DsO) 
(p<0.05) and (C) 0D versus offspring born to control diet mothers from birth to 30 days of age (30D)  
(p< 0.05). (B) p< 0.05 30D versus 7DsO. * p<0.05 30D versus one year old lean group; Lean group 
versus Obese group.           
  
5.3.2 Metabolic, endocrinological and physical adaptation in response to an 
obesogenic environment at 6 months of age 
At 6 months of age, the body weight of those sheep exposed to an obesogenic 
environment, regardless of maternal diet during gestation, were for first time statistically 
heavier than the lean group (Table 5.1) and the weight observed was similar for both 
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obese groups (Sharkey et al., 2009). An adaptation that was accompanied by raised 
plasma IGF-1 (Table 5.1). At this age offspring born to NR mothers exhibit both raised 
leptin (p<0.05; Fig. 5.2.A) and cortisol (p<0.05; Fig 5.2.B). 
 
 
 
 
 
 
 
 
5.3.3 Adipose tissue gene expression 
5.3.3.1 Ontogeny of DNMT-1 in the adipose tissue 
Gene expression of DNMT-1within the perirenal adipose tissue increased from 
birth until the age of 30 days and was clearly affected by maternal nutrient restriction at 
7 days of age, demonstrated by a significant rise in mRNA abundance compared with 
the one week old offspring born to control fed mothers (p<0.05; Fig 5.3). Then, between 
30 days and 1 year of age, the gene expression of DNMT-1 in the perirenal adipose 
tissue strongly declined but obese offspring born to NR mothers still exhibited raised 
DNMT-1 mRNA abundance. Whereas obesity per se had no effect on DNMT-1 gene 
expression (p<0.05; Fig. 5.3).   
Figure 5.2 (A) Leptin and (B) Cortisol concentration in plasma of 6 month old lean 
and obese offspring born to mothers exposed to nutrient restriction or fed to appetite 
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Figure 5.3  Increase in mRNA expression of the gene DNMT-1 in the perirenal adipose tissue depot 
at different time points from birth to one year old in sheep. The data are expressed as mean ± SEM.  
(A) p<0.05 offspring born to control diet mothers at birth (0D) versus 7 day old siblings from the 
obese group (7DsO).  (B) p<0.05 statistical analysis of 7 day old offspring born to control fed 
mothers (7DsO) versus 7 day old NR sheep (7DsNR-O). (C) p<0.05 Statistical analysis of 30 day of 
offspring born from control mothers versus 7DsO. (D)  Newborn offspring born to control fed 
mothers (0D) versus one year old lean sheep. * p<0.05 Statistical significance between the offspring 
born to mothers exposed to nutrient restriction and those born to mothers fed to appetite at 1 year 
of age.      
             
5.3.3.2 Regulation of genes associated with adipose tissue remodelling and 
collagen deposition 
Obesity resulted in a down regulation of VEGF-A mRNA expression at one year 
of age (Table 5.1), irrespective of prenatal diet. Gene expression of iNOS was 
significantly up-regulated by obesity but this effect was amplified in offspring born to 
NR mothers (p<0.05; Fig. 5.4). Histological staining by the Masson trichrome technique 
showed clear evidence of the deposition of collagen peptides on the areas of crown-like 
structures, together with infiltration of immune cells or division of adipose stroma 
indigenous cells (Fig. 5.5). 
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Figure  5.5 Representative histological sections obtained from perirenal adipose tissue (PAT) 
stained by Masson trichrome technique. A) Perirenal adipose tissue of a lean subject. B) PAT of 
obese offspring born to mothers fed standard diet during gestation without crown-like structure. C) 
PAT from obese offspring exposed to maternal nutrient restriction showing an early adipocyte 
dysfunction. D) PAT from an obese offspring born to appetite fed mother at the site of the death 
adipocyte apparent showing collagen deposition (green) surrounded by infiltrating or dividing 
stroma cells (red). E) Advanced crown-like structure observed on obese nutrient restricted sheep. 
Note the extensive collagen deposition (green-blue) and large number of infiltrating or dividing cells 
(red), which is evidence of adipose tissue remodelling (Magnification X 20). 
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5.3.3.3 Regulation at gene expression of receptors belonging to the IGF-GH axis 
Obesity, in addition to maternal nutrient restriction, resulted in a trend towards 
low mRNA expression of growth hormone receptor (p=0.079; Fig. 5.6)). However, at 
one year of age, after 9 months exposure to an obesogenic environment, the gene 
expression of IGF-1 receptor was similar in obese and lean animals (Table 5.1). 
 
 
 
 
 
 
 
 
Table 5.1  IGF-1 plasma concentration at six months of age, mRNA abundance of 
IGF-1R and VEGF-A at one year of age and the total rate of weight  increase in 
lean and obese juvenile offspring, born to mothers either exposed to nutrient 
restriction during early to mid gestation or fed to appetite throughout pregnancy  
 
* Statistical significance in lean group vs. both obese groups, regardless of maternal diet 
 
41. 00±2.08 61.74±1.68* 60.08±1.80* P<0.05Weight at six months (kg)
Increase weight increase 
(AUC- kg/month) 416± 34.52 617±13.36* 610±13.36* P<0.05
VEGF-A (2ǻ&7) 1.00± 0.26 0.45±0.11* 0.33±0.09* P<0.05
IGF-1R (2ǻ&7) 1.00±0.19 1.28±0.17 1.43±0.18 NS
IGF-1(ng/ml) 6.31±0.48 16.92±3.55* 13.09±1.06* P<0.05
Parameter Lean Obese NR-Obese group P
Figure 5.6 Data expressed as 
mean ± SEM. It shows the 
influence of pre-natal nutrient 
restriction and postnatal obesity 
on the gene expression of GHR in 
the perirenal adipose tissue. 
Statistics are p= 0.079 Obese 
versus NR-Obese group.  
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5.4 Discussion 
The main finding of this part of my thesis is that the gene expression of DNMT-1, 
an enzyme involved in cellular differentiation increases in parallel to adiposity within 
the perirenal adipose tissue during the first 30 days of postnatal life. Importantly, the 
mRNA abundance of this gene strongly declines in juvenile offspring and it is not 
influenced by obesity per se. Therefore, it follows a similar  pattern of adipogenesis, as 
described in humans (Spalding et al., 2008). Furthermore, I also observed that, in 
offspring exposed to maternal nutrient restriction, the gene expression of DNMT-1 was 
further raised at one week of age compared to those offspring born from mothers fed ad 
libitum throughout gestation, without any change in fat mass. Interestingly, this 
adaptation persisted up to in one year of DJH DIWHU QLQH PRQWKV¶ H[SRVXUH WR DQ
obesogenic environment. In addition, in those offspring born to NR mothers, it was 
accompanied by several hormonal and histological changes in the adipose tissue in 
response to exposure to an obesogenic environment (Sharkey et al., 2009). These 
include an elevation in plasma leptin and cortisol at six months of age whilst at one year 
of age, the appearance of cytotoxic stressors within adipose tissue, such as CLS, which 
might be linked to increases in lipid ectopic deposition observed in the kidneys, heart 
and liver of these animals (Chan et al., 2009; unpublished observation). Overall, these 
results suggest the strong possibility that maternal nutrient restriction produced a 
different adipose tissue phenotype, which accelerated the process of  adipocyte  
maturation when these NR offspring are exposed to an obesogenic environment 
(Sharkey et al., 2009; Chapter 4). 
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5.4.1 DNMT-1 gene expression and its possible role in adipocyte development 
Although the function of DNMT-1 in the adipose tissue remains to be elucidated, 
one putative role is in adipogenesis (Takebayashi et al., 2007; van Beek et al., 2008). It 
is essential for cell replication, as it is primarily responsible for copying methylation 
patterns after cell mitosis (Leonhardt et al., 1992; Takebayashi et al., 2007). Previous 
analysis has revealed an increase in gene expression of DNMT-1 during the process of 
adipocyte differentiation (van Beek et al., 2008). It was demonstrated recently that the 
role of DNMT-1 in the process of adipocyte differentiation is mediated through the 
formation of a complex with pRB (Robertson et al., 2000; Hansen et al., 2004; Dali-
Youcef et al., 2007). Thereby, DNMT-1 may be involved in one of the first molecular 
events occurring in adipocyte differentiation, the activation of C/EBP-ȕ DQG į, and 
initiation of the transcriptional cascade that results in the deposition of lipids, and which 
drives these cells to maturity (Cao et al., 1991; Chen et al., 1996; Richon et al., 1997; 
Wu et al., 1999). Gene expression of DNMT-1 appears to increase gradually during the 
first month of postnatal life in ovine adipose tissue. It may therefore follow the 
characteristics of adipocyte differentiation, including lipid accumulation and, in turn, the 
subsequent rise in the weight of the perirenal fat depot. Importantly, gene expression of 
DNMT-1 then declines up to one year of age and the expression of this gene is not 
affected by obesity per se. This may be possible because pBR has opposing roles during 
the adipocyte life cycle, which are independent of DNMT-1; pRB can interact with other 
proteins including PPAR-Ȗ UHSUHVVLQJ DGLSRVH GLIIHUHQWLDWLRQ DQG LQGXFLQJ FHOO DUUHVW
(Cram et al., 1998; Fajas et al., 2002). Thus, due to this role in cell differentiation, the 
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mRNA abundance of DNMT-1 may reflects certain similarities with the process of 
adipogenesis (Spalding et al., 2008). 
5.4.1.1 Evidence for changes in adipocyte maturation rate induced by maternal 
nutrient restriction 
As seen as in Chapter 3, at birth and at one week of age, there were no major 
morphometric differences observed between offspring born to control fed or nutrient 
restricted mothers. During this first week of postnatal life, the majority of changes 
observed in adipose tissue with maternal nutrient restriction were primarily at the level 
of gene expression. This extensive analysis included several other tissues, such as 
hypothalamus, kidney, liver skeletal muscle and heart (Sebert et al., 2009).  
The only hypothalamic gene of those tested previously by Serbert et al. that was 
shown to be affected by maternal nutrition at 7 days of age was the neuropeptide Y 
(NPY), leading to a reduction in mRNA abundance (Sebert et al., 2009). In the 
hypothalamus, NPY controls the appetite regulating network by stimulating food intake 
and its activity is enhanced by glucocorticoids and inhibited by leptin, thereby 
suppressing appetite (Schwartz et al., 1996; Pinto et al., 2004; Kuo et al., 2007). 
Importantly, immunohistological analysis demonstrated that leptin secretion increases in 
parallel to maturation of adipocytes (Bornstein et al., 2000). Unfortunately, Sebert et al. 
was unable measure the concentration of leptin in plasma at seven days of age (Sebert et 
al., 2009). However, the reduction in mRNA abundance of NPY in the hypothalamus in 
neonatal animals born to maternal nutrient restricted mothers could be mediated be an 
increase in plasma leptin (Sebert et al., 2009). This is in agreement with the current 
hypothesis that increased DNMT-1 mRNA abundance is associated with enhanced 
   
195 
 
adipocyte development. Further evidence of an alteration in the adipose tissue function 
induced by maternal nutrient restriction during early neonatal life has been demonstrated 
by the reduction in mRNA abundance for both IGF-2 and its receptor (Chapter 3).  
Additionally, differing plasma concentrations of leptin and cortisol also point 
towards metabolic alterations in the adipose tissue induced by maternal NR. At six 
months of age, plasma leptin was increased in all obese animals but this adaptation to 
increased fat mass was enhanced in those offspring exposed to in utero maternal nutrient 
restriction. Another significant outcome in the obese offspring exposed to maternal 
nutrient restriction after three month exposure to an obesogenic environment was an 
increase in plasma cortisol concentration. This effect may be mediated as inhibitory 
feedback, resulting from a potential rise in sympathetic activity induced by leptin 
(Malcher-Lopes et al., 2006). Furthermore, 6 months later, no differences in body mass 
were found in either obese group and they also showed similar increases in weight gain 
(Sharkey et al., 2009). Finally, these changes in adipocyte development may have 
profound implications in later life, as extreme obesity and the subsequent 
hyperleptinemia are associated with the appearance of cytotoxic stress markers on 
adipose tissue, such as CLS, influencing lipid deposition and dysfunction in other 
tissues, including the kidney (Cinti et al., 2005; Kolak et al., 2007; Deji et al., 2009). 
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5.4.2 The effects of maternal nutrient restriction in adipose tissue remodelling in 
juvenile obese sheep 
$IWHU QLQH PRQWKV¶ H[SRVXUH WR DQ REHVRJHQLF HQYLURQPHQW DOO RIIVSULQJ
irrespective of the prenatal nutritional environment exhibited a similar increase in 
plasma concentrations of leptin, FFA and triglycerides compared with the lean animals 
although plasma insulin concentrations  were further raised in offspring born to nutrient 
restricted mothers (Williams et al., 2007; Sebert et al., 2009). In contrast, differences 
between the two obese groups within their adipose tissue were apparent both 
morphologically and at the level of gene expression. Recently, Sharkey et al., using the 
same animal model, showed that maternal nutrient restriction in addition to exposure to 
an obesogenic environment induced an activation of the unfolded protein response 
(UPR). This adaptation is characterised by the induction of endoplasmatic reticulum 
stress, which might promote infiltration of macrophages and ultimately induced adipose 
tissue remodelling (Roll et al., 1991; Cinti et al., 2005; Sharkey et al., 2009). Thereby, 
the increased presence of CLS may explain the rise in gene expression of iNOS and 
other factors associated with the inflammatory response also observed by Sharkey et al. 
such as CCR-2 (CC chemokine receptor-2), particularly within the adipose tissue of the 
NR-O group (Sharkey et al., 2009).  
In addition to their role in immunity, macrophages are able to promote vascular 
remodelling and hypoxia plays a pivotal role in this adaptive response (Hosogai et al., 
2007; Duffield et al., 2008). As observed in the present animal model, the adipocytes of 
both obese groups became equally hypertrophic, which might limit their capacity for 
oxygen diffusion, leading to cell death (Cinti et al., 2005; Hosogai et al., 2007; Sharkey 
   
197 
 
et al., 2009). Importantly, hypoxia has been reported to induce endoplasmatic reticulum 
stress as an initial pathway for cellular adaptation, triggering the process of angiogenesis 
(Fukumura et al., 2003; Hosogai et al., 2007). Adipocyte necrosis, as demonstrated by 
Strissel et al., is associated with matrix deposition and the cell differentiation. This may 
explain the increase in abundance of DNMT-1 mRNA as observed in the NR-O group 
compared with the O group (Strissel et al., 2007). A recent in vivo study, based on 
histological examination of adipose tissue, demonstrated that angiogenesis in obesity 
requires a coordinated action between macrophages, differentiating adipocytes, stroma 
and blood cells (Nishimura et al., 2007). This close interplay forms angiogenic 
microenvironments within the adipose tissue, which are found to occur in parallel to 
CLS at the early stages of obesity (Nishimura et al., 2007). Importantly, inside these 
clusters is an increase of VEGF-A protein abundance and its inhibition with anti-VEGF 
antibodies not only reduces angiogenesis, but also inhibits adipogenesis in obesity 
(Nishimura et al., 2007). Tumour cells are also exposed to hypoxia and reticulum 
endoplasmatic stress with their survival also depending on angiogenesis, of which a 
critical mediator in tumour vascular development is also VEGF-A (Abcouwer et al., 
2002). However, it was observed in wild-type endothelial cells, that VEGF-A is 
inhibited at gene expression level by RNAse enzymes, when UPR is activated by 
hypoxia or glucose deprivation. In addition, tumour cells undergo a series of DNA 
mutations and epigenetic changes before starting the process of vascularisation (Drogat 
et al., 2007); however to date, such a mechanism has not been demonstrated to occur in 
adipocytes (Drogat et al., 2007; Nishimura et al., 2007). Under those circumstances, the 
adipose tissue cells may depend on macrophage activation for the induction of 
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angiogenesis, however, due to the low level of mRNA abundance of VEGF-A this 
process may have been inhibited, which explains the possible decline in adipogenesis 
observed in obese adults (van Harmelen et al., 2003; Strissel et al., 2007).                  
One particularly interesting outcome from my study was that the obese offspring 
born to nutrient restricted mothers showed a tendency to exhibit low GHR mRNA 
abundance, when compared to obese offspring born from control-fed mothers at one 
year of age. This may be indicative of differences in adipocyte metabolism (Asada et al., 
2000). Further illustration was the fact that the adipocyte size was similar in both obese 
groups, regardless of maternal diet during gestation, whilst there were substantial 
increases in cytotoxic stressors on the adipose tissue of the NR-O compared with that of 
the O group (Sharkey et al., 2009). Importantly, several authors have demonstrated that 
the number of CLS is positively correlated with increased adipocyte size in obese 
humans and rodents (Clement et al., 2004; Cinti et al., 2005). Thus, a reduction in gene 
expression of GHR might predispose the adipose tissue to abnormal lipid metabolism, 
leading to cell hypoxia and cell necrosis (Asada et al., 2000; Hosogai et al., 2007; 
Ukropec et al., 2008). 
In addition, adipose tissue dysfunction is associated with an increase in 
triglyceride content in non-adipose organs, such as the liver of extremely obese humans 
(Kolak et al., 2007). Free lipid droplets released from necrotic adipocytes are a source of 
toxic fatty acids that could not only damage other white adipocytes but also peripheral 
organs, including the kidneys (Kolak et al., 2007). Zager et al. recently reported that 
renal cortical accumulation of non-saturated free fatty acids, such as triglycerides, is a 
normal cell mechanism that may confer a certain degree of cellular resistance in 
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response to a toxic challenge (Zager et al., 2007). In the present model of obesity, a 
substantial increase in triglyceride incorporation was observed in several tissues, 
including the kidneys, liver and heart of obese offspring born to NR mothers (Chan et 
al., 2009). Compromised renal function was observed in all juvenile obese sheep, 
however in obese maternal nutrient restricted offspring, enhanced ectopic lipid 
deposition and tissue remodelling in the kidneys coincided with a substantial decrease in 
renal apoptosis compared with the obese group (Williams et al., 2007; Chapter 4). Thus, 
the increase in crown-like structures and inflammation of the adipose tissue may induce 
a series of local events, such as adipocyte necrosis, proliferation of inflammatory cells 
and remodelling of the adipose tissue. Systemic events may also be initiated, including 
increased lipid accumulation in non-adipose tissues. These might be indicative of 
different stages in the adaptation to the toxic effects induced by obesity (Kolak et al., 
2007; Strissel et al., 2007; Chan et al., 2009). 
5.5 Summary 
In this study it was observed that maternal nutrient restriction targeted  between 
early to mid gestation altered the expression of central genes related to white and brown 
adipocyte differentiation during early neonatal life, such as DNMT-1 and IGF-2 (see 
also Chapter 3). Interestingly, the over-expression of DNMT-1 persisted in juvenile 
PDWHUQDOQXWULHQWUHVWULFWHGRIIVSULQJHYHQDIWHUQLQHPRQWKV¶H[SRVXUHWRDQREesogenic 
environment. This was not the case in obese offspring born from mothers fed ad libitum. 
The importance of DNMT-1 is that it has a major role in terminal differentiation, 
replicating the DNA methylation motif after cell division (Rai et al., 2006). In addition, 
changes in the epigenome have been recently associated with susceptibility to metabolic 
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complications linked with obesity in adulthood (Dolinoy et al., 2006). In my study, 
during the first month of neonatal life there was an increase in DNMT-1 mRNA 
abundance in offspring born to control fed mothers, followed by a substantial elevation 
in the weight of perirenal fat. At one year of age, the expression of this gene had 
strongly declined and was not affected by obesity per se. These results suggest a 
potential role for DNMT-1 in adipocyte differentiation. At 6 months of age, which 
LQFOXGHGPRQWKV¶H[SRVXUHWRDQREHVRJHQLFHQYLURQPHQWDOOWKHREHVHDQLPDOV were 
equally overweight compared with the lean group. As seen in humans, an increase in 
plasma leptin was observed but this adaptation was amplified in offspring born to 
nutrient restricted mothers, indicating a difference in adipocyte adaptation to nutrition 
intake (Bornstein et al., 2000; Farooqi et al., 2002). Indeed, at one year of age, when the 
adipose tissue of both obese groups was compared, different developmental adipocyte 
characteristics were found in those offspring born from nutrient restricted mothers. This 
may be related to a limited storage capacity for excess lipid. The perirenal adipose tissue 
of the NR-O group exhibited the formation of crown-like structures and signs of an 
inflammatory response, which might be associated with a reduction in oxygen cellular 
diffusion (Hosogai et al., 2007; Sharkey et al., 2009). These events are of significant 
importance for evaluating the phenotype of mature adipocytes, whereas the cells of both 
obese groups, regardless of maternal nutrition during gestation, were similar in size and 
number (Sharkey et al., 2009). Therefore, these results indicate that the change in gene 
expression of DNMT-1 induced by the in utero nutritional environment may have a 
significant effect in the final adult adipocyte phenotype (Fig. 5.7). 
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Figure 5.7  Schematic summary of findings of this chapter. 
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Chapter 6 ± Conclusion 
 
 
6.1 Previous studies of the effects of maternal nutrient restriction during 
gestation and their influence on this investigation 
Many publications, from the pioneering 1934 publication by Kermack et al. until 
today, including later epidemiological research of the studies of non-transmittable 
diseases, support the concept that maternal welfare and early life nutrition influence 
adulthood health outcome (Kermack et al., 2001; Stettler et al., 2005; Olson et al., 
2008). In addition, different animal models have validated the role of the gestational 
environment as an important factor in the development of metabolic associated diseases 
in later life (Gardner et al., 2004; Bispham et al., 2005). Over the past two decades, 
research in this area has determined some of the maternal mechanisms by which an 
alteration in nutrition during gestation leads to long term life consequences for  
offspring (Jaquiery et al., 2006; Hyatt et al., 2007; Rumball et al., 2008). Important 
conclusions from these detailed investigations include an understanding of the molecular 
and physiological mechanisms, which alter the metabolism of these offspring, leading to 
a decline in renal-cardiovascular function (Gardner et al., 2004; Gopalakrishnan et al., 
2004). The present thesis incorporates another factor in this field: the induction of 
obesity and patterns of adaptation in renal tissues, including the interaction of the 
kidneys with the surrounding adipose tissue in a population exposed to maternal nutrient 
restriction during the period of maximal organogenesis. This is an emerging area of 
interest owing to the increasing prevalence of obesity worldwide in recent years and its 
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association with the development of renal disease (Iseki et al., 2004). Thus, the 
modulation induced by the changes in maternal-fetal nutrient supply during early to mid 
JHVWDWLRQWRGD\VWHUP§GD\VVKHHSPD\DOWHUWKHPHWDEROLFSKHQRW\SHRI
those offspring, influencing a different pattern of adaptation to obesity in comparison to 
obese sheep born to mothers  fed to appetite (Williams et al., 2007; Sharkey et al., 
2009). 
6.2 Effects of maternal nutrient restriction in early to mid gestation on renal and 
perirenal adipose tissue 
Previously, Williams et al., using the same obesogenic animal model as  my study, 
observed that juvenile obesity in sheep, regardless of maternal diet during gestation, 
follows a similar pattern to that seen in humans:  chronic hyperleptinemia, hypertension 
and a reduction in vascular-renal functions (Chagnac et al., 2000; Williams et al., 2007). 
However, the Williams et al. investigation found that the common molecular pathologic 
markers associated with renal dysfunction, such as responses to pro-inflammatory 
cytokines, angiotensin II and the induction of apoptosis, were apparently reduced in 
obese offspring born to NR mothers (Henegar et al., 2001; Rea et al., 2006; Williams et 
al., 2007). Subsequent examinations under similar experimental conditions have shown 
different patterns of adaptation in the adipose tissue surrounding the kidneys of both 
obese groups (Sharkey et al., 2009). Therefore, exposure to maternal nutrient restriction 
in one year old obese sheep had influenced an increase in pro-inflammatory markers 
within the adipose tissue in relation to juvenile obese offspring born to control fed 
mothers (Sharkey et al., 2009).  
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Therefore, my experimental studies were undertaken to elucidate possible early 
developmental differences, induced by maternal nutrient restriction in offspring kidneys 
and surrounding adipose tissue, by seven days postnatal age.  
At the end of the first week of postnatal life, measured physiological parameters in 
these NR offspring had not significantly altered, compared with those offspring born to 
mothers who were fed to appetite. Possibly for that reason, only small changes were 
induced by maternal nutrient restriction in the renal tissues. These included a decrease in 
the mRNA abundance of the growth hormone receptor and a significant reduction in 
oxidative stress (Chapter 3). However, this alteration in prenatal nutrition induced 
changes in genes associated primarily with adipocyte differentiation in the perirenal 
adipose tissue. At seven days of age, a decrease in mRNA expression of IGF-2 and its 
receptor was observed in perirenal adipose tissue of offspring exposed to maternal 
nutrient restriction. The activity of these genes is linked to the development of brown 
adipocytes throughout the interaction with prolactin receptors (Viengchareun et al., 
2008). An additional gene affected by maternal nutrient restriction in this fat depot was 
DNA methyltransferase-1 (DNMT-1), whose mRNA abundance increased in the 
perirenal adipose tissue of those offspring exposed to prenatal undernutrition. DNMT-1 
is involved in cell differentiation and lipid accumulation in white fat cells (Hansen et al., 
2004; Dali-Youcef et al., 2007; van Beek et al., 2008a).  
The changes in activity of DNMT-1 and IGF-2 may have both short and long term 
metabolic consequences. For instance, alterations in the expression of these genes could 
affect the production of leptin by adipose tissue and its action in appetite regulation, 
may explain the different hypothalamic NPY mRNA abundance observed during at this 
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age between both prenatal nutritional groups. (Schwartz et al., 1996; Sebert et al., 
2009). In the long term, such changes in gene expression within the adipose tissue may 
underlie differences in metabolic adipocyte function and the subsequent ectopic lipid 
deposition in non-adipose tissues, seen at one year of age in both obese groups (Sharkey 
et al., 2009; Chan et al., 2009). 
6.3 Effects of obesity in renal tissue of young sheep exposed to maternal nutrient 
restriction between early to mid gestation 
The present study describes some of the different renal adaptations induced by 
exposure to an obesogenic environment in both prenatal nutritional groups of offspring. 
In utero nutrient restriction, followed by nine months exposure to an obesogenic 
environment in young sheep, results in a different regulation of the proliferative -
apoptotic pathways in renal tissues, - a common characteristic of processes associated 
with tissue dysfunction, scarring and healing (Abrass et al., 1995; Verrecchia et al., 
2002; Zager et al., 2007). The kidneys of both obese groups showed major similarities 
that are associated with a reduction in renal function: an increase in collagen deposition 
and oxidative stress compared with the renal tissues of the lean group (Han et al., 2001; 
Chen et al., 2004). However, both obese groups differed in the predominant adaptive 
process observed in the kidneys. In my study, as in the findings of Williams et al., an 
increase in cell renal apoptosis was also observed, possibly catalysed by the deposition 
of iron in offspring born to appetite fed mothers (Ishizaka et al., 2002; Williams et al., 
2007). On the other hand, in those maternal nutrient restricted obese offspring, cell 
proliferation or cell hypertrophy appears to be the predominant process, which may be a 
consequence of past renal injuries or dysfunction induced by the fast weight gain (Praga 
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et al., 2001). Whereas detailed  analysis of the renal cortex of NR obese sheep indicated 
that there was an increase in triglyceride ectopic deposition, this may be a post-injury 
response to toxic exposure and a mechanism possibly linked to cell survival 
(Listenberger et al., 2003; Zager et al., 2007).  Whilst this cellular mechanism serves as 
an adaptation that could reduce temporary cell apoptosis, it may also lead to other forms 
of cell dysfunction commonly seen in renal tissue, including mesangial hyperplasia and 
podocyte hypertrophy (Berfield et al., 2002; Wiggins et al., 2005; Berfield et al., 2006). 
Given these considerations, I speculate that obese subjects exposed to maternal nutrient 
restriction may pass through a similar pro-apoptotic stage, as seen as in the kidneys of 
those obese offspring born to control fed mothers. This interpretation of the present 
findings is also compatible with the grade of dysfunction observed in other tissues in 
this animal model, which may be a consequence of the level of dysfunction observed in 
the surrounding adipose tissue (Sharkey et al., 2009; Chan et al., 2009). 
6.4 The influence of the adipose tissue development on renal adaptation in 
maternal nutrient restricted offspring after exposure to juvenile obesity  
As previously seen by Williams et al., the kidneys of both obese groups showed 
important morphological and functional similarities, associated mainly with the adverse 
conditions induced by exposure to an obesogenic juvenile environment. However, 
indices of renal pathology, such as expression of factors associated with inflammation, 
elements of the RAS and cells apoptosis were reduced in obese NR offspring. 
Interestingly, this renal adaptation was accompanied by an accumulation in 
triglycerides, Listenberger et al. have suggested that a physiological response by non-
adipose cells represents a temporary protection against the toxic effects of certain lipid 
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derivates (Listenberger et al., 2003). These cytotoxic metabolites may be released by 
necrotic adipocytes, forming a pathological hallmark of severe obesity (Cinti et al., 
2005; Kolak et al., 2007). Sharkey et al. observed that exposure to an obesogenic 
environment in juvenile maternal nutrient restricted offspring increases the markers of 
cellular stress within the adipose tissue compared with those offspring born to mothers 
fed to appetite (Sharkey et al., 2009). Therefore, the hypothesis of my study was to 
elucidate the means by which maternal nutrient restriction, under the experimental 
conditions applied in this animal model, affects the mechanisms associated with 
adipocyte maturation. These alterations may induce several changes, including alteration 
in the secretion of hormones and also in the expression of genes associated with the cell 
cycle and the function of adipocytes over a period of time.  
The main finding of my study is that, in the adipose tissue of those offspring 
exposed to maternal nutrient restriction, there may be an alteration in the process of cell 
differentiation, the most important feature of which is the increase in mRNA abundance 
of the methyltransferase DNMT-1. The ontogeny of this gene reveals that, during the 
first month of neonatal life, there is a time dependent rise in the mRNA abundance of 
DNMT-1 in the adipose tissue surrounding the kidneys. At juvenile age, the mRNA 
abundance of this gene strongly declines and is not influenced by obesity per se, thus 
following a similar pattern seen in adipogenesis in humans (Spalding et al., 2008). In 
addition, exposure to an obesogenic environment in those offspring born to nutrient 
restricted mothers induced more acute hormonal, histological and inflammatory 
responses compared with the obese group. These include an elevation in leptin and 
cortisol at six months of age and the appearance of markers of cellular stress within the 
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adipose tissue, such as an increase in the mRNA abundance of iNOS (an inflammatory 
associated gene) and an increase in the frequency of necrotic adipocytes at one year of 
age (Soukas et al., 2000; Cinti et al., 2005; Sharkey et al. 2009). Furthermore, in 
perirenal adipose tissue, the gene expression of DNMT-1 is enhanced in offspring 
exposed to an obesogenic environment following maternal nutrient restriction, 
suggesting evidence of some adipose tissue remodelling or cell differentiation (Rai et 
al., 2006; Strissel et al., 2007; van Beek et al., 2008). 
Several authors have described the link between the inflammation and infiltration 
of macrophages in adipose tissue of older obese animals but little is known about the 
role that both processes play during obesity (Cinti et al., 2005; Strissel et al., 2007). In 
adipose tissue, macrophages may interact with stroma cells, promoting angiogenesis and 
tissue remodelling under a specific angiogenic microenvironment in the area 
surrounding the necrotic adipocyte (Nishimura et al., 2007). The interaction of 
macrophages and stroma cells under this angiogenic environment allows the formation 
of blood vessels, improving cellular oxygen diffusion for the induction of adipogenesis 
or further enlargement of fully differentiated adipocytes (Hosogai et al., 2007; 
Nishimura et al., 2007; Strissel et al., 2007). However, a reduction in expression of the 
angiogenic gene, VEGF-A mRNA, may indicate that this process is inhibited in my 
obesogenic animal model. Therefore, the presence of matrix proteins, such as collagen 
peptides in addition to increase in expression of DNMT-1, may suggest that other cell 
types associated with tissue remodelling, other than adipocytes, are undergoing terminal 
differentiation. It is important to note that the rate of increase in weight, adipocyte 
numbers and sizes and the majority of metabolites analysed, including cortisol and 
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leptin, during this study were similar in both obese groups at one year of age (Sharkey et 
al., 2009; Sebert et al., 2009). 
Taken together, these observations suggest that maternal nutrient restriction 
influences of the development of adipose tissue by inducing acceleration in the rate of 
adipocyte maturation, possibly due a reduction in vascularisation. Finally, the chronic 
cytotoxic process, induced by the release of lipids and insoluble proteins from necrotic 
adipocytes, generates a unique adaptive-degenerative path for the kidneys and other 
surrounding organs in response to an obesogenic environment (Yang et al., 2006; Kolak 
et al., 2007; Chan et al., 2009). 
6.5 Final conclusions 
Despite the many confounding factors induced by exposure to obesity, the current 
results indicate that a reduction in maternal nutrition supply during early to mid 
gestation may reset the overall development of offspring perirenal adipose tissue. In 
addition, this prenatal nutritional intervention may affect other physiological responses 
linked to the development of adiposity, such as early life appetite regulation and 
hormone milieu, including the secretion of leptin and cortisol. Moreover, substantial 
changes were observed in gene expression within the adipose tissue at seven days and 
one year of age in those offspring exposed to prenatal undernutrition. Some of these 
genes, such as IGF-2 and DNMT-1, may bring to light evidence of a developmental 
alteration involving an epigenetic mechanism. Although there are clear differences 
between species, the ovine animal model is able to mimic many molecular aspects 
commonly observed in obese human dysfunction. Therefore, from the results of my 
study, it would appear that adipose tissue dysfunction influences the inflammatory stage 
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in neighbouring renal tissue. Finally, these responses in perirenal adipose tissue possibly 
lead from an initial cycle of cell apoptosis to temporary cell resistance to lipotoxity, 
characterised by an increase in lipid deposition in renal tissue, which might after all, be 
part of the same long term degenerative process. 
6.6 Future perspectives 
6.6.1 Future work in the adipose tissue 
As clear differences in gene expression of DNMT-1 have been shown here, future 
investigations of the epigenetic modifications in the perirenal adipose tissue need to 
include offspring exposed to postnatal obesity and prior maternal nutrient restriction. In 
addition, this would  enable us to estimate the importance of the inheritance of genomic 
DNA methylation and the influence of maternal nutrient restriction, as well as the later 
phenotypic changes induced by exposure to an obesogenic environment. Moreover, for 
completion of an epigenetic analysis, further methylation tests on the promoters of 
specific adipogenic genes would add to our understanding of the cell mechanisms 
involved in this model of prenatal nutrition and juvenile obesity. Finally, a combination 
of basic histology and in situ hybridisation for genes such as DNMT-1 and VEGF-A on 
perirenal adipose tissue, might help identify which types of cells are undergoing 
differentiation. This analysis would have the potential to answer important questions 
about the function of this methyltransferase on adipocyte maturation, in what is thought 
to be a highly heterogenic cell population within adipose tissue. 
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6.6.2 Future work in renal tissue 
In order to increase our understanding regarding the fundamental cellular 
mechanisms through which the accumulation of triglycerides exerts effects on renal 
tissues, further investigations are required. These should include a series of analyses to 
determine whether the lipids accumulated originate from sources exogenous or 
HQGRJHQRXV WR WKHNLGQH\7KHUHIRUHDVSHFLILFFRPSDULVRQRI WKH OLSLGV¶FRQWHQW IURP
the perirenal adipose tissue and kidneys would help to reveal the cellular process behind 
this interesting effect.  
As discussed in Chapter 2, as similar oxidative stress values were obtained in both 
obese groups, TBARS may not be the most suitable assay to perform on renal tissues. A 
more accurate marker of lipid peroxidation and oxidative stress, such as specific 
markers for MDA and protein oxidation, could provide more information. This might 
enable differentiation of the origin of oxidation and its relationship to the cellular 
mechanism involved in lipid cellular accumulation. Finally, lipid staining of renal 
histological sections and their comparison with the immuno-staining of PCNA would be 
useful to identify cell type and renal structures susceptible to lipid accumulation. 
6.7 Limitations of this study  
6.7.1 The effects of maternal nutrient restriction in lean animals 
A limitation of this study is the lack of a lean one-year-old maternal nutrient 
restricted group. However, previous studies by our research group characterised 
extensively the phenotype differences between lean animals with and without maternal 
nutrient restriction (Gopalakrishnan et al., 2004). Thus, the current hypothesis of this 
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project was limited to an examination of the effects of obesity on maternal nutrient 
restricted offspring and their patterns of renal adaptation. Therefore, a future 
investigation using tissues from lean one-year-old animals, who had experienced 
maternal nutrient restriction during the same period of gestation, would strengthen the 
outcome of the present study and, importantly, would allow detailed comparisons to be 
conducted using this control group. 
6.7.2  The effects of gender on maternal nutrient restriction and obesity 
The role of gender has not been addressed in the present study. Some authors have 
noted that exposure to the prenatal in utero environment can  induce specific gender 
effects, particularly in hypertension and insulin sensitivity (Ozaki et al., 2001; Poore et 
al., 2007). For instance, male rats exposed to maternal nutrient restriction are more 
susceptible to a reduction in nephron number, changes in RAS function and 
hypertension than female dams (Woods et al., 2004). Nevertheless, obesity per se in 
humans is a factor independent of gender, but there are minor regional differences in 
adipose tissue metabolism in females (Chen et al., 2003; Tchernof et al., 2006). 
Unfortunately, in my study it was not possible to measure specific gender effects, as the 
study was not powered to address this question. The gender imbalance occurred by 
chance, as the initial nutritional intervention at early gestation (at 30 gestational days; 
WHUP§GD\V UHTXLUHG WKDW WKHPRWKHUVwere randomised and it was impossible to 
know the gender of the fetus at this stage of pregnancy. As described in Chapter 3, 
similar renal characteristics were observed, including nephron number, in both groups of 
offspring at seven days, regardless of maternal nutrition. Several parameters influenced 
by gender, such as blood pressure, renin-angiotensin responses and renal function, as 
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assessed by Williams et al., deteriorated in a similar manner in both obese groups after 
exposure to an obesogenic environment (Williams et al., 2007). Furthermore, the rate of 
increase in body weight over time and the amounts of oxidative stress at systemic or 
renal level were also similar between both obese groups. I am aware that some 
parameters analysed during this investigation were possibly affected by gender. 
Nonetheless, it seems likely that gender has not played a significant role in this 
particular obesogenic animal model of maternal nutrient restriction.  
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Appendices 
 
A. Abstracts, original presentation and conferences attended  
 
Fainberg HP, Gardner DS, Sinclair KD, Budge H, Symonds M.E (2009) - In-utero 
nutritional programming of kidney development and its long term impact on renal 
oxidative stress following juvenile obesity 
Oral presentation- Main Meeting of the Physiological Society, Dublin, RoI, July 2009 
 
Maternal nutrient restriction, coincident with early fetal kidney development, can increase 
glucocorticoid action in the newborn kidney. Fetal adaptations in the kidney may also determine 
the long term consequences following juvenile obesity and the onset of hypertension. One 
important mechanism implicated in both obesity and renal disease is enhanced oxidative stress, 
leading to glomerulosclerosis. Two key regulators of this process are the angiogenic hypoxia 
inducible factor-ĮDQGWKHSUR-apoptotic receptor Fas. The present study, therefore, examined 
how the early in-utero diet results in renal adaptations to oxidative stress induced by juvenile 
obesity.  
Pregnant sheep (n=26) were randomly assigned to a normal (7 MJ/day) or nutrient restricted diet 
(NR, 3.5 MJ/day), from 30-80 days of gestation (term = 147 days) and fed to requirements at all 
other times. After weaning, the NR (NR-O, n=11) and obese (O, n=7) offspring were reared in 
an obesogenic environment to promote fat deposition. The lean group (L, n=8) remained out to 
pasture. At one year of age, all sheep underwent measurements of plasma cysteine concentration 
and were then humanely euthanased with kidneys sampled for renal malondialdehyde (MDA) 
concentrations and real-time gene expression of the Fas and HIF-ĮJHQHV 
Obesity raised the total plasma cysteine (L 12.8±1.1; O 18.3±1; NR-O 18±1.6 (p<0.05)) and 
intra-renal (i.e. MDA) oxidative stress in both obese groups. In addition, although gene 
expression of HIF-ĮDOVRLQFUHDVHGZLWKREHVLW\WKLVUHsponse was amplified in offspring born 
to NR mothers (L 1±0.285; O 1.964±0.552; NR-O 5.353 ±1.025 2-ǻ&T) (p<0.05)), whereas 
mRNA abundance for Fas was reduced (NR-O 1.89±1.56; O 4.68 ±1.72 2-ǻ&T) (p<0.05)). 
Our study suggests that abnormal patterns of renal adaptation are induced by juvenile obesity in 
NR offspring, with persistent changes in markers of oxidation. We have, therefore, shown, for 
the first time in this model of fetal programming, that increased systemic and renal oxidative 
stress alters the gene regulation of angiogenic and pro-apoptotic genes such as HIF-ĮDQG)DV
These differential adaptations may delay the onset of glomerulosclerosis without necessarily 
improving vascular function.                      
 
 
 
   
252 
 
Fainberg HP, Saeed A, Gardner DS, Budge H, Symonds ME (2008) - Differences in 
renal adaptation to oxidative stress in juvenile offspring, following maternal nutrient 
restriction 
Poster presentation- Beijing Joint Conference of Physiological Sciences, Beijing China, 
October 2008 
  
Introduction 
The gestational diet of offspring modulates environmental adaptation, altering renal oxidative 
stress (OxS). We demonstrated that maternal nutrient restriction (NR) from early to mid-
gestation decreases apoptosis in renal cells, common in obesity associated with 
glomerulosclerosis1. This study follows the effects of renal growth hormone receptor (GHR) on 
OxS in newborn sheep, following early obesity.  
Methods 
Pregnant twin-bearing sheep (n=18) were randomly assigned to normal (C, 7 MJ/day) or nutrient 
restricted diets (NR, 3.5 MJ/day), from days 30 to 80 gestation and fed to requirements to term 
(147 days). One twin from each mother was euthanased after seven days. All kidneys were 
collected and analysed for expression of the pro-apoptotic p53 and GHR genes and 
malondialdehyde (MDA) concentrations. Procedures conformed to U.K. legislation. 
Results 
MDA concentrations were higher in the C group (C 2.465 SE 0.180; NR 1.764 SE 0.102, [MDA 
µM]/ [protein µg/µl] (p<0.05)). NR reduced the expression of GHR (C 1.00 SE 0.12; NR 0.54 
SE 0.12, 2-ǻ&7 (p<0.05)) whilst p53 expression was similar. 
Conclusions 
Low concentrations of MDA found in NR animals may result from GHR down regulation, 
which controls the expression of several antioxidant enzymes. Decreased OxS in the NR group 
was unconnected to reduced apoptotic markers, like p53. This may reduce glomerulosclerosis, 
protecting NR offspring from renal damage induced by early obesity, as previously 
demonstrated. 
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Fainberg HP, Saeed A, Gardner DS, Budge H, Symonds ME (2008) - Evidences in the 
reduction of renal oxidative stress in offspring of nutrient restricted sheep, following 
juvenile obesity  
Poster Presentation - Nutrition Society Annual Summer Meeting, Nottingham UK, July 
2008 
 
Obesity is associated with an increase in reactive oxygen species (ROS), and the development of 
renal damage. We have previously demonstrated that exposure to a period of maternal nutrient 
restriction (NR), between early-to-mid gestation, prevents the occurrence of glomerulosclerosis 
that follows juvenile obesity. The aim of this study was to elucidate whether this adaptation is 
accompanied by a reduction in renal ROS production. 
Pregnant sheep (n=26) were randomly assigned to a normal (7 MJ/day) or nutrient restricted diet 
(NR, 3.5 MJ/day), from days 30 to 80 gestation (term = 147 days) and fed to requirements at all 
other times. Nutrient restricted (NR-O, n=11) and obese (O, n=7) offspring groups were reared 
in an environment of restricted activity and increased energy dense food to promote fat 
deposition and, thus, obesity following weaning at 10 weeks postnatal age. The lean group (L, 
n=8) remained out to pasture. All sheep were humanely euthanased at one year of age and 
kidneys sampled for nitric oxide (NO) determination, superoxide dismutase (SOD) activity 
measurement and immunoblotting for SOD1 and SOD2. All animal procedures had local 
Animal Ethics Committee Approval and were performed in accordance with U.K. legislation. 
SOD2 abundance showed an increase in obese offspring compared to lean animals (O 127.85 SE 
6.46; L 104.59 SE 6.46 arbitrary units (p<0.01)): whereas the SOD1 abundance was similar. 
However, the SOD activity was higher in NR-O compared with O (O 0.03 SE 0.004; NR-O 
0.059 SE 0.009 U/ml (p<0.05)). In addition, NO oxidation was lower in the NR-O, compared 
with O, offspring (O 1.562 SE 0.3; NR-O 0.866 SE 0.1 Nitrate µM/ [protein µg/µl] (p<0.05)). 
Exposure to nutrient restriction over the period of early kidney development when followed by 
juvenile obesity is associated with an increase in renal SOD activity and reduction in NO 
concentrations.  
These adaptations may reduce the production of ROS and contribute to avoidance of the early 
renal damage induced by obesity. The factors that may protect offspring born to nutrient 
restricted mothers from early-onset of glomerulosclerosis induced by obesity are currently being 
investigated. 
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Fainberg HP, Saeed A, Sébert SP, Rashid A, Gardner DS, Budge H, Symonds ME 
(2008) -   Evidence for a role for the voltage-dependent anion channel protein (VDAC) 
in the reduction of renal oxidative stress following juvenile obesity in offspring of 
nutrient restricted sheep 
Poster presentation - International Symposium Demonstrating early programming in 
human and animal models, Granada Spain, April 2008  
Renal injuries are linked to obesity through a rise in oxidative stress (OxS) and mitochondrial 
dysfunction. The voltage-dependent anion channel 1 protein (VDAC) is a critical gatekeeper 
regulating mitochondrial function able to control the cell cycle. Exposure to maternal nutrient 
restriction (NR) from early to mid-gestation reduced the number of apoptotic renal cells link to 
obesity, a feature of the development of glomerulosclerosis. This study evaluates the status of 
VDAC expression in regard to OxS in this NR ovine model. 
Pregnant sheep (n=26) were randomly assigned to a normal (7 MJ/day) or nutrient restricted diet 
(NR, 3.5 MJ/day), from days 30 to 80 gestation (term = 147 days) and fed to requirements at 
other times. After weaning, the nutrient restricted (NR-O, n=11) and obese (O, n=7) offspring 
were reared in an obesogenic environment to promote fat deposition, and thus obesity. The lean 
group (L, n=8) remained out to pasture. At one year of age, all sheep were humanely euthanased 
and kidneys sampled for the following analysis: 1) immunoblotting for VDAC, 2) real time gene 
expression of pro-apoptotic BAX and anti-apoptotic Bcl-2 as well as the endothelial (eNOS) and 
inducible (iNOS) nitric oxide synthase and 3) nitric oxide (NO) concentration. All procedures 
were in accordance with U.K. legislation, with local Animal Ethics Committee approval. 
The analysis of VDAC abundance showed a doubling (P<0.05) in NR-O compared to the O 
group whereas VDAC was similar in the lean and obese groups. The expression of BAX and 
Bcl-2 were up regulated with obesity (P<0.05) and the gene expression of iNOS and eNOS was 
similar. NO production was higher in O, compared to the NR-O (O 1.562 SE 0.3; NR-O 0.866 
SE 0.1 Nitrate µM/ [protein µg/µl] (p<0.05)). 
The rise in VDAC abundance in the NR-O may reduce the level of mitochondrial dysfunction 
induced by BAX/Bcl-2 in obesity, as suggested by reduction in NO concentrations. This 
adaptation may reduce the production of OxS and protect NR offspring from renal injuries 
induced by early onset of obesity. However, this is not related to up regulation of the NOS 
isoforms. Further analyses are needed to characterize the sources of the increase in renal NO in 
NR animals. 
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Fainberg HP, Gardner DS, Budge H, Symonds M.E (2007) - Protective Renal adaptations in 
obese young sheep exposed to maternal nutrient restriction between early to mid gestation.  
Poster presentation - 5th International Congress on Developmental Origins of Health & Disease, 
Perth Australia, November 2007 
 
AIMS 
  
Maternal nutrient restriction (NR) between early to mid gestation protects the kidney against 
later glomerulosclerosis following obesity. This study aimed to elucidate whether a defined 
period of NR prevents renal apoptosis before the onset of obesity associated kidney disease. 
STUDY DESIGN 
  
Twenty six sheep were randomly allocated into either NR, (NR, n=11, 50% metabolic energy 
requirements) or control nutrition (100 % requirements) from gestation days 30 to 80 (term ~148 
days) and to an obesogenic (O, n=7) or lean (L, n=8) postnatal environment induced by 
restricted physical activity with ad libitum feeding after weaning, or pasture, respectively.  At 1 
year of age, renal gene expression of Fas, Bax and Bcl-2 were measured using real time PCR. 
RESULTS 
  
Offspring exposed to the obesogenic environment were fatter (relative fat mass g/kg: L - 24 ± 3; 
O - 80 ± 3; NR-O - 74 ± 4 (p<0.01 compared to L).  
Values are means ± SEM; *=P<0.05, **=P<0.01 compared to L; #=p<0.05 compared to O  
 
CONCLUSIONS  
 
Obesity caused upregulation of the apoptotic pathway. Exposure to NR during fetal 
development prevented the usual increase in renal Fas expression with obesity and may act to 
prevent glomerulosclerosis.  
 
 
 
 L O NR ± O 
Fas mRNA 1.1 ± 0.4 3.3 ± 0.5** 1.4 ± 0.3# 
Bax mRNA 1.1 ± 0.3 2.5 ± 0.2* 2.4 ± 0.3* 
Bcl-2 mRNA 0.3 ± 0.1 0.8 ± 0.1* 0.7 ± 0.1 
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B. Title of publications and awards 
 
H.P Fainberg, (D.S Gardner1, H. Budge and M.E Symonds) (2010) Alterations induced 
by juvenile obesity on the renal tissue of nutrient restricted offspring  
Nutrition Society Postgraduate Symposium, Dublin, RoI, February 2010 - Winning 
paper of the Nutrition Society postgraduate competition 2010. 
   
Sébert SP, Hyatt MA, Chan M, Yiallourides M, Fainberg HP, Patel N, Sharkey D, Stephenson 
T, Rhind SM, Bell C, Budge H, Gardner DS, Symonds ME Influence of prenatal nutrition and 
obesity on tissue specific fat mass and obesity-associated (FTO) gene expression. Reproduction 
2009; [Epub ahead of print] 
Sharkey D, Fainberg HP, Wilson V, Gardner DS, Symonds ME, Budge H The impact of early-
onset obesity and hypertension on the unfolded protein response in renal tissues of juvenile 
sheep. Hypertension 2009; 53:925-31 
Sharkey D, Gardner DS, Fainberg HP, Sébert SP, Bos P, Wilson V, Bell R, Symonds ME, 
Budge H Maternal nutrient restriction during pregnancy differentially alters the unfolded 
protein response in adipose and renal tissue of obese juvenile offspring. Faseb J 2009; 23:1314-
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D. Standard buffers and stock solutions 
 
Reagents for RNA work 
Tri Reagent: Pre-made solution (Sigma-Aldrich) 
Chloroform: Used for phase separation of RNA (Fisher Scientific, UK) 
Isopropanol: Used to precipitate RNA (Fisher Scientific, UK) 
75% Ethanol: 75ml ethanol and 25 ml deionised water (RNAse free). 
Reagents for protein work  
Whole cell lysate solution: 
RIPA buffer: 1 x PBS (pH 7.4), 0.1% SDS, 1 % Igepal CA-630 (Sigma-Aldrich) and 0.5 
% Sodium Deoxycholate 
3URWHDVHLQKLELWRUVPJPO306)ȝOPORIEXIIHU$SURWLQLQ6LJPD-Aldrich) and 
100 mM Sodium Orthovanadate 
Immunoblotting (western Blotting) solutions: 
Transfer buffer: 14 g Tris-base, 7.25g glycine, 500 ml methanol, 9.25 ml 10% SDS and 
deionised H2O to 2.5 L. 
Ponceaux S dye: 2 g Ponceaux S, 30 g trichloroacetic acid (TCA), 30 g salpasalcyclic 
acid and deionised water to 100 ml (used 1 part dye to 9 parts deionised water) 
TBS: 20 mM Tris (pH 7.4), 500 mM NaCl, pH to 7.5 and deionised water to 2.5 L. 
TTBS buffer: 0.2 % Tween in TBS 
Blocking buffer:  1 % milk fat (Marvel®) in 70 ml TTBS 
Primary/Secondary antibody buffer: TTBS containing 3 % (w/v; Marvel®) and antibody 
of interest. 
Electrophoresis buffers 
DNA/RNA electrophoresis 
5 x TBE: 44 mM Tris-borate (pH 8) and 2.5 mM EDTA 
50 x TAE: 242 g Tris Base, 57.1 ml glacial acetic  acid, 100 ml  0.5 M EDTA ( pH 8) 
and made up to 1 L  using deionised water 
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Ethidium Bromide: A 5 mg/ml solution was prepared in 1 x TBE buffer 
%S'1$ODGGHUPJPO3XUFKDVHGIURP$%JHQHȝO'1$PDUNHUZDVDGGHG
WRȝORI[ORDGLQJG\HDQGȝO51$VHIUHHZDWHUȝOZDVORDGHGRQWKHDJDURVH
gel. 
1 x DNA loading dye: 30% (w/v) glycerol and (w/v) bromophenol blue. 
Protein electrophoresis (SDS-PAGE) 
 30% bis- acrylamide: pre-made solution purchased from Severn Biotech 
12% SDS-PAGE resolving gel: 6.6 ml deionised water, 8 ml bis-acrylamide, 5 ml 1.5 M 
Tris-+&OS+ȝO6'6ȝO$PPRQLXPSUHVXOSKDWH$36DQG
ȝO111¶1¶-Tetramethlylethylenediamine (TEMED). 
5% SDS-PAGE  stacking gel: 6.8 ml deionised water, 1.7 ml 30 % bis-acrylamide, 1.25 
ml 1 M Tris-+&OS+ȝO6'6ȝO$36DQGȝO7(0(' 
Protein dissociation buffer: 50 M Tris (pH 6.8), containing: 10% glycerol, 10% SDS, 
made up to 10 L with deionised water 
Gel loading dye: stock: 0.1 g bromophenol blue, 14.9 ml 0.01 M NaOH and 23.5 ml 
GHLRQLVHG ZDWHU ZRUNLQJ VROXWLRQ  ȝO VWRFN VROXWLRQ  ȝO JO\FHURO DQG  PO
deionised water 
SDS-Precision Plus ProteinTM standard: Pre-stained standard marker purchased from 
Bio-Rad 
Coomassie blue staining solution: purchased from Bio-Rad 
Reagents for immunohistochemistry 
10% Formalin sock: 100 ml (37/40%) formaldehyde (Fisher Scientific, UK) in 900 ml 
saline 
0.05 M TBS (pH 7.2-7.6) stock solution: 175.2 g NaCl, 12.12 g Tris, approx. 40 ml  M 
HCl to pH  and 2 L deionised water. This was diluted 1: 10 for use 
0.25% solution TBS/Bovine Serum Albumin (BSA): TBS-0.25% BSA 0.25 g BSA and 
PO7%62QFHPDGH WKH VROXWLRQZDV ILOWHUHG WKURXJKȝP ILOWHUV DOLTXRWHG
out into 10 ml portions and stored at -20oC until use 
0.1 M Citrate buffer (pH 6) stock solution: 29.41 g Tris-sodium citrate, 900 ml 
deionised water, pH using 1 M HCl and make up to 1 L with deionised water. This was 
diluted 1:10 for use 
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6% Hydrogen Peroxide (H2O2) in Methanol: 5 ml 30% H2O2 (sigma-Aldrich), 295 ml 
methanol. Once this solution was made up, it was stored at 4oC and use within a week 
Normal Swine Serum: This was commercially bought serum (DAKO, cat. 0901) and use 
in 1:10 dilution was made using TBS/BSA as the diluents 
6FRWW¶V7DS:DWHUJSRWDVVLXPbicarbonate, 20 g magnesium sulphate and 1000 ml 
deionised H2O 
Acid Alcohol: 99 ml 70% alcohol and 1 ml conc. HCl    
 
